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Summary 
 
Children contribute little to disease transmission and the maintenance of the tuberculosis 
epidemic, but they constitute a significant proportion of the total tuberculosis (TB) caseload 
and experience considerable morbidity and mortality in endemic areas, despite the availability 
of cheap and effective treatment.  The difficulty of diagnosing childhood tuberculosis is one of 
the major obstacles that hinder the provision of antituberculosis treatment to children in 
endemic areas.   
  
The diagnosis of childhood tuberculosis is complicated by the lack of a practical gold 
standard, as bacteriologic specimens are difficult to collect and the yield is low. In non-
endemic countries the diagnosis of childhood tuberculosis is based on the triad of: 1) 
exposure to an adult index case, 2) a positive tuberculin skin test, and 3) suggestive 
radiographic signs.   However, the triad has limited value in endemic areas where exposure to 
and/or infection with Mycobacterium tuberculosis is common, and chest radiography is rarely 
available.  The objective of this dissertation was to address the diagnostic dilemma faced by 
health professionals in endemic areas with limited resources, where children currently have 
poor access to chemoprophylaxis and antituberculosis treatment. 
 
We first clarified basic disease concepts, through a critical review of the pre-chemotherapy 
literature that documented the natural history of childhood tuberculosis.  Three central 
concepts were identified; 1) the importance of accurate case definition, 2) the relevance of 
risk stratification, and 3) the diverse spectrum of disease, which necessitates accurate 
disease classification.  The importance of accurate case definition is illustrated by the fact that 
isolated hilar adenopathy, considered the principal radiographic sign of primary tuberculosis, 
becomes transiently visible in the majority of children following recent primary infection.  Our 
analysis of the natural history of childhood tuberculosis allowed accurate quantification of the 
risk to progress to disease following primary infection with M.tuberculosis.  This demonstrated 
that the risk depends mainly on the age and/or immune-status of the child, the time since 
primary infection occurred and the presence or absence of symptoms.   
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After analysing these historic studies, we proceeded to document the burden of childhood 
tuberculosis in an endemic area.  We first conducted a retrospective study to describe current 
diagnostic practices and demonstrated almost exclusive reliance on chest radiography. We 
then calculated the burden of childhood tuberculosis in a prospective descriptive study.  The 
corrected tuberculosis incidence rate in children was 407/100 000/year and children with 
severe forms of disease, such as disseminated (miliary) tuberculosis and/or tuberculous 
meningitis, were rarely recorded in the TB treatment register used for routine community-
based surveillance.   
 
An additional obstacle to progress in the field of childhood tuberculosis has been the lack of 
standard descriptive terminology.  Following a careful review of the literature, we proposed a 
radiological classification of childhood intra-thoracic tuberculosis and explored the different 
pathologic mechanisms that underlie these diverse disease manifestations.  We then 
conducted a prospective descriptive study to document the disease spectrum in children 
treated for tuberculosis in an endemic area.  The disease patterns observed were consistent 
with those described in the pre-chemotherapy literature. In addition, we demonstrated that 
bacteriologic confirmation may be achieved in the majority of children with intra-thoracic 
tuberculosis, in highly endemic settings. 
 
Finally we developed a novel symptom-based approach to diagnose pulmonary tuberculosis 
in children from endemic areas with limited resources.  We followed a step-wise approach by 
first conducting a community-based survey to document the prevalence of symptoms 
traditionally associated with tuberculosis in a random selection of children from an endemic 
area. The survey demonstrated that poorly defined symptoms offer poor diagnostic value.  
The second step was to evaluate the diagnostic value of well-defined (persistent, non-
remitting) symptoms in a small prospective study.  Well-defined symptoms demonstrated 
good diagnostic value, but these promising results required further validation.  As a final step, 
we validated the diagnostic value of a novel symptom-based approach in a large prospective, 
community-based study.  In this study, a simple symptom-based approach diagnosed 
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childhood pulmonary tuberculosis with a remarkable degree of accuracy, particularly in HIV-
uninfected children older than 3 years of age.   
 
This novel diagnostic approach offers the exciting prospect of extending antituberculosis 
treatment to children in endemic areas with limited resources, where current treatment access 
is poor.   
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Opsomming 
 
Tuberkulose beheer programme plaas feitlik geen klem op die behandeling van kinders nie, 
omdat kindertuberkulose selde aansteeklik is en die persepsie bestaan dat kinders slegs in 
raar gevalle ernstig siek word.  Tuberkulose lewer egter ‘n betekenisvole bydrae tot 
kindermorbiditeit en mortaliteit in endemiese areas, terwyl dit ‘n maklik behandelbare siekte 
is.  Kindertuberkulose is moeilik om te diagnoseer en dit is ‘n belangrike faktor wat daartoe 
bydra dat kinders dikwels nie antituberkulose behandeling ontvang wanneer hulle dit benodig 
nie.  
 
Die diagnose van kindertuberkulose is moeilik, omdat die organisme selde aangetoon kan 
word.  In nie endemiese areas word kindertuberkulose dikwels gediagnoseer na aanleiding 
van: 1) blootstelling aan ‘n volwasse indeks geval, 2) ‘n positiewe tuberkulien veltoets, en 3) 
die teenwoordigheid van radiologiese tekens suggestief van tuberkulose.  Hierdie benadering 
het defnitiewe tekortkominge in endemiese areas, waar blootstelling aan en infeksie met 
Mycobacterium tuberculosis algemeen is.  Gevolglik berus die diagnose van 
kindertuberkulose hoofsaaklik op die subjektiewe interpretasie van die borskasplaat, wat 
welbekende tekortkominge het en verder is radiologiese toetse dikwels nie beskikbaar in 
hierdie areas nie.  Die doel van die navorsingsprojek was om die dilemma rondom die 
diagnose van kindertuberkulose in endemiese areas aan te spreek.   
 
Eerstens is basiese siektekonsepte uitsorteer deur ‘n kritiese oorsig van studies uit die pre-
chemoterapie era.  Hierdie kosbare studies het die natuurlike verloop van tuberkulose in 
kinders beskryf, nog voordat antituberkulose middels beskikbaar was.  Drie sentrale konsepte 
is geidentifiseer; 1) die belang van akkurate siekte definisie, 2) die relevansie van risiko 
stratifikasie en 3) die diverse spektrum van patologie wat akkurate siekte klassifikasie 
noodsaak.  Die belang van akkurate siekte definisie word geïllustreer deur die feit dat 
geïsoleerde hilêre adenopatie ‘n verbygaande verskynsel is in die meerderheid van kinders 
kort na primêre infeksie. Ons analise het daarop gefokus om die risiko om siekte te ontwikkel 
nadat primêre infeksie met M.tuberculosis plaasgevind het, te kwantifiseer.  Die hoof risiko 
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faktore was; 1) die ouderdom en/of immuunstatus van die kind, 2) die tydsverloop sedert 
infeksie, en 3) die teenwoordigheid van simptome al dan nie.  
 
Hierna het ons die siektelas wat tuberkulose vandag op kinders in endemiese areas plaas 
gedokumenteer.  Ons het eers die huidige diagnostiese praktyke geëvaluaeer in ‘n 
retrospektiewe studie en toe ‘n prospektiewe beskrywende studie gedoen om die siektelas so 
akkuraat as moontlik te meet.  Die insidensie van kindertuberkulose was hoog (>400/100 
000/jaar), selfs na korreksie vir kinders wat ontoepaslik behandeling ontvang het.  Verder is 
gevind dat die meerderheid van kinders met ernstige siekte toestande soos miliêre 
tuberkulose en/of meningitis, nie in roetine moniterings data reflekteer word nie.   
 
‘n Bykomende struikelblok in kindertuberkulose is die gebrek aan standaard beskrywende 
terminologie.  Om dit te bevorder ontwikkel ons ‘n nuwe radiologiese klassifikasie van intra-
torakale kindertuberkulose en beskryf ons die verskillende patologiese meganismes 
onderliggend tot hierdie uiteenlopende siektebeelde.  Daarna dokumenteer ons die volledige 
spektum van kindertuberkulose in ‘n endemiese area en demonstreer dat die siektepatrone 
wat ons vandag observeer soortgelyk is aan die wat in die pre-chemoterapie literatuur beskryf 
is.  Ons toon ook dat bakteriologiese bevestiging moontlik blyk te wees in die meerderheid 
van kinders wat vir intra-torakale tuberkulose behandel word in endemiese areas.   
 
Nadat ons duidelikheid verkry het oor die basiese siektekonsepte, siekte klassifikasie en die 
siektelading in ons omgewing, kon ons op die ontwikkeling van ‘n simptoom-gebaseerde 
benadering tot die diagnose van kindertuberkulose fokus.  Ons het ‘n stapsgewyse 
benadering gevolg.  Die eerste stap was om die voorkoms van simptome wat gebruiklik met 
tuberkulose vereenselwig word te dokumenteer in ‘n ewekansige groep kinders.  Die 
gemeenskapsopname het getoon dat swak gedefiniëerde simptome swak diagnostiese 
waarde bied.  Die tweede stap was om vas te stel of verbeterde simptoom definisie die 
diagnostiese waarde kan verbeter.  ‘n Klein prospektiewe studie het getoon dat goed 
gedefiniëerde simptome (persisterende simptome van onlangse aankoms) goeie diagnostiese 
waarde bied.  Die finale stap was om hierdie belowende benadering formeel te toets in ‘n 
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groot prospektiewe, gemeenskapsgebaseerde studie.  Hierdie studie het getoon dat ‘n 
eenvoudige simptoom-gebaseerde benadering pulmonale tuberkulose met goeie 
akkuraatheid kan diagnoseer, veral in HIV-ongeïnfekteerde kinders wat ouer is as 3 jaar.   
 
Hierdie nuwe diagnostiese benadering bied die moontlikheid om antituberkulose behandeling 
te voorsien aan kinders in endemiese areas wat tans feitlik geen behandeling ontvang nie.   
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Dedication 
 
To my wife for her patience and support, to my children despite their lack of patience, and to the 
children of Africa who need our support 
 
 
“It is a struggle of the African people, inspired by our own suffering and our own experience.  It is 
a struggle for the right to live……. I have cherished the ideal of a democratic and free society in 
which all persons live together in harmony and with equal opportunities” 
 
Nelson Mandela at the Rivonia trial 1964 
From “Higher than Hope”, Fatima Meer 1988 
 
 
“The resilience of the community of life and the well-being of humanity depend upon preserving a 
healthy biosphere with all its ecological systems, a rich variety of plants and animals, fertile soils, 
pure waters, and clean air.  The global environment with its finite resources is a common concern 
of all peoples.  The protection of the Earth’s vitality, diversity, and beauty is a sacred trust” 
 
From the preamble of “The Earth Charter”, www.earthcharter.org 
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Chapter 1. 
Introduction 
 
Tuberculosis (TB) is an old disease that has affected humankind since the earliest times.  
Suggestive spinal changes have been recorded in neolithic man, while tuberculosis has been 
confirmed in mummified remains from Egypt, dating back to 3400 BC.1 Hippocrates (460-377 
BC) introduced the ancient Greek term, phthisis, which became better known as 
consumption; later renamed tuberculosis. Tuberculosis flourished in Europe during the time of 
industrialization, causing an estimated 20% of all deaths in the British Isles during the 17th 
century;2 John Bunyan declared tuberculosis “The captain of all these men of death”, in 1680. 
During the 20th century the prevalence of tuberculosis in Europe decreased to such an extent 
that it was commonly regarded a conquered foe in the developed world.  However, during the 
later half of the 20th century the prevalence of tuberculosis escalated to epidemic proportions 
in many developing countries.  
 
Fuelled by the immune-compromise that results from human immunodeficiency virus (HIV) 
infection, Sub-Saharan Africa currently has the highest tuberculosis incidence rates in the 
world and is worst affected by the dual TB-HIV epidemic.3,4  As the gravity of the problem 
became apparent, a global tuberculosis emergency was declared by the World Health 
Organization (WHO) in 1993.  At the start of the new millennium it was estimated that a third 
of the world’s population is infected with M. tuberculosis; 8.3 million people develop 
tuberculosis annually and 1.8 million people die every year from tuberculosis.3 However, the 
prevalence of tuberculosis varies greatly between countries, with poor developing countries 
carrying the bulk of the disease burden, while tuberculosis has become a disease of 
immigrant and marginalized populations in the developed world.5   
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 2
The common perception is that children are not severely affected by tuberculosis, that they 
get mild forms of disease and that the main contribution of anti-tuberculosis chemotherapy in 
children is to eradicate the pool of latent infection, from which future reactivation disease may 
result.  From a tuberculosis control point of view, the argument concludes that as children 
rarely become seriously ill and do not transmit the organism, their treatment is not a priority in 
highly endemic areas, and the best way to help children in these areas is to treat and prevent 
adult tuberculosis.  Unfortunately, the almost exclusive emphasis placed on the treatment of 
adults with sputum smear-positive disease in endemic areas undermines service delivery to 
children.6  
 
In reality, children contribute a substantial proportion of the tuberculosis disease burden, 
particularly in endemic areas such as sub-Saharan Africa.  Of the estimated 8.3 million new 
tuberculosis cases diagnosed in 2000, 884 019 (11%) were children less than 15 years of 
age.4 More recent estimates indicate that children contribute approximately 15% of the 
tuberculosis disease burden in low-income countries,4 and this may be even higher in 
endemic areas.7,8  Childhood tuberculosis results from recent transmission within a 
community, and therefore the number of diseased children reflects the level of epidemic 
control achieved in a particular setting.  This explains the severe disease burden imposed on 
African children, where the epidemic is poorly controlled.  Proof that African children suffer 
severe tuberculosis-related morbidity and mortality is provided by an autopsy study done in 
Zambia.9 This study found that tuberculosis rivals acute pneumonia as a major cause of death 
from respiratory causes in children older than 1 year of age, particularly in HIV-uninfected 
children.9 The two most common respiratory causes of death reported were; 1) in HIV-
uninfected children 12-17 months of age, acute pyogenic pneumonia 57.9% and tuberculosis 
36.8%, 2) in HIV-uninfected children 18 months to <16 years, tuberculosis 39.1% and acute 
pyogenic pneumonia 34.8%, 3) in HIV-infected children 12-17 months of age, acute pyogenic 
pneumonia 45.5% and tuberculosis 31.8%, 4) in HIV-infected children 18 months to <16 
years, acute pyogenic pneumonia 52.0% and tuberculosis 20.0%.9   
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The majority of children who suffer from tuberculosis develop intra-thoracic disease.  This is a 
more inclusive term than pulmonary tuberculosis, which is often defined as sputum smear-
positive disease only.  We used the terms intra-thoracic disease and childhood pulmonary 
tuberculosis interchangeably. A small percentage of children do develop sputum smear-
positive disease, but they are usually older than 10 years of age and pose a major 
transmission risk in congregate settings such as schools.10 Children with sputum smear-
negative intra-thoracic tuberculosis do not pose a high transmission risk, but they suffer 
significant morbidity and mortality from a readily treatable disease. 
 
The worldwide role-out of the Directly Observed Therapy Short course (DOTS) strategy has 
created an excellent treatment infrastructure, extending to the most resource-limited settings.  
However, despite the existence of this excellent infrastructure few children receive 
antituberculosis treatment at present.6 Multiple factors contribute to the poor service delivery, 
but three of the main factors are 1) a lack of political commitment, 2) the almost exclusive 
emphasis on adults with sputum smear-positive disease, and 3) the difficulty of diagnosing 
childhood tuberculosis, especially in resource-limited endemic areas.    
 
Diagnostic dilemma 
The diagnosis of childhood tuberculosis is complicated by the absence of a practical gold 
standard.  Bacteriological confirmation, the gold standard used in adults, is problematic as 
culture yields in children are considered to be low and collecting an adequate specimen is 
difficult. Acid-fast smears, often the only diagnostic test available in endemic areas, is positive 
in less than 10-15% of children with probable tuberculosis,11,12  while M. tuberculosis can be 
isolated from less than 30-40% of children,11 despite using optimal methods for specimen 
collection such as induced sputum.12   
 
Due to the difficulty of achieving bacteriologic confirmation, the diagnosis of childhood 
tuberculosis in non-endemic areas is based upon; 1) known contact with an adult index case 
(usually within the household), 2) a positive tuberculin skin test (TST), and 3) suggestive 
signs on the chest radiograph.  This triad provides a fairly accurate diagnosis in settings 
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where exposure to M. tuberculosis is rare and well documented.  However, the diagnostic 
value of this triad is greatly reduced in endemic areas where exposure to M. tuberculosis is 
common and often undocumented as the majority of exposure occurs outside the 
household.13,14  Infection with M.tuberculosis, as measured by a positive TST is also common.  
Consequently, the diagnosis of tuberculosis in endemic areas depends mainly on clinical 
features and the subjective interpretation of the chest radiograph,15 which has well known 
limitations that result in both under- and over-diagnosis of tuberculosis.16,17 In addition, chest 
radiography is rarely available in areas with limited resources.18  
 
The tuberculin skin test (TST) was adapted from Robert Koch’s failed attempt to treat 
tuberculosis using purified protein derivative (PPD).  A positive TST provides a fairly accurate 
indication of infection with M.tuberculosis, although specificity is a concern with BCG 
vaccination or exposure to environmental mycobacteria,19 and sensitivity is poor in HIV-
infected and/or immune compromised children.20 Recent advances in identifying 
M.tuberculosis infection include the development of T-cell based assays (T-spot and 
Quantiferon gold), which use a combination of M. tuberculosis specific antigens (ESAT-6 and 
CFP-10) that provide improved specificity and sensitivity in comparison to the traditional 
TST.19,21 These new tests may offer particular value in HIV-infected and or immune 
compromised children,21 where the TST performs poorly and the diagnosis of latent M. 
tuberculosis infection is highly relevant. However, current T-cell based assays do not 
differentiate latent M. tuberculosis infection from active disease, which is the major diagnostic 
challenge in endemic areas.   
 
Current serological tests are unable to diagnose childhood tuberculosis with accuracy,22  
while sputum-based polymerase chain reaction (PCR) tests showed variable results and 
limited utlility.23  Good results were recently reported with the use of a heminested PCR 
technique, but the study used uninfected children as the control group and could therefore not 
evaluate the ability of this novel PCR-based test to differentiate latent infection from active 
disease.24     
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A variety of clinical diagnostic approaches, which include the use of symptoms, have been 
developed.  A recent critical review evaluated all 16 clinical diagnostic approaches that have 
been published and concluded that they are limited by a lack of standard symptom definitions 
and adequate validation.25 Recommendations were that symptom characteristics should be 
standardized, that novel diagnostic approaches should be developed for use in endemic 
areas with limited resources and that these approaches should be adequately validated.  In 
addition, hospital-based studies have reported widely variable results regarding the utility of 
symptom-based approaches to diagnose tuberculosis in children.  However, hospital-based 
studies are limited by extensive selection bias, which complicates interpretation and 
extrapolation of results to the community level.   
 
The validation of novel diagnostic approaches is problematic, due to the absence of a gold 
standard case definition.  Bacteriological confirmation is mainly limited by poor bacteriologic 
yields, but it is restricted by two other factors as well.  Firstly, amongst diseased children, 
those with bacteriologic confirmation may represent a select sub-population that does not 
represent the full disease spectrum.  Secondly, the ability to culture M.tuberculosis in healthy 
children shortly after primary infection indicates that the presence of a positive culture, in the 
absence of signs or symptoms suggestive of tuberculosis, does not necessarily represent 
disease.  The alternative case definition that is frequently used is the presence of suggestive 
changes on the chest radiograph.  Chest radiography has major limitations as well; 1) the 
subjective nature of radiograph interpretation, 2) the fact that minimal radiographic changes in 
isolation do not necessarily indicate disease, and 3) the fact that it cannot be included in both 
the case definition and the diagnostic approach evaluated.  
 
In summary, accurate diagnosis is essential in order to improve service delivery to children 
with tuberculosis in resource-limited settings.  Novel diagnostic approaches are required as 
none of the available diagnostic approaches are adequately validated and/or feasible in these 
settings.  Adequate validation of a novel diagnostic approach requires a large, prospective 
study with; 1) community-based study entry to limit patient selection, and 2) accurate case 
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definitions that are both independent of the predictor variables tested and inclusive of the full 
disease spectrum in children.  
 
Study objectives 
The main objective was to develop a novel symptom-based approach to diagnose childhood 
tuberculosis in a prospective, community-based study.  However, we had to apply a stepwise 
approach with multiple specific aims to achieve this objective.  
1) to clarify basic epidemiologic and clinical concepts by critically reviewing the pre-
chemotherapy literature that documented the natural history of tuberculosis in 
children  
These aims are addressed in chapter 2.   
Two review articles describe the clinical epidemiology and the natural history of intra-thoracic 
tuberculosis in children.   
 
2) to document the burden of childhood tuberculosis and to determine the accuracy of 
community-based surveillance data in an endemic area 
These aims are addressed in chapter 3.   
A retrospective descriptive study documented the diagnostic criteria used and the contribution 
of children to the overall tuberculosis disease burden in an endemic area.  A prospective 
descriptive study then evaluated the accuracy of community-based surveillance data and 
calculated the actual disease burden in children.   
 
3) to accurately classify the diverse manifestations of intra-thoracic tuberculosis in 
children and document the disease spectrum found in children from an endemic area 
These aims are addressed in chapter 4.   
A radiological classification of childhood intra-thoracic tuberculosis, based on a thorough 
review of the literature, is proposed and the pathologic mechanisms that underlie these 
diverse disease manifestations are described.  A case-series described the occurrence of 
adult-type disease in children aged 10-14 years of age.  A prospective descriptive study 
documented the complete spectrum of disease in children treated for tuberculosis in an 
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endemic area.  A sub-analysis of this study demonstrated that bacteriologic confirmation may 
be achieved in the majority of children with intra-thoracic tuberculosis. A separate prospective 
descriptive study described the clinical presentation of tuberculous lymphadenitis, the most 
common extra-thoracic manifestation of tuberculosis in children. 
 
4) to explore the value of symptom-based approaches; a) to screen household contacts 
for tuberculosis, and b) to diagnose pulmonary tuberculosis in children from an 
endemic area  
These aims are addressed in chapter 5.    
a) A prospective descriptive study evaluated the potential value of symptom-based screening 
to improve access to preventive chemotherapy in resource-limited settings.  b) To achieve our 
main objective we performed 3 separate studies.  A community-based survey documented 
the prevalence of symptoms traditionally associated with tuberculosis in a random selection of 
children.  Then a small prospective cohort study evaluated the diagnostic value of well-
defined symptoms.  Finally, the diagnostic value of a novel symptom-based approach to 
diagnose pulmonary tuberculosis in children was validated in a large prospective, community-
based study.  
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Chapter 2. 
The pre-chemotherapy literature 
 
The pre-chemotherapy literature documents the natural history of tuberculosis in children. 
Unfortunately, modern clinicians and researchers have limited access to these important 
studies as they were all conducted before 1950 and are not included in modern electronic 
data banks.  After the discovery of safe and effective anti-tuberculosis treatment, it became 
unethical to repeat studies on the natural history of disease, and therefore these historic 
disease descriptions remain invaluable.  We attempted to make the most important findings 
from the pre-chemotherapy literature accessible for modern researchers and clinicians, and to 
interpret its relevance for the situation clinicians are faced with today. 
 
 
1. Marais BJ, Gie RP, Schaaf HS, Hesseling AC, Obihara C, Nelson LJ, Enarson 
DA, Donald PR, Beyers N. The clinical epidemiology of childhood pulmonary 
tuberculosis – A critical review of the pre-chemotherapy literature. Int J Tuberc 
L Dis. 2004; 8: 278-285 
This review focused on the two major transitions in tuberculosis; 1) from exposure to infection, 
and 2) from infection to disease.  Exposure occurred both inside the household and in the 
community. The risk of infection was highest (70-80%) following household exposure to a 
sputum smear-positive adult index case, but the risk remained appreciable, although greatly 
reduced (30-40%), if the adult index case was sputum-smear negative.  The annual risk of 
infection (ARI) was not constant across age groups, but increased during times of widening 
social contact.  Disease definition was problematic and not consistent across studies.  
Routine surveillance data indicated that very young children and adolescents were the groups 
at highest risk for disease and death. 
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2. Marais BJ, Gie RP, Schaaf HS, Hesseling AC, Obihara C, Starke JR, Enarson 
DA, Donald PR, Beyers N. The natural history of childhood intra-thoracic 
tuberculosis – A critical review of the pre-chemotherapy literature. Int J Tuberc 
L Dis. 2004; 8: 392-402. 
This review focused primarily on the transition from infection to disease, which was poorly 
quantified in the epidemiologic studies.  It demonstrated the difficulty of distinguishing 
infection from disease, as elements of the primary complex became transiently visible on the 
chest radiograph, in the majority of children (50-60%) following primary infection. It illustrated 
the diverse spectrum of pathology in children with intra-thoracic tuberculosis and the 
prognostic relevance of accurate disease classification. It quantified the risk to progress to 
disease following primary infection with M.tuberculosis and emphasized the important concept 
of risk stratification.  The most important determinants of risk were; 1) the age and/or immune-
status of the child, 2) the time elapsed since primary infection occurred, and 3) the presence 
or absence of significant symptoms, defined as the breakpoint of clinical relevance.    
  
3. Marais BJ. On the definition of relevant disease. Arch Dis Child 2004; 89: 497  
This letter addresses the important issue of how to define normality and disease.  The 
relevance of any condition depends on the risk it poses to the individual and/or the 
community, which illustrates the importance of accurate risk analyses. Relevant disease 
defines the point where the risk posed by a particular condition, increases significantly beyond 
the baseline risk within a particular community. This definition challenges both the classic 
public health approach, which ranks relevance according to the proportional contribution 
made to the total disease burden; and the approach promoted by the pharmaceutical industry, 
which defines any statistically significant benefit as the “accepted standard of care”, 
irrespective of the baseline risk within a particular community.   
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The pre-chemotherapy literature represents an impres-
sive body of evidence that clarifies important epidemio-
logical concepts in childhood tuberculosis. Reports
describe the major transitions in tuberculosis, from ex-
posure to infection and from infection to disease (mor-
bidity and mortality), without the influence of chemo-
therapy. Children with household exposure to a sputum
smear-positive source case experienced the greatest risk
of becoming infected and of developing subsequent dis-
ease. Household exposure to a sputum smear-negative
source case or non-household exposure still posed an
appreciable, although greatly reduced, risk. Infection in
children less than 2 years of age indicated a probable
household source case. The majority of older children
who were infected did not have a household source iden-
tified, and presumably became infected in the commu-
nity. The annual risk of infection (ARI) was not constant
across all ages, but seemed to increase during periods of
widening social contact. Infants and adolescents were
the groups at highest risk for disease development and
death following primary infection.
KEY WORDS: review; pre-chemotherapy; epidemiology;
childhood pulmonary tuberculosis
THE TWENTIETH CENTURY witnessed major
advances in the understanding of the pathophysiol-
ogy of childhood tuberculosis as well as its diagnosis
and treatment. In particular, the period from 1920,
when chest radiography became available for diag-
nosis, to 1950, when effective chemotherapy became
available, represented an optimal window for the
documentation of the natural history of tuberculosis.
During this period tuberculosis was still highly
prevalent in Europe and America, where adequate
infrastructure permitted the careful diagnosis and
follow-up of tuberculosis patients. Detection of infec-
tion was possible with the tuberculin skin test (TST),
while chest radiography allowed a more accurate
diagnosis of pulmonary tuberculosis in children.
The aim of this review is to document the findings
from the pre-chemotherapy literature concerning the
clinical epidemiology of childhood pulmonary tuber-
culosis in a critical manner. The relevance of these his-
toric findings is interpreted for the public health chal-
lenges faced today.
METHODS AND MATERIALS
Original studies on childhood pulmonary tuberculo-
sis, including the period 1920 to 1950 and published
in the English literature, were identified from text-
book references and extensive cross-referencing. Only
studies reporting on more than 1000 children, with a
study duration of at least 10 years, were included.1–8
The database collected was compared to the Inter-
national Union Against Tuberculosis and Lung Dis-
ease (IUATLD) archive in order to ensure that no
major study was excluded. One exception was made
with the inclusion of Gedde-Dahl’s community-based
article on tuberculin conversion. He followed patients
for a maximum of 8 years, before the Second World
War interrupted the study. However, his unique
approach provided valuable insight by documenting
tuberculin conversion and subsequent disease devel-
opment in the community. Hospital-based studies
introduced bias by preselection and therefore the
inclusion of community-based studies was essential.
Correspondence to: B J Marais, MD, Department of Paediatrics and Child Health, Centre for TB Research and Education,
Faculty of Health Sciences, Stellenbosch University, PO Box 19063, Tygerberg, 7505, South Africa, Tel: (27) 21-938 9155.
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Studies are reported in chronological order to illus-
trate the progression in knowledge. This review sum-
marises the clinical epidemiological aspects of pulmo-
nary tuberculosis in children. During this same
period, basic science studies also improved the under-
standing of the epidemiology of tuberculosis by the
accurate description of droplet airborne infection.
These studies have been reviewed previously and are
not included.9
A brief description of the individual studies and the
study design employed in each is provided (Table 1).
This is followed by a summary of the key findings and
major limitations of each individual study (Table 2).
The combined study results summarise the most
important findings, with reference to the individual
studies described in Tables 1 and 2.
The risk of developing disease (morbidity) or of
dying from tuberculosis (mortality), following pri-
mary infection within a specific age group, was calcu-
lated from the original data reported by Bentley et al.
(Table 3).5 The percentage of children who developed
primary infection within a specific age period was cal-
culated by deducting the cumulative percentage of
children with a positive TST recorded at entry from
the cumulative percentage of children with a positive
TST at exit from that age category. Multiplying this
percentage with the average number of children who
entered that age category annually provided an esti-
mate of the number of children who developed pri-
mary infection within that age period. This number
was used as denominator. The annual number of noti-
fications for tuberculosis-related disease and death
within that age group was used as numerator when
calculating the disease and mortality percentages
(Table 3).
COMBINED STUDY RESULTS
Exposure to infection
The Mantoux TST using 5 tuberculin units (TU) was
the optimal test to identify tuberculosis infection.6,7
The use of different tuberculin strengths complicated
the interpretation of TST results and comparison be-
tween studies.7 Reaction to high dose tuberculin (1 mg
or 100 TU) probably represented exposure to environ-
mental mycobacteria and not infection with Mycobac-
terium tuberculosis.7,8 High-dose tuberculin was used
following a negative reaction to standard-dose tuber-
culin in three of the studies.3,5,8 Those with a positive
reaction to high dose tuberculin were included amongst
the infected group without further subanalysis, but
they represented a small minority. The degree of indu-
ration induced by BCG vaccination was usually 10
mm, compared to natural infection, which was usually
10 mm.7 BCG-induced hypersensitivity diminished
with time and tuberculin responses frequently reverted
after variable time periods depending on the BCG
strain used. After natural infection, permanent rever-
sion occurred in less than 0.5% of children.4,6–8 Tem-
porary tuberculin inhibition did occur and was associ-
ated with wasting, viral illnesses or severe forms of
tuberculosis.7
Following prolonged household contact with a
sputum smear-positive source case, 60–80% of children
became infected.3,6–8 When the source case was smear-
negative, 30–40% of children became infected.4,7,8 The
probability of infection in children depended on the
infectivity of the source case together with the prox-
imity and duration of contact with the source case.
Local cultural practices may have contributed to dif-
ferent epidemiological patterns of disease spread,7
e.g., extensive socialisation within rural African vil-
lages or the isolation of children and women in cer-
tain cultures. Brailey was the only author who related
the time of TST conversion in the child contact to the
time of symptom onset in the adult source case. More
than 60% of the children who became infected did so
within 3 months of symptom onset in the adult source
case.3 Infection was often delayed in household con-
tacts under 2 years of age compared to older children,
suggesting some protection from their reduced social
contact within the family.3 This delay was not evalu-
ated separately in cases where the primary caregiver
was the source case. Viral upper respiratory tract
infections may have increased the likelihood of tuber-
culosis infection and contributed to the observed
peak in infection during winter months.7
Most children (80%) who became infected before 2
years of age were infected by a household source
case.3,5,7 Additional caregivers outside the household
were also important, especially grandparents or ex-
tended family members who took care of the children
during the day, if both parents worked.7 The majority of
children who became infected after 2 years of age had
no household contact identified, and were therefore
likely to have been infected in the community.2,3,5,7,8
A separate issue raised by these studies was how
the contribution of household exposure to primary
infection varied according to the prevalence of tuber-
culosis in a specific community. In high prevalence
areas, household exposure contributed to primary
infection up until 15 years of age, by which time most
children were already infected.5,8 In low prevalence
areas, household exposure remained an important con-
tributor to primary infection until old age.5,8 The risk of
infection following household exposure was reduced
under good socio-economic conditions.5,8 There were
no racial differences in the rate of infection following
household exposure.3,8
The annual risk of infection (ARI) was not con-
stant across all ages.5,7 There were specific age periods
when infection rates increased.5 These age periods
seemed to correlate with times of widening social
contact. This occurred with increased mobility after 2
years of age, school entry at 5 to 7 years of age and
school exit at 15 to 20 years of age (Table 3).5,7 Primary
12
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Table 1 Description of the original studies and individual study designs documenting the clinical epidemiology
of childhood pulmonary tuberculosis
Individual study reference Time frame Study type Study population Data collection methods
1 Opie E, McPhedran F M,
Putnam P – 1935
Henry Phipps Institute, Philadelphia, 
PA, USA
The fate of children in contact with 
tuberculosis: the exogenous 
infection of children and adults1
1907–1934
Follow-up period
of 1–27 years
Retrospective 
descriptive,
out-patient 
based
Children 15 years
from 1000 families 
with an adult source 
case
Mortality data for the city 
of Philadelphia
Adult source cases were 
self-selected
Annual clinical follow-up 
of all source case 
contacts
Annual CXR (if available)
2 Pope A S, Sartwell M D,
Zacks D – 1939
State Department of Public Health 
(Chadwick Clinics), Boston, MA, 
USA
Development of tuberculosis in 
infected children2
1924–1939
Follow-up period 
of 5–15 years
Prospective
TST survey, 
school based
400 330 school children 
6–16 years
TB notification data for 
Boston
TST survey (Von Pirquet)
CXR done if TST positive
Annual CXR if the initial 
CXR was abnormal
3 Brailey M – 1940
Johns Hopkins (Harriet Lane Clinic), 
Baltimore, MD, USA
A study of tuberculous infection and 
mortality in the children of 
tuberculous households3
1928–1937 
Follow-up period 
of 1–10 years
Retrospective
descriptive,
out-patient
based
1383 children 15 years 
from 285 families 
with an adult source 
case
Mortality data for 
Baltimore
All children from 
tuberculous 
households screened
Old tuberculin TST
(0.1 or 1 mg)
Annual CXR if TST positive
4 Gedde-Dahl T – 1951
Kinn district, Bergen, Norway
Tuberculous infection in the light of 
tuberculin matriculation4
1937–1944
Follow-up period 
of 1–8 years
Prospective
TST survey, 
community
based
6739 people of all ages
3138 children
15 years
Annual community based 
TST survey (Von Pirquet)
Documented TST 
conversion/
matriculation
Annual CXR once TST 
positive
5 Bentley F J, Grzybowski S,
Benjamin B – 1954
High Wood Hospital for children, 
Brentwood, Essex, UK
Tuberculosis in childhood and 
adolescence5
1901–1952 
Notification
data used
Audit of TB
notifications
Mathematical
deductions
UK national TB 
notification data
British MRC national TST 
survey
Reviewed TB notifications 
for the whole UK and 
specifically for London 
(1901–1952)
Reviewed TST surveys 
D’Arcy Hart (1929), 
Prophit (1935–1944), 
British MRC (1949–
1950)
6 Davies P D B – 1961
Brompton Hospital, London, UK
The natural history of tuberculosis in 
children6
1930–1954
Follow-up period 
of 1–25 years
Retrospective
descriptive,
out-patient 
based
2377 children 15 years 
in household contact 
with an adult source 
case
Included all asymptomatic 
household contacts
Different TSTs were 
compared
Annual CXR
7 Miller F J W, Seal R M E,
Taylor M D – 1963
Royal Victoria Infirmary, Newcastle 
upon Tyne Children’s 
Sanatorium, Stannington, 
Northumberland, UK
Tuberculosis in children7
1) 1947–1954
2) 1951–1961
Follow-up period 
of 1–10 years
Retrospective
descriptive,
out-patient
based
1) Children 7 years 
from 1000 families 
with an adult source 
case
2) 1500 children 5 years 
in household contact 
with an adult source 
case
1) 1000 family study
Household contacts
7 years
Annual CXR  TST
(until positive)
2) Household contact
study
Household contacts
5 years
Annual CXR  TST
(until positive)
8 Zeidberg L D, Gass R S, Dillon A,
et al. – 1963
Tennessee Department of Public
Health, USA
The Williamson County tuberculosis
study: a 24 year epidemiologic
study8
1931–1955
Follow-up period 
of 1–24 years
Prospective
community
cohort study
1746 children 15 years 
from 828 families
with an adult source
case
Tennessee mortality data
Voluntary inclusion of all 
household contacts
Detailed questionnaire 
and physical 
examination
Old tuberculin TST
(0.1 or 1 mg)
6–12 monthly CXR
CXR  chest radiograph; TST  tuberculin skin test; MRC  Medical Research Council; UK  United Kingdom.
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Table 2 Summary of key findings and major limitations of the original studies, documenting the clinical epidemiology
of childhood pulmonary tuberculosis
Citation Features Key findings Major limitations
Opie et al.1 First to focus on 
families and 
children
Sputum positive exposure increased the frequency 
and severity of disease in childhood contacts
The lifetime risk for the development of cavitating 
disease depended on the age at primary
infection, increasing significantly after
10 years of age
TST not recorded
Age groups poorly defined 
Limited CXR availability
Sputum positivity not specified (smear
or culture)
Pope et al.2 TST positivity
School survey
Only 30% of infected school children had household 
contact with a known source case
Cavitating pulmonary tuberculosis was seen 
in children 10 years of age only
TST conversion not recorded
Selective follow-up (only those with initial 
CXR abnormalities were followed)
Documented cavitating disease only
Brailey3 Focus on children 
2 years of age
Racial comparison
Infected children 2 years of age indicated an active 
household source case
The majority of household contacts were infected 
within 3 months of symptom onset in the adult 
source case
No racial difference in infection following exposure
Definite racial difference in disease and mortality
following infection
Public health entry point selected the poor
Response to high dose (1 mg) tuberculin, 
used in a small minority of patients, is 
not specific for M. tuberculosis infection
Sputum positivity not specified (smear or 
culture)
Socio-economic differences were not 
evaluated
Gedde-Dahl4 TST conversion
Community survey
The rate of TB infection and TB related mortality was 
increased in urban areas
Radiological abnormalities were visible in 75% of
children following primary TB infection
Preschool children were selectively
represented (only contacts and
symptomatic cases included)
Results from this isolated community may 
be difficult to generalise
Bentley 
et al.5
Tuberculosis disease 
and mortality 
specified per 
age group
Concept of relative 
contribution
The annual rate of infection (ARI) was not constant, 
but varied between different age groups
The majority (90%) of TB-related radiological
abnormalities were not detected in routine
clinical practice
The risk of disease and death following infection was 
the highest during infancy
The relative contribution of TB to age-specific 
all-cause mortality was the lowest during infancy
TB contributed significantly to all-cause mortality 
throughout childhood
Response to high dose (100 TU) tuberculin, 
used in 24% of subjects in the British 
MRC survey, is not specific for
M. tuberculosis infection
Relied exclusively on TB notification data 
for disease and mortality analysis
Davies6 Long-term
follow-up
Persistence of TST 
conversion
The Mantoux skin test outperformed other TSTs
A positive tuberculin response persisted for
20 years
Exposure to a sputum smear-positive vs. a 
smear-negative source case doubled the risk 
of infection
Infection after exposure to a sputum smear-positive 
source case doubled the risk for disease and 
death
Majority of patients were already infected 
at study entry
Selected only asymptomatic children at 
study entry, to ensure clinical
uniformity
Miller et al.7 Comprehensive
literature review
Clarified the confusion surrounding the
interpretation of different TST techniques and 
doses
Described the importance of cultural influences and 
the extended family
Viral respiratory infections might have contributed to 
the seasonal variation in TB infection
Few deductions were made from own 
studies
Validity of quoted studies was not
evaluated
Relied extensively on notification data
Zeidberg et al.8 Long term
follow-up
in the
community
Identified critical periods of risk for disease
development (infancy, puberty)
Documented a drastic reduction in TB-related disease
and mortality over the 24-year study period 
in black patients
Age at primary infection was not
documented
Entry criteria were adapted during the 
study
A controversial finding, not supported by
mortality data or results from other
studies reviewed, was the delayed
progression of disease reported in
children infected between 1 and 15
years of age
TST  tuberculin skin test; CXR  chest radiograph; MRC  Medical Research Council; TU  tuberculin units.
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infection occurred at a younger age in high-density,
low-income, urban areas.4–7 The age-specific infec-
tion rate was the single most important public health
indicator of the prevalence of disease in a given
community.5,7,8
Infection to disease (morbidity)
To describe the progression from infection to disease
accurately, a clear case definition of disease is re-
quired. Definitions of disease were not consistent
across studies and disease was not well defined. Noti-
fication data were routinely used, reflecting passive
case finding where any radiological abnormality
attributed to tuberculosis was reported as tubercu-
lous disease.
With constant community surveillance and active
case finding it was found that a high percentage of
children (50–70%) developed radiological abnormal-
ities following primary infection. This was most com-
mon (60–80%) following primary infection before 2
years of age.3–5 On comparison with notification data,
it was clear that only 5–10% of children who devel-
oped radiological abnormalities during the natural
course of the disease were notified as diseased (Table
3). This implied that more than 90% of radiological
abnormalities passed undetected in routine clinical
practice.5,7
The risk of radiological abnormality in children
with household exposure to a sputum smear-positive
source case and a positive TST was 30–50%.1,4,6–8
This risk was reduced by 50% when the source case
was sputum smear-negative or not a household mem-
ber.1,4,6–8 Duration since primary infection and age at
primary infection determined the risk for disease
development.4,5,7 Most disease developed in the first
year following primary infection.1,3,4,5,7 Children with
primary infection before 2 years or after 10 years of
age5,7 and black children1,3,7,8 were at increased risk for
disease development. The increased susceptibility of
black children declined drastically as socio-economic
conditions improved during the Tennessee study.8
The risk of developing cavitating pulmonary tuber-
culosis depended on the age at primary infection. The
highest risk for cavitating disease (10–20%) occurred
in children who were first infected after 10 years of age,
with perimenarchal girls being most vulnerable.1,2,5–8
Mortality
Tuberculosis-related mortality following infection
from a sputum smear-positive household source case
was twice as high as when infection occurred from an
unknown source case.6–8 All-cause mortality was sim-
ilar in both these groups, indicating that the differ-
ence was not due to general increased mortality in the
households of sputum smear-positive patients.1,3,7,8
The highest risk for TB-related mortality fol-
lowing primary infection (5–10%), occurred during
infancy.1,3–5,7,8 This risk declined to 1% between 1
and 4 years of age, with the lowest levels maintained
at less than 0.5% from 5 to 14 years of age, before ris-
ing to more than 2% from 15 to 25 years of age
(Table 3).5,7 Most deaths from tuberculosis occurred
within the first year following primary infection in
children under 10 years of age,1,3,4,5,7 but mortality
lagged 5–10 years behind the onset of cavitating dis-
ease in older children.8
All-cause mortality exhibited an age-related pat-
tern similar to that of tuberculosis-related mortality.5
Therefore, the relative tuberculosis-related mortality
best described the impact of tuberculosis on all-cause
mortality within a specific age group.5 Tuberculosis
contributed significantly to all-cause mortality in all
Table 3 The calculated risk of developing primary tuberculosis (TB) infection, compared to the calculated risk
of being notified with TB-related disease or death following primary TB infection, within specific age groups
Age group,
years
Calculated risk
to develop
primary TB
infection*
%
Calculated risk
to be notified
with TB-related
disease, following
primary TB infection†
%
Calculated risk
to be notified
with TB-related
death, following
primary TB infection‡
%
Relative
TB-related
mortality§
%
1 1 11.9 6 0.6
1–4 10 5.6 1 12.1
5–9 20 3.8 0.3 9.1
10–14 10 6.4 0.5 9.1
15–24 30 10 (males)
13 (females)
1.5 (males)
2.6 (females)
16.7 (males)
39.4 (females)
* Indicates the calculated percentage of children who develop primary infection (tuberculin conversion) within a specific age group.
† Indicates the number of children notified with TB, as a percentage of the total number expected to have developed primary TB infection, within a specific age
group.
‡ Indicates the number of children notified with death due to TB, as a percentage of the total number expected to have developed primary TB infection within a
specific age group.
§ Indicates the percentage of TB-related mortality compared to all-cause mortality within a specific age group.
Data on primary TB infection were collected from the British MRC tuberculin skin test survey for London (1949–1950).5 This was converted into the number of
children expected to develop primary infection within a specific age group, using national census data for London (1951). Data on TB-related disease and death
were collected from TB notifications and death certificates for London (1945–1949).5 Absolute notification numbers were converted into percentages, using the
number expected to develop primary infection within a specific age group as denominator and accepting that all notifications result from recent primary infec-
tion. Relative TB-related mortality was calculated from death certificates for England and Wales (1950), comparing TB-related mortality with all-cause mortality.5
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age groups, except in infancy.3,5 The low rate of infec-
tion and the high mortality from other causes during
infancy explain this contradiction (Table 3).3,5,8 Urban-
ised, densely populated areas suffered increased mor-
tality from both tuberculosis and other causes.4,6
Black children suffered double the tuberculosis-
related mortality and four times the all-cause mortal-
ity experienced by white children.3,7,8 The tuberculo-
sis-related mortality in black children declined by 80%
during the Tennessee study.8 A 10-fold decline in tuber-
culosis-related mortality occurred in Britain between
1900 and 1950, without a comparable decrease in
tuberculosis infection.5,7
DISCUSSION
The combined studies represent an impressive body
of evidence and clarify some important epidemiolog-
ical concepts in childhood tuberculosis. Household
exposure to a sputum smear-positive source case
posed the greatest risk to children. Household expo-
sure to a sputum smear-negative source case or non-
household exposure to a sputum smear-positive source
case posed a reduced, but still appreciable risk.
It is a public health priority to identify and treat all
sputum smear-positive source cases in the commu-
nity. Therefore, prudent public health policy should
encourage active case finding amongst household
members of children infected before 2 years of age, as
part of an expanded (‘reverse’) contact investigation.
In low prevalence areas this active case finding may be
extended to household members of all recently infected
or diseased children, irrespective of age.
After 2 years of age, the majority of children from
high prevalence areas became infected in the commu-
nity. However, household exposure to a sputum
smear-positive source case remained an important
contributor to primary infection up to 5–10 years of
age. Children with primary infection at 5–10 years
of age had the lowest risk of disease development and
death. In low-prevalence areas household exposure
remains an important contributor to primary infec-
tion throughout life, and all household contacts, irre-
spective of age, require screening. These findings
provided the scientific basis for classical contact inves-
tigation practices, which focus on children less than 5
years of age in most developing countries and all house-
hold contacts in most industrialised countries.
Another public health priority is the identification
of children at risk of disease development and death.
The calculated risk for disease development and
death following primary infection within a specific
age group represents a reinterpretation of original
data, as outlined under methods (Table 3). Infants
were at highest risk of disease development and death
following primary infection. However, the use of
accumulated tuberculin positivity as denominator in
the original publication,5 instead of tuberculin con-
verters within a specific age group, obscured the
emergence of the second high-risk period around
puberty. Children who were uninfected at 10 years of
age were at considerable risk of developing adult-type
cavitating disease following primary infection. This
marked increase in risk may be obscured by analysis
of notification data, due to the delay in disease notifi-
cation that results from passive case finding in adult-
type disease. Disease and mortality data for the age
group 15–25 years probably contain a significant
contribution from delayed disease notification fol-
lowing primary infection in the 10–14 year age group
(Table 3).
Previously uninfected adolescents are a particu-
larly vulnerable group, especially in high-prevalence
communities where the risk of future infection is
high. Mantoux skin testing at 7–9 years of age may
aid in the identification of children who are still unin-
fected. Effective immunisation or active case finding
may be warranted in this vulnerable group to reduce
individual morbidity and disease transmission in the
community. Children with a significant Mantoux
reaction without prior anti-tuberculosis treatment
may be offered treatment of latent infection to reduce
the possible risk of future reactivation.
The relative tuberculosis-related mortality indicates
that tuberculosis contributes significantly to all-cause
mortality in high-burden areas throughout child-
hood. The relative contribution to all-cause mortality
is lowest in infancy, but it does not detract from the
important observation that infected infants represent
the group at highest risk of death from tuberculosis.
It is difficult to separate racial and genetic factors
from socio-economic and cultural influences. How-
ever, the dramatic decline in disease and mortality
documented within a single generation, without a
comparable decrease in infection,5,8 emphasises the
considerable influence of socio-economic improve-
ment. This is contrary to the natural selection view
proposed by Grigg in his influential article, ‘The
arcana of tuberculosis’.10 The nature versus nurture
issue is complex, and is far from resolved,11 but
improvement in the environment rather than genetic
selection seems to be the main contributor to the dra-
matic reduction in tuberculosis witnessed in the
developed world during the 20th century.
Important limitations of the individual studies were
identified, and although the combined study results
compensate for many of the individual study deficien-
cies, major limitations remain. Different methods of
tuberculin administration were used, with the Man-
toux intradermal technique established as the best
method. Different strengths of tuberculin were used,
with 5 TU providing the best sensitivity whilst retain-
ing specificity. The sensitivity of the TST could not be
measured due to lack of a gold standard, but it corre-
lated well with exposure and radiographic proof of
infection. The Mantoux skin test remains the accepted
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method of documenting infection. Even with the advent
of more sensitive and specific T-cell based assays (e.g.,
ELISPOT),12 the skin test’s sensitivity and specificity
remain favourable and its simplicity unsurpassed.
The most important limitation to this analysis was
the absence of a clear definition of disease. To gain a
better understanding of the crucial transition from
infection to disease, it is important to accurately define
disease. Pulmonary tuberculosis represents a whole
spectrum of pathology, and different disease entities
need to be separated. Notification data often provide
unreliable information due to under- or over-report-
ing of disease and inaccurate cause of death identifi-
cation. Under-reporting of primary pulmonary tuber-
culosis in children was a particular problem.7 In
addition, the reported rate of infection varied consid-
erably among studies, especially within the important
younger age groups. The rate of primary infection
accepted at a specific age influences the calculated risk
of subsequent disease and mortality. Due to these limi-
tations, risk calculations may vary widely. The optimal
way to define risk and to describe exact disease entities
is by prospectively following an unselected cohort of
children with recent primary infection for subsequent
disease development and death. Studies that docu-
mented the natural history of disease achieved this.
Despite the limitations of the articles reviewed,
valuable epidemiological information is provided,
which may assist with the formulation of evidence-
based public health policies. The recent emergence of
human immunodeficiency virus (HIV) infection in
many high-prevalence areas, and its influence on mor-
bidity and mortality, establish the need for new epide-
miological data and the global epidemiological sur-
veillance of tuberculosis in children.
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R É S U M É
La littérature pré-chimiothérapique représente un
ensemble de faits impressionnants qui permettent de
clarifier un important concept épidémiologique au sujet
de la tuberculose de l’enfant. Elle décrit les transitions
majeures dans la tuberculose : de l’exposition à l’infec-
tion et de l’infection à la maladie (morbidité et mortalité)
en dehors de toute influence de la chimiothérapie. Les
enfants exposés à leur domicile à un cas-source à bacil-
loscopie positive des expectorations ont le risque le plus
élevé de développer une infection et une maladie
ultérieure. L’exposition à domicile à un cas-source à bacil-
loscopie négative ou l’exposition en dehors du domicile
comporte toujours un risque appréciable quoique forte-
ment réduit. Les enfants chez qui l’on découvre une
infection avant l’âge de 2 ans suggèrent la probabilité
d’un cas-source dans le ménage. Chez la majorité des
enfants plus âgés qui ont été infectés, on n’a pas pu iden-
tifier une source au sein de ménage ; ils ont probable-
ment été infectés dans la collectivité. Le risque annuel
d’infection (RAI) n’est pas constant au fil des âges mais
semble augmenter au cours des périodes d’élargissement
des contacts sociaux. Les nourrissons et les adolescents
ont été les groupes où le risque de développement de la
maladie et celui de décès sont les plus élevés dans les
suites de la primo-infection.
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R E S U M E N
La literatura de la era prequimioterapia representa un
conjunto impresionante de evidencias que clarifican
importantes conceptos epidemiológicos de la tuberculo-
sis infantil. Ella describe las transiciones más impor-
tantes de la tuberculosis, desde la exposición y desde la
infección hasta la enfermedad (morbilidad y morta-
lidad), sin la influencia de la quimioterapia. Los niños
expuestos en el domicilio a casos índices con bacilosco-
pia positiva tenían el mayor riesgo de desarrollar la
infección y la enfermedad subsecuente. La exposición en
el domicilio a casos índices con baciloscopia negativa o
la exposición fuera del domicilio tenía un riesgo apreci-
able, aunque considerablemente reducido. La consta-
tación de una infección en un niño menor de 2 años in-
dicaba la existencia probable de un caso índice en el
domicilio. En la mayoría de los niños mayores de 2 años
que estaban infectados no se identificaba un caso índice
en el domicilio y presumiblemente habían sido infecta-
dos en la comunidad. El riesgo anual de infección (ARI)
no era constante a través de las edades, sino que parecía
aumentar durante los períodos en los que los contactos
sociales se multiplicaban. Los lactantes y los adoles-
centes eran grupos de alto riesgo para el desarrollo de la
enfermedad y muerte después de la infección primaria.
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The natural history of childhood intra-thoracic tuberculosis:
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The pre-chemotherapy literature documented the natu-
ral history of tuberculosis in childhood. These disease
descriptions remain invaluable for guiding public health
policy and research, as the introduction of effective chemo-
therapy radically changed the history of disease. Specific
high-risk groups were identified. Primary infection before
2 years of age frequently progressed to serious disease
within the first 12 months without significant prior
symptoms. Primary infection between 2 and 10 years of
age rarely progressed to serious disease, and such pro-
gression was associated with significant clinical symp-
toms. In children aged 3 years the presence of symptoms
represented a window of opportunity in which to estab-
lish a clinical diagnosis before serious disease progres-
sion. Primary infection after 10 years of age frequently
progressed to adult-type disease. Early effective inter-
vention in this group will reduce the burden of cavitating
disease and associated disease transmission in the commu-
nity. Although the pre-chemotherapy literature excluded
the influence of human immune deficiency virus (HIV)
infection, recent disease descriptions in HIV-infected
children indicate that immune-compromised children
behave in a similar fashion to immune immature chil-
dren (less than 2 years of age). An important concept
deduced from the natural history of tuberculosis in
childhood is that of relevant disease. Deciding which
children to treat may be extremely difficult in high-
prevalence, low-resource settings. The concept of rele-
vant disease provides guidance for more effective public
health intervention.
KEY WORDS: review; pre-chemotherapy; natural his-
tory; child pulmonary tuberculosis
DURING THE TWENTIETH CENTURY, major
advances occurred in the diagnosis and treatment of
tuberculosis. Detection of infection became possible
with the tuberculin skin test (TST), and diagnosis of
disease was enhanced with the use of chest radiogra-
phy. When chest radiography became available after
the First World War, it increased the capacity to detect
pulmonary tuberculosis and permitted the evaluation
of the extent of lung disease, but it was not particu-
larly specific in determining disease activity. The most
important advance in the diagnosis of tuberculosis
was the ability to detect the causative organism on
direct microscopy of clinical specimens and to isolate
Mycobacterium tuberculosis in cultures of these spec-
imens. This advance, however, had minimal impact
on improving the management of tuberculosis in chil-
dren, as compared to adults, few children display the
organism in clinical specimens.
The first anti-tuberculosis drugs were introduced
after the Second World War with more effective drugs
following in the early 1950s. This enabled most cases
of tuberculosis to be cured of their disease. The
period from 1920 to 1950 represents the time when
chest radiography was available for accurate disease
diagnosis and description, without effective treatment
to influence the natural history of disease. Excellent
observational studies were conducted during this
time, characterised by the meticulous long-term follow-
up of patients. This invaluable source of informa-
tion provided detailed descriptions of disease pre-
sentation and progression without the influence of
chemotherapy or human immunodeficiency virus (HIV)
infection.
A review of the pre-chemotherapy literature and
the knowledge gained is important for the following
reasons: 1) to assist with establishing an optimal case
definition to be used as an outcome measure for research
purposes when evaluating new drug treatments, new
Correspondence to: Dr Ben J Marais, Centre for TB Research and Education, Stellenbosch University, P O Box 19063, Cape
Town, Western Cape 7505, South Africa. Tel: (27) 21 9389155. Fax: (27) 21 9389155. e-mail: bjmarais@sun.ac.za
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[A version in French of this article is available from the Editorial Office in Paris and from the UNION website www.iuatld.org]
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diagnostic modalities or new vaccines; and 2) to assist
in establishing a working case definition to guide public
health intervention by determining which infected cases
(drug-sensitive or drug-resistant) require treatment.
The aim of this review was to document the find-
ings of the pre-chemotherapy literature in a critical
manner and to describe the natural history of intra-
thoracic tuberculosis in children. The relevance of
these findings is interpreted for the public health chal-
lenges faced today.
METHODS AND MATERIALS
Original studies on childhood pulmonary tuberculo-
sis, conducted between 1920 and 1950 and published
in the English literature, were identified from text-
book references and extensive cross-referencing.
Major studies reporting on more than 1000 children
and with a study duration of at least 10 years were
included.1–9 The database collected was then com-
pared to the International Union Against Tuberculo-
sis and Lung Disease (IUATLD) archive to ensure that
no major study had been excluded. Three exceptions
were made: 1) Avrid Wallgren’s findings were based
on a lifetime of personal experience and careful
observation. Although he only reported prospectively
on 100 exposed children who became infected under
observation, he described the very influential time-
table of primary tuberculosis.1–3 2) Tobias Gedde-Dahl
included 3138 children, but the study was interrupted
after 8 years due to the Second World War. The study’s
contribution is important because it provides the only
accurate description of active community surveil-
lance. 3) Edith Lincoln reported on 964 children fol-
lowed for up to 25 years and provided unique
descriptions of the clinical signs and symptoms that
develop during disease progression.8 The combina-
tion of community and hospital-based studies ensures
representation of the whole spectrum of disease.
Studies are reported in chronological order to illus-
trate the progression in knowledge.
A brief description of the individual studies and
the design used in each study is provided (Table 1).
This is followed by a summary of the key findings and
major limitations of each individual study (Table 2).
The combined study results provide a summary of the
major findings.
A uniform template of disease classification was
developed and applied to all the studies included in this
review to facilitate the comparison and combination of
results. This template is based on disease descriptions
and concepts of pathology derived from the pre-
chemotherapy literature (Table 3). It is important to
note that more than one disease entity may co-exist at
the same time or develop during the course of disease.
Children were defined as age less than 15 years. Only
Bentley et al. included 15 years in their definition of a
child.6 Adolescents were defined as children aged over
10 years. Primary infection was defined as first time
tuberculosis infection as represented by TST conversion.
COMBINED STUDY RESULTS
Wallgren summarised the sequence of pathology fol-
lowing primary infection in childhood in great detail.1
His pathological summary correlated well with clini-
cal observations, which he documented in the time-
table of tuberculosis. This was later confirmed and
expanded by other investigators.
Sequence of pathology after pulmonary
infection in childhood
Pulmonary infection occurs when a few tuberculosis
bacilli successfully reach a terminal airway after in-
halation. A localised pneumonic inflammatory pro-
cess results, called the parenchymal focus. From this
parenchymal (Ghon) focus, bacilli drain via local lym-
phatics to the regional lymph nodes. The Ghon focus,
with associated local tuberculous lymphangitis and
involvement of the regional lymph nodes, is called the
primary complex. From the regional lymph nodes,
bacilli enter the systemic circulation directly or via the
lymphatic duct. This occult haematogenous spread
occurs during the incubation period, before adequate
immune responses contain the disease. After dissemi-
nation, bacilli may survive in target organs for pro-
longed periods.1 The future course of the disease
depends on the dynamic balance between host immu-
nity and the pathogen.1,3,6,8,9
Timetable of clinical disease after pulmonary
infection in childhood
• Phase 1 occurred 3-8 weeks after primary infec-
tion.1,3 The end of the initial asymptomatic incuba-
tion period was heralded clinically by hypersensi-
tivity reactions such as initial fever, erythema
nodosum, a positive tuberculin skin test response
and formation of the primary complex visible on
chest radiograph.1,3
• Phase 2 occurred 1–3 months after primary infec-
tion.3 This period followed the occult haematoge-
nous spread that occurred during incubation, and
represented the period of highest risk for the devel-
opment of tuberculous meningitis and miliary tuber-
culosis in young children.1,3 However, tuberculous
meningitis and miliary disease occurred after any
time interval following disease progression with
haematogenous dissemination.5,6,6,9
• Phase 3 occurred 3–7 months after primary infec-
tion.3 This was the period of pleural effusions in
children aged over 5 years,3 and bronchial disease
in children aged less than 5 years.5,6,8,9
• Phase 4 lasted until the primary complex was calci-
fied, 1–3 years after primary infection.3 This was
the period of osteo-articular tuberculosis in chil-
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dren aged under 5 years,3,9 and adult-type disease in
adolescents.2–9 As a general rule the risk of disease
progression following primary infection had passed
by the time calcification appeared.4–9 However, adult-
type disease with delayed clinical onset after primary
infection did occur after calcification was present.7,9
• Phase 5 occurred after calcification was completed,
more than 3 years after primary infection. This
represented the period in which the late manifesta-
tions of tuberculosis, including pulmonary reacti-
vation disease, developed.6,9
The classic timetable, illustrated schematically as
the timeline of tuberculosis (Figure 1), described com-
mon clinical patterns of disease and does not represent
dogmatic rules regarding the course of tuberculosis in
Table 1 Description of original studies and individual study designs documenting the natural history
of childhood intra-thoracic tuberculosis
Individual study reference Time frame Study type Study population Data collection methods
1 Wallgren A—1935, 1938, 1948
Children’s Hospital, Gothenburg and 
the Karolinska Medical Institute,
Stockholm, Sweden
Primary pulmonary tuberculosis in
childhood1
Relation of childhood infection to 
the disease in adults2
The timetable of tuberculosis3
1930–1950 
Follow-up 
period not 
specified
Prospective 
descriptive, 
hospital-based
Personal experience
100 newly infected 
children
All children with TB 
seen on referral
Children observed after 
household exposure
Meticulous documentation of 
signs/symptoms following 
infection
In addition, Wallgren drew 
from vast personal 
experience
2 Brailey M—1940
Johns Hopkins (Harriet Lane Clinic), 
Baltimore, Maryland, USA
Prognosis in white and coloured 
tuberculous children according to
initial chest X-ray findings4
1928–1937 
Follow-up 
period of
1–10 years
Retrospective 
descriptive,
out-patient-based
285 families with 
1383 children
15 years
40% white
60% black
All children from tuberculous 
households
TST (Old tuberculin at 0.1 or
1 mg)
Annual CXR if TST-positive
3 Gedde-Dahl T—1951
Kinn District, Bergen, Norway
Tuberculous infection in the light of 
tuberculin matriculation/conversion5
1937–1944 
Follow-up 
period of
1–8 years
Prospective TST 
survey, 
community-based
6739 people
3138 children
15 years
Annual community-based TST 
survey (Von Pirquet)
Documented TST conversion
Annual CXR if TST-positive
4 Bentley F J, Grzbowski S, Benjamin B—
1954
High Wood Hospital for children, 
Brentwood, Essex, UK
Tuberculosis in childhood and
adolescence6
1942–1952 
Follow-up 
period of
5–10 years
Retrospective 
descriptive, 
hospital-based
Literature review
1) Sanatorium 
patients
1049 children 
16 years
2) Death investigation
100 consecutive TB 
deaths in children 
Successive referrals admitted 
over a 10-year period
Observation and CXR in 
hospital
Review CXR 5–10 years after 
hospital discharge
5 Davies P D B—1961
Brompton Hospital, London, UK
The natural history of tuberculosis in 
children7
1930–1954 
Follow-up 
period of
2–25 years
Retrospective 
descriptive,
out-patient-based
2377 children
15 years
All asymptomatic household 
contacts 
Different TSTs compared
Annual CXR
70% follow-up achieved
6 Lincoln E M, Sewell E M—1963
Bellevue Hospital, New York City,
New York, USA
Tuberculosis in children8
1930–1960 
Follow-up 
period of 
10–25 
years
Prospective 
descriptive, 
hospital-based 
Sanatorium patients 
954 15 years 
50% white 
25% black
25% Puerto
Rican
Children referred with 
evidence of recent 
(uncalcified) TB
Observation and CXR in 
hospital
Hospitalised for extended 
periods with careful 
documentation of disease 
progression
Annual CXR after discharge
90% follow-up achieved
7 Miller F J W, Seal R M E, Taylor M D—1963 
Royal Victoria Infirmary, Newcastle upon
Tyne and Children’s Sanatorium at
Stannington, Northumberland, UK 
Tuberculosis in children9
;
1) 1941–1951
2) 1951–1961
Follow-up
period of
1–10 years
Retrospective
descriptive,
out-patient-based
Literature review
1) Children 7 years
from 1000 families
with an adult
source case
2) 1500 children 5
years in household
contact with an
adult source case
1) 1000 family study
Household contacts
7 years
Annual CXRTST
(until positive)
99 TST converted 
2) Household contact study
Household contacts 
5 years
Annual CXRTST 
(until positive)
72 TST converted
TST  tuberculin skin test; CXR  chest radiograph; TB  tuberculosis.
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children. The vast majority of disease manifestations
occurred in the first 6–12 months following primary
infection.5,7,9
COMBINED STUDY RESULTS ACCORDING
TO THE TEMPLATE USED FOR
DISEASE CLASSIFICATION
The pathology-based disease classification outlined in
Table 3 describes distinct disease entities. This was used
as a template to compare and combine results. The
combined results illustrate the clinical and radiologi-
cal presentation, as well as the risk factors for and the
prognosis of each distinct disease entity.
Pulmonary infection
Pulmonary infection was identified after active con-
tact tracing or presentation of children by anxious
parents.6,8,9 Pulmonary infection was associated with
TST conversion and non-specific, self limiting, viral-
like respiratory symptoms.1–3,6,9 Enlarged regional
lymph nodes on chest radiograph were the hallmark
of pulmonary infection with or without a visible
Ghon focus.5–9 Following primary infection, 50–70%
of children showed these radiological signs, irrespec-
tive of symptoms.5,7,9 Good quality antero-posterior
and lateral radiographic views were required for opti-
mal visualisation of enlarged regional lymph nodes.6,8,9
The Ghon focus had no predilection for any specific
part of the lung:5,7,8 a Ghon focus in the apex of the
lung affected the ipsilateral paratracheal nodes;6,8 a
Ghon focus in other parts of the right lung caused
right-sided hilar adenopathy; and a Ghon focus in the
lower parts of the left lung caused bilateral hilar ade-
nopathy.6,8 Paratracheal nodes reflected a Ghon focus
in the apex, spread from hilar glands, or haematoge-
nous spread.6 It occurred more frequently in children
under 2 years of age and showed a consistent trend
Table 2 Summary of key findings and major limitations of the original studies that documented
the natural history of childhood intra-thoracic tuberculosis
Citation Age groups Unique feature Key findings Major limitations
Wallgren1–3 2 groups
3, 3–14 years
Meticulous 
observation
Detailed description 
of symptoms 
and signs 
following 
primary infection
Age at primary infection and time since primary 
infection were major determinants of risk 
for disease development following 
infection. It also influenced the type of 
disease manifestation
Host immunity was influenced by age and 
considered to be of crucial importance
Documented the timetable of disease
Study methodology was not 
specified
Observations were illustrated 
with case studies
Guidelines provided were 
dogmatic
Brailey4 5 groups
1, 1–2, 2–4, 
5–9,
10–14 years
Relevant age groups
Racial differences
In all children 2 years and in black children 
5 years segmental lung lesions were 
predominant
Black children suffered increased morbidity and 
mortality
Public health entry point 
selected the poor
Type of segmental lesion not 
specified
Socio-economic differences not 
evaluated
Gedde-Dahl5 3 groups
5, 5–9,
10–14 years
TST conversion in 
the community
Enlarged nodes were visible on CXR in the vast 
majority of recently infected children
All CXR changes apart from cavitation and 
calcification were seen within 1 year after 
infection
Pre-school children were poorly 
and selectively represented
Isolated community
Bentley et al.6 4 groups
1, 1–4, 5–9, 
10–15 years
First dedicated 
childhood TB 
study in UK
Described the slow rate at which adenopathy 
undergoes radiological regression
Suggested to focus on high risk groups: 
(2 years and 10 years of age)
Excessive preselection occurred 
due to the referral system 
and long waiting periods
Disease progression was not 
well documented
Davies7 4 groups
1, 1–4, 5–9, 
10–14 years
UK study with 
longest follow-
up period
Progression of disease was documented even 
after calcification became visible
Risk of cavitating disease was highly dependent 
on age at primary infection (10 years)
Selected only asymptomatic 
children at study entry, to 
ensure clinical unity
Majority of children were already 
infected at study entry
Lincoln et al.8 4 groups
1, 1–4, 5–9, 
10–14 years
Detailed description 
of disease 
progression
Meticulously documented disease progression 
together with the signs, symptoms and 
outcome associated with each specific 
disease entity
Study inclusion was selective 
(symptomatic children with 
CXR evidence of recent 
infection)
Limited racial sub-analysis
Miller et al.9 5 groups
1, 1–2, 2–4, 
5–9,
10–14 years
Relevant age groups
Comprehensive
literature review
Informative illustrations of lymph drainage and
TB lung pathology
Re-emphasised high-risk groups following
primary infection (2 years and 10 years of 
age
Cavitating disease may follow primary infection,
reinfection or reactivation
Cavitation with visible
calcification was accepted as
proof of reactivation
Validity of studies quoted were
not evaluated
TST  tuberculin skin test; CXR  chest radiograph; UK  United Kingdom; TB  tuberculosis.
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towards increased haematogenous spread, even with
correction for age.6 During the first 3–4 months the
lymph nodes were in a phase of ‘full activity’: vaguely
defined, cloudy and homogeneous.6 Over the follow-
ing months the radiological signs of ‘activity’ re-
gressed, the shadow became denser, better defined and
more heterogeneous.6 With serial radiographs, 40%
of lesions cleared within 6 months, a further 30%
within 1 year, and the remainder persisted for up to 4
years.6,9 Calcification developed in 20–50% of chil-
dren with visible lymph node involvement.6,7,9 Calci-
fication usually occurred between 12 and 24 months,
but was rarely delayed up to 4 years after primary in-
fection.6,9 Calcification in young children tended to
be more extensive and developed earlier (within 6–12
months) than in older children.6,7 In general, calcifica-
tion was an indication of clinical quiescence, but not
a guarantee thereof.7–9 The disappearance of calcifica-
tion was rare and was attributed to either resorption
or bronchial escape of a pneumolyth.9 The prognosis
of pulmonary infection was favourable, with the as-
sociated risk mainly dependent on the age at the time
of primary infection (Table 4).1–9 Neither the presence
of a visible parenchymal lesion nor the size of regional
Table 3 Disease classification of childhood pulmonary tuberculosis used as template
Pulmonary infection Tuberculosis infection uncomplicated by clinical symptoms (other than self-limiting, viral-like illness) 
or radiological abnormalities (other than the primary complex). The primary complex includes 
the Ghon focus with associated tuberculous lymphangitis and affected regional lymph nodes. 
Pulmonary infection without progression to disease implies successful containment of the 
organism.
Pulmonary disease Tuberculosis infection complicated by marked clinical symptoms or additional radiological 
abnormalities apart from the primary complex. Pulmonary disease includes a diverse spectrum of 
pathology, described as separate disease entities.
Separate disease entities
Ghon focus with/without
cavitation
Progressive parenchymal caseation surrounding the Ghon focus represents poor organism 
containment. The area of caseation may discharge into a bronchus, resulting in the formation of 
a cavity with possible endobronchial spread.
Lymph node disease Regional lymph node enlargement forms part of the primary complex, but the presence of marked 
clinical symptoms differentiates lymph node disease from pulmonary infection.
Bronchial disease With pulmonary infection, affected regional lymph nodes attach to the bronchus, but rarely 
progress to clinical or radiological disease. If disease progression follows this ‘lympho-bronchial 
involvement’, the affected bronchus may become partially or totally obstructed as a result of 
nodal compression, inflammatory oedema, polyps, granulomatous tissue or caseous material 
extruded from ulcerated lymph nodes. Distal parenchymal disease may result from aspiration of 
caseous material. Variation in the degree of airway obstruction, dose and virulence of the bacilli 
aspirated and the immune status of the host, determines the degree of pathology.
With airway obstruction Airway obstruction occurs due to enlarged matted nodes encircling and compressing an airway, 
together with associated inflammation or additional processes described above.
With collapse/hyperinflation Complete airway obstruction leads to resorption of distal air and collapse, while partial airway 
obstruction may cause a ball-valve effect with hyperinflation of the segment or lobe supplied.
With allergic consolidation Nodal perforation into an airway with endobronchial aspiration of allergic products causes an acute 
hypersensitivity response (epituberculosis) with dense consolidation.
With brochopneumonic
consolidation
Nodal perforation into an airway with endobronchial aspiration of live bacilli causes local areas of 
caseation surrounding the airways, resulting in patchy consolidation.
With caseating consolidation Nodal perforation into an airway with endobronchial aspiration of live bacilli causes extensive 
parenchymal caseation, resulting in dense expansile consolidation of the affected segment or 
lobe.
Pleural disease Pleural involvement occurs after direct spread of caseous material from a sub-pleural parenchymal 
or lymph node focus, or from haematogenous spread. Variation in the dose and virulence of 
bacilli that enter the pleural space together with the immune status of the host determines the 
degree of pathology.
With effusion The presence of caseous material in the pleural space triggers a hypersensitivity inflammatory 
response with the accumulation of serous straw-coloured fluid containing few tuberculosis 
bacilli.
WIth empyema Active caseation in the pleural space causes thick loculated pus, containing many tuberculosis 
bacilli.
With adult-type disease Excessive local containment may cause parenchymal destruction and resultant cavity formation. 
Tubercle bacilli flourish in these cavities from where they disseminate to other parts of the lung 
via endobronchial spread. Endobronchial spread occurs directly from these infected cavities and 
is not dependent on lymphobronchial breakthrough, as with bronchial disease.
Haematogenous spread Tuberculosis bacilli may enter the blood stream via pulmonary lymphatic drainage, from affected 
regional lymph nodes or directly from the parenchymal focus. Haematogenous spread is a 
condition of infinite gradation, depending on the frequency, dose and virulence of the bacilli 
released as well as host immunity. During occult spread bacilli are seeded into susceptible 
organs, while the child remains asymptomatic.
With miliary disease Following invasion of the blood stream, tuberculosis bacilli lodge in small capillaries, where they 
may progress to form tubercles, visible on chest radiograph as typical, even-sized miliary lesions 
(2 mm) or atypical lesions of differing size.
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hilar lymph nodes influenced the prognosis, apart from
an increase in segmental lesions.6 
Pulmonary disease
Host immunity was considered to be the major deter-
minant of risk for disease development following
infection.1 Infants, with immature immune systems,
were at highest risk,1–9 with pulmonary disease devel-
oping in 30–40% and tuberculous meningitis (TBM)
or miliary disease in a further 10–20%.4,6,8,9 The risk
decreased considerably in the second year of life, but
remained significant, with 10–20% of infected chil-
dren developing pulmonary disease and a further 2–
5% TBM or miliary disease.8,9 This risk decreased to
less significant levels in the 2–5 year age group before
reaching its lowest level at 5–10 years of age (Table
4).4,6,8,9 Bronchial disease predominated in children
aged under 5 years.6–9 Pleural effusions in-creased in
incidence from 5 years of age onward.6–9 Disease rarely
occurred in children aged 5–10 years, with pleural
effusion the most common manifestation. Within this
age group bronchial disease was more common in
younger children and adult-type disease in older chil-
dren.6–9 Black children had an increased risk of devel-
oping bronchial disease across all age groups.4 Primary
infection during adolescence was associated with a
high risk (10–20%) of developing adult-type dis-
ease.1–9 The risk and the type of disease that followed
primary infection is summarised for specific age groups
(Table 4).
Ghon focus with/without cavitation
A Ghon focus with cavitation was rare. It occurred pre-
dominantly in black children aged under 2 years.4,6,8,9
Clinical symptoms of Ghon focus cavitation included
weight loss, fatigue, fever and chronic cough.8,9 In
those with cavitation, disease progressed to death
within 1 year in the majority of cases.8,9 Healing was
rare, and even those that survived the initial illness
ultimately died from tuberculosis or associated com-
plications.8 Cavitation following primary infection
occurred frequently during adolescence,2,5–9 but in this
age group parenchymal breakdown probably reflected
excessive rather than poor disease containment. This
is discussed under the heading, adult-type disease.2,9
Lymph node disease
Enlarged regional lymph nodes on chest radiograph
rarely caused symptoms except when they were asso-
ciated with bronchial disease, or when excessive
nodal caseation caused persistent fever and weight
loss.9 The subcarinal nodes were most commonly
involved and rarely pericardial effusion developed fol-
lowing nodal erosion with caseous discharge into the
pericardial space.9
Bronchial disease
Different degrees of airway obstruction and/or paren-
chymal involvement reflected a spectrum bronchial
disease. Bronchial disease occurred predominantly in
children aged under 5 years. It occurred more fre-
quently in younger children, boys,6–9 and black chil-
dren.4 The most frequently affected lobes were the
right upper lobe (anterior segment), the right middle
Table 4 Average age specific risk for disease development 
following primary infection
Age at primary
infection
Immune-competent children
(dominant disease entity
indicated in brackets)
Risk of disease
following
primary infection
%
1 year No disease 50
Pulmonary disease (Gnon
focus, lymph node, or
bronchial)
30–40
TBM or miliary disease 10–20
1–2 years No disease 70–80
Pulmonary disease (Gnon
focus, lymph node, or
bronchial)
10–10
TBM or miliary disease 2–5
2–5 years No disease 95
Pulmonary disease (lymph 
node, or bronchial)
5
TBM or miliary disease 0.5
5–10 years No disease 98
Pulmonary disease (lymph
node, bronchial,
effusion or adult-type)
2
TBM or miliary disease 0.5
10 years No disease 80–90
Pulmonary disease (effusion
or adult-type) 10–20
TBM or miliary disease 0.5
TBM  tuberculous meningitis.
Figure 1 Schematic timeline of primary pulmonary tuberculo-
sis. Phase of disease (adapted from the timetable of tuberculosis
described by Wallgren3)
0 Incubation phase
I Hypersensitivity phase
II Phase of miliary tuberculosis and tuberculous meningitis
III Phase of segmental lesions in children aged under 5
years and pleural effusion in those aged over 5 years
IV Phase of osteo-articular tuberculosis in children aged
under 5 years and adult-type disease in those aged over
10 years
V Phase of late manifestations including pulmonary reacti-
vation disease.
Not all these disease manifestations (phases) are equally com-
mon, and while hypersensitivity is a nearly universal phenome-
non following primary infection, the late manifestations are
extremely rare. Table 4 provides an indication of how common
the most important of these disease manifestations are in spe-
cific age groups.
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lobe and the left upper lobe.6–9 The lobes most fre-
quently affected in combination were the right middle
and lower lobes, indicating involvement of the bron-
chus intermedius.6–9 Rebound enlargement of segmen-
tal lesions, attributed to immune reconstitution, were
described after cessation of high-dose steroid treat-
ment.9 Bronchoscopy results reflected the pathological
spectrum of bronchial involvement: no visible involve-
ment, obstruction from external nodal compression,
endobronchial nodal breakthrough with caseous drain-
age, granulation tissue with polyps and fistula forma-
tion.6,8 A very rare sequel was the expectoration of a
pneumolyth after perforation of a calcified lymph node
into an airway.8,9 The prognosis of bronchial disease
and associated distal parenchymal involvement de-
pended on the type and duration of involvement.6,8,9
Bronchial disease
With airway obstruction. Symptoms varied
according to the degree of airway irritation and obstruc-
tion. Infants frequently developed a persistent cough,
sometimes mimicking pertussis.8,9 With disease pro-
gression the cough became more prominent, often
brassy or bitonal, with associated large airway wheeze
or stridor.1,8,9 Imminent total airway obstruction was
viewed as an indication for surgery.9
With collapse/hyperinflation. Collapse and
hyperinflation were mostly radiological diagnoses, with
minimal clinical symptoms, unless large lung segments
collapsed or hyperinflation caused symptoms related
to pressure on surrounding structures.6,8
With allergic consolidation (epitubercu-
losis). The onset of symptoms could be dramatic,
with a high fever, acute respiratory symptoms and
signs of consolidation.8 Chest radiography revealed a
densely consolidated segment or lobe with minimal
volume change.8,9 Consolidation resolved completely
within months, without permanent sequellae.8
With bronchopneumonic consolidation.
Bronchopneumonic caseating consolidation was rare.
Symptoms were not well described, but depended on
the extent of involvement. On chest radiograph
patchy infiltration usually involved more than one
lobe of a single lung.6 Bilateral patchy infiltration was
mostly due to protracted (atypical) miliary disease.6
With caseating consolidation. Children with
alveolar caseating consolidation were ill, with high
undulating fever, chronic cough and even haemopty-
sis.8 On chest radiograph expansile lobar involve-
ment with or without areas of breakdown was visible,
and mycobacterial cultures were positive in more
than 80% of cases.6,8,9 Secondary bacterial infection
often complicated the picture.6,9 Bronchoscopy showed
total airway obstruction and surgical re-establishment
of airway patency together with penicillin gave dra-
matic symptomatic relief.8,9 Following resolution of
the consolidation, non-parenchymal bullae appeared
with extensive fibrotic scarring in the surrounding
lung tissue.6,8 Without intervention the prognosis was
poor, with frequent haematogenous spread terminat-
ing in tuberculous meningitis.6,8
The end result of bronchopneumonic or caseating
consolidation was a contracted, fibrotic area.6–9 Con-
tracted segments were often impossible to visualise
on follow-up chest radiographs.6,8 Bronchial damage
was a common sequel that resulted in bronchial steno-
sis and/or bronchiectasis, ranging from mild to severe
saccular forms.6–9 Most children with bronchiectasis
remained asymptomatic on long-term follow-up.6–9
Apical lesions hardly ever caused complications, but
large basal lesions did predispose to future suppura-
tive disease.6–9 A few case reports of the middle lobe
syndrome (recurrent bacterial pneumonia in adults
with previous tuberculous damage of the right middle
lobe) were quoted.9 Surgery was only indicated when
a bronchiectatic lobe caused symptomatic disease.6,8,9
Very rarely, massive fibrosis and contraction of a
whole lung (chronic fibroid lung) caused mediastinal
shift and scoliosis.6,8
Pleural disease
With effusion. Localised pleurisy overlying a
peripheral Ghon focus was common.8 Limited adhe-
sions developed between the visceral and parietal
pleura, but this did not cause symptoms or lung func-
tion abnormality.8 Effusions were rare in children
under 5 years of age and were most common in adoles-
cent boys.6,7,9 A seasonal variation was observed, with
the lowest incidence during late summer and autumn,
accounted for by reduced tuberculous infection in the
preceding summer months.6 Pleural effusion had a
characteristic clinical course, starting with an acute
pleuritic pain in the chest, accompanied by a high fever
in the absence of acute illness, an ill-defined loss of
vigour and a dry cough.6,8,9 The tuberculin skin test
was highly reactive.6,8 On chest radiograph, pleural
effusions varied in size from small (obliterating only the
costophrenic angle) to massive (causing opacification
of a whole lung, with mediastinal shift to the opposite
side).6,8 In most cases only a third to a half of the lung
was obliterated with a clear meniscus sign.6 With fluid
in the pleural space it is nearly impossible to exclude
lesions in the underlying lung.6,8 Localised interlobular
effusions required radiological differentiation from
segmental lesions.9 A unilateral effusion, ipsilateral to
the Ghon focus, indicated direct spread to the pleural
space from a sub-pleural focus. Bilateral effusions indi-
cated haematogenous spread or bilateral Ghon foci.6–9
Pleural fluid was straw coloured and represented an
exudate with high protein content and lymphocyte pre-
dominance,8,9 although the amount of polymorphonu-
clear cells depended on the acuteness of onset.9 Direct
microscopy was negative, but culture yields were as
high as 70% with immediate inoculation.8
In children the prognosis of pleural effusion was
generally good. The high fever showed gradual effer-
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vescence over 3–4 weeks,6,8 while the fluid collection
resolved slowly over 3–6 months.6,9 Some oblitera-
tion of the costophrenic angle and slight pleural
thickening remained permanently.6,8,9 The main com-
plication described was future adult-type disease,
which was not a complication of the effusion per se,
but reflected the risk associated with primary infec-
tion at an older age.6–9 Rarely, extensive pleural fibro-
sis caused contraction of the affected hemithorax
with scoliosis.4,6 Bilateral effusions were associated
with double the risk for haematogenous spread and
future adult-type disease.6–9
With empyema. The presence of caseating empy-
ema was indicated by a persistent high swinging fever
and a loculated pleural collection on chest radio-
graph.9 Aspiration was difficult due to thick pus with
tubercle bacilli on microscopy.9 Caseating empyema
was rare and the prognosis was variable, with slow
disease progression and death or slow resolution with
pleural calcification and fibrosis.9
With adult-type disease. Adult-type disease
resulted from primary infection, endogenous reacti-
vation or exogenous reinfection.9 Adult-type disease
was most common after recent primary infection in
children over 10 years of age.2,4–9 The interval from
primary infection to adult-type disease was widely
variable (3 months to 20 years), mostly dependent on
the age at primary infection.6–8 The shortest time
intervals and highest risk followed primary infection
during adolescence, especially in girls of perimen-
archal age.5–9 Disease started off with minimal symp-
toms such as cough, loss of appetite and fatigue.8
With disease progression, typical tuberculosis symp-
toms of chronic cough, chest pain, lethargy, anorexia
and weight loss became evident.5,6,8,9 Children with
advanced disease became anaemic, developing an oscil-
lating fever and haemoptysis.8 A frequent complaint,
even in the absence of fever, was night sweats.8 On chest
radiograph an initial rounded homogeneous shadow,
2–3 cm in diameter, situated in the vicinity of the clav-
icle was typical, followed by parenchymal breakdown
and cavity formation.8,9 Cavities did not contain a fluid
level and were characteristically surrounded by inflam-
mation.9 Bilateral disease was common, mainly involv-
ing the apical segments of the upper lobes, with lower
lobe involvement less frequent.9 Previous radiographic
appearances were non-predictive and highly variable,
ranging from no visible abnormality to a densely calci-
fied primary complex.6 The prognosis of adult-type
disease was poor, with 50–60% mortality within 5–10
years.5,6–9 These children were sputum smear-positive
and able to transmit infection.
Haematogenous spread
During incubation and occult spread, bacilli seed to
susceptible organs, especially the spleen, bone, kid-
ney and cerebral cortex, and possibly to the lung
apices (Simon foci).1,8,9 The age at the time of infec-
tion and the time since infection were the main deter-
minants of risk for metastatic disease development.
Infection under 2 years of age carried a significant
risk of serious disease, even if the radiograph was
considered normal.6,9 TBM was present in over 30%
of children who presented with tuberculosis before 2
years of age.6,9 The risk of TBM after 3 years of age
was extremely low and those who did develop TBM
had significant preceding symptoms.8,9
With miliary disease. Infants were most vulner-
able to developing miliary disease.1,8,9 The symptoms
included prolonged py-rexia, lassitude, anorexia and
weight loss.6,8,9 Children appeared acutely ill, with
minimal physical signs apart from possible tachypnoea
and hepatosplenomegaly.6,8 Radiological mottling fol-
lowed 7–21 days after febrile onset, starting as barely
visible nodules that slowly progressed to large, poorly
defined patches.8 The initial miliary lesions were often
difficult to visualise, with 30–40% of autopsy proven
miliary lesions missed on chest radiograph before
death.6 Bone marrow biopsy and ophthalmoscopy
were useful diagnostic aids.6 The reported presence
of choroidal tubercles varied widely, from 10% to
70%.6,8,9 The majority of children were TST positive,
and in those children with an initial negative TST, skin
test conversion occurred within 1–4 months when
effective treatment became available.8 The prognosis
of miliary disease was poor. Clinical progression
with persistent fever, increased irritability and weight
loss frequently terminated in TBM.6,8,9 The majority
died within 6 months, but chronic forms were occa-
sionally seen where children eventually died from
toxaemia, malnutrition or amyloidosis.8 Typical even-
sized miliary mottling indicated an acute invasion of
the blood stream. Protracted release of bacilli from a
chronic focus, e.g., a matted lymph node mass or,
rarely, a skeletal lesion, also occurred.8 The symp-
toms of protracted seeding were similar to those of
acute invasion, but were initially intermittent, pre-
sumably corresponding to periods of bacilli or toxic
product release.8 This repetitive seeding was some-
times manifested by successive crops of papulone-
crotic tuberculides.8 The chest radiograph revealed
large hilar lymph node masses with mottling of vari-
able size.8,9 Eventual progression occurred with acute
or chronic deterioration.8
DISCUSSION
Pulmonary tuberculosis in childhood is often consid-
ered a benign condition, with little risk to the child
and no contribution to the transmission of disease
within the community. Although this is true for the
majority of infected children, specific high-risk groups
exist where disease poses a high risk of fatality for
the individual and/or a high risk of transmission to
the community.
Recent primary infection posed the greatest risk
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for disease progression in children. The period under
2 years of age represents the first high-risk period, as
infected children showed frequent progression to mil-
iary disease or tuberculous meningitis without signif-
icant prior symptoms. Children infected between 2
and 10 years of age rarely developed serious disease.
However, the majority of children from high-prevalence
communities were infected during this period, and
therefore relative low risk still translated into large
numbers and a significant burden of disease. In these
low-risk children, persistent, non-remitting symptoms
preceded progression to serious disease. This creates
a window of opportunity for clinical diagnosis. Ado-
lescence represent the second high-risk period, because
primary infection after 10 years of age showed fre-
quent progression to adult-type disease. Early inter-
vention in this group may reduce the burden of cavi-
tating disease and associated disease transmission in
the community.
An important concept deduced from the natural
history of tuberculosis in childhood is that of relevant
disease. Relevant disease reflects the level of risk posed
by the condition together with the calculated risk-benefit
ratio of treatment vs. no treatment in a particular set-
ting. Thus, in well-resourced settings with a low preva-
lence of tuberculosis, the minimal risk posed to the indi-
vidual and the community following infection may be
unacceptable and treatment indicated. However, in low-
resource settings with a high prevalence of tuberculosis,
a different definition of relevant disease is required, as
the majority of the population may be infected during
childhood. The vast majority of these children will suc-
cessfully contain the disease without chemotherapy. Pri-
ority for scarce resources indicates a need to target those
children who are most likely to develop serious disease
progression or pose a threat to the community. In high-
burden settings, resources should be prioritised accord-
ing to the clinical natural history of infection or the spe-
cific disease entity. Consideration of the risk posed to the
individual and the community utilises the same ratio-
nale used in adult tuberculosis, with the focus on spu-
tum smear-positive cases.
Previous guidelines did not provide clear definitions
of relevant disease in a particular setting. This led to a
Table 5 Suggested definition of relevant childhood tuberculosis* in high-burden countries, 
according to the specific age and immune category of the child
Relevant disease
Age category (years) Immune-competent Immune-compromised
2 years Recenty primary infection
or
symptomatic disease
Positive Mantoux important
Household source case important
Symptoms important
Diagnostic need
Sensitive/specific marker of infection
(all infection is recent and primary)
2–5 years
Positive Mantoux less important Symptomatic disease
Household source case less important
Symptoms important
Diagnostic need All infection
or
symptomatic disease
Validated symptoms-based algorithm
Sensitive/specific marker of symptomatic
disease
5–10 years
Positive Mantoux less important Symptomatic disease Positive Mantoux important
Household source case less important Household source important
Symptoms important Symptoms important
Diagnostic need Diagnostic need: Sensitive/
specific marker of all
infection (primary or
reinfection; recent or past)
Validated symptoms-based algorithm
Sensitive/specific marker of symptomatic 
disease
10 years Recent primary infection
or
symptomatic disease
Positive Mantoux less important
Negative Mantoux important
Mantoux conversion important
Household source case less important
Symptoms important
Diagnostic need
Validated symptoms-based algorithm
Sensitive/specific marker of recent 
primary infection or symptomatic disease
*This reflects the level of risk for disease development accepted, following tuberculosis infection in a specific setting,
together with the risk-benefit ratio to the individual and the community of treatment vs. no treatment in that particular
setting.
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confusing multitude of scoring systems with adap-
tations suggested for high-prevalence, low-resource
settings. A recent critical analysis of these scoring sys-
tems demonstrated a lack of uniform symptom defini-
tions and scientific validation.10 The confusion sur-
rounding tuberculosis in childhood is related to our
inability to confidently diagnose disease.11 This diag-
nostic dilemma, highlighted in numerous recent review
articles,12–16 hampers scientific research and, most im-
portantly, service delivery in the areas where it is most
needed. The natural history of disease indicates that
disease in childhood cannot be viewed as a single
entity. The clear age-related patterns described in Table
4 indicate that relevant disease requires separate defini-
tion in each age category (Table 5).
Unfortunately, most low-resource settings bear the
double burden of HIV and TB,17 and this must be
taken into account when defining relevant disease in
these settings. Unlike adults, the majority of children
with TB, even from HIV-affected communities, are
not HIV-infected.18,19 The natural history disease
descriptions provided do not include the influence of
HIV. However, recent disease descriptions in HIV-
infected children confirm that those with significant
immune compromise illustrate poor disease contain-
ment, similar to that seen in children under 2 years of
age who are immune immature.20–24 The definition
of relevant disease in immune-compromised children
is therefore similar to that in children under 2 years of
age and include any infection, recent or past, primary
or reinfection (Table 5).
Two major challenges emerge regarding the diag-
nosis of tuberculosis in childhood. The first challenge
is to identify any untreated infection (recent or past,
primary or reinfection), with a high degree of sensitiv-
ity and specificity in immune-compromised children.
In immune-competent children, a positive TST under
2 years of age or TST conversion after 10 years of age
indicate a high risk for disease progression and a need
for intervention. The second challenge is to identify
symptomatic disease as early as possible, especially
in immune-competent children over 3 years of age. In
this group the onset of clinical symptoms allows the
differentiation between self-contained infection and
relevant disease. This is defined as the breakpoint of
clinical relevance (Figure 2). A validated clinical diag-
nostic algorithm will be of great value to identify this
breakpoint.
Tuberculosis is a curable disease, and it is possible
to prevent the morbidity and mortality caused by
tuberculosis in childhood. However, access to accu-
rate diagnosis and treatment is imperative.25 The con-
cept of relevant disease allows a rational and focused
approach to childhood tuberculosis in high-burden
settings. Its application will improve service delivery
to those children who need it most.
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R É S U M É
La littérature avant l’introduction de la chimiothérapie
spécifique permet de documenter l’histoire naturelle de
la tuberculose dans l’enfance. Ces descriptions de la ma-
ladie restent d’une grande valeur pour guider la politique
de santé publique et la recherche, puisque l’introduction
d’une chimiothérapie effective a modifié radicalement
l’histoire de la maladie. Des groupes spécifiques à risque
élevé ont été identifiés. La primo-infection avant l’âge de
2 ans progresse fréquemment vers une maladie grave au
cours des 12 premiers mois sans symptômes prémoni-
toires significatifs. La primo-infection entre les âges de 2
et de 10 ans ne progresse que rarement vers une maladie
sévère, et cette progression est associée à des symptômes
cliniques significatifs. Chez les enfants âgés de 3 ans la
présence de symptômes a représenté une opportunité
pour porter un diagnostic clinique avant la progression
vers une maladie plus grave. L’infection primaire après
l’âge de 10 ans progresse fréquemment vers une maladie
du type adulte. Une intervention efficiente et précoce
dans ce groupe réduira le fardeau des maladies cavitaires
ainsi que la transmission de la maladie qui y est associée
au sein de la collectivité. Bien que la littérature avant la
chimiothérapie excluait l’influence de l’infection par le
virus de l’immunodéficience humaine (VIH), des descrip-
tions récentes de la maladie chez des enfants infectés par
le VIH indique que les enfants en état de dépression
immunitaire se comportent d’une manière similaire aux
enfants négatifs pour le VIH âgés de moins de 2 ans dont
l’immunité n’est pas arrivée à maturité. Un concept
déduit de l’histoire naturelle de la tuberculose dans
l’enfance est qu’il s’agit d’une maladie significative. Décider
quels enfants doivent être traités peut être extrêmement
difficile dans des contextes à haute prévalence et à faibles
ressources. Le concept d’une maladie significative fournit
des informations permettant de guider des interventions
de santé publique plus efficientes.
R E S U M E N
La literatura antes de la introducción de la quimiotera-
pia específica informaba sobre la historia natural de esta
afección de los niños. Estas descripciones de la enfer-
medad siguen siendo valiosas para orientar las políticas
de salud pública y de investigación, a pesar de que la
introducción de una quimioterapia eficaz ha cambiado
radicalmente la historia de la enfermedad. Se habían
identificado grupos específicos con alto riesgo. La infec-
ción primaria antes de los 2 años de edad con frecuencia
progresaba a una enfermedad severa durante los 12
primeros meses sin síntomas premonitorios significati-
vos. La infección primaria entre los 2 y 10 años de edad
raramente progresaba hacia la enfermedad grave y la
progresión se acompañaba de síntomas clínicos signifi-
cativos. En niños más de 3 años de edad, la presencia de
estos síntomas representaba una oportunidad para
establecer un diagnóstico clínico antes de la presentación
de una enfermedad grave. La infección primaria después
de los 10 años frecuentemente progresaba hacia una
enfermedad de tipo adulto. La intervención eficaz y rá-
pida en este grupo reducirá la frecuencia de la enfermedad
cavitaria y la transmisión a la comunidad que le está aso-
ciada. Aunque la literatura de la era prequimioterapia
no incluía la influencia de la infección por el virus de la
inmunodeficiencia humana (VIH), las recientes descrip-
ciones de la enfermedad en niños infectados con el VIH
indican que los niños inmunocomprometidos se com-
portan de manera similar que los niños inmuno inma-
duros (menos de 2 años de edad). Un concepto impor-
tante que ha aportado el estudio de la historia natural de
la tuberculosis infantil es su consideración como enfer-
medad significativa. La decisión con respecto a los niños
que deben ser tratados puede ser extremadamente difícil
en los contextos de alta prevalencia y escasos recursos.
El concepto de enfermedad significativa puede servir de
guía para realizar intervenciones más eficaces de salud
pública.
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Historically the art of medicine was defined by the ability to develop a personal reference for 
normality.  This internal reference allowed the subjective identification of abnormality by pure 
clinical acumen.  In contrast, modern medicine provides an objective scientific definition of 
abnormality, based on accurate measurement and statistical analysis.  However, the medical 
profession still struggles to find the optimal balance between the art (subjective) and the 
science (objective), in providing holistic health care.   
 
Statistical differentiation into normal and abnormal serves us well when dealing with 
continuous physiological variables like blood pressure, cholesterol or weight.  The 
differentiation becomes problematic when dealing with the complex biological balance that 
exists between infecting organisms and host responses.  The initial simplistic differentiation 
into harmless colonizing organisms and dangerous invasive pathogens has been replaced by 
a more complete appreciation of the complex, dynamic relationship that exists between the 
host and the organism.  The challenge facing modern medicine is to translate, improved 
scientific understanding into clear, pragmatic guidelines applicable in diverse settings.   
 
Once abnormality is identified, whether subjectively or objectively, the crucial question that 
remains is: Does this abnormality constitute disease?  Disease is defined by present reduced 
quality of life (morbidity) as well as the increased risk for future morbidity or mortality. 
Knowledge of a condition’s natural history becomes invaluable when initial morbidity is 
minimal.  Accurate description of the natural history of disease allows scientific risk:benefit 
analyses of a proposed intervention.  The scientific quest does not end here; the true quest is 
to quantify the relative benefit of the suggested intervention within a particular setting.    
 
The idea of relative benefit or risk, to an individual within a particular setting, differs from the 
classical public health approach.  With this approach the relevance of disease is determined 
by the total burden placed on a specific society, completely ignoring the individual patient.  
Although it assists with focusing scarce resources, it undermines the moral basis of the 
medical profession, which promises sympathetic care to every individual who seeks help. In 
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contrast the concept of relative risk maintains the primary focus on the individual patient, but 
takes the baseline risk determined by his/her particular setting into account.   
 
Relevant disease defines the point where the risk posed by a specific condition, increases 
significantly beyond the baseline risk within a particular community.  This implies that contrary 
to the classic public health approach, any severe disease represents relevant disease, 
irrespective of its contribution to the total burden of disease. This definition also challenges 
the approach promoted by the pharmaceutical industry, which defines any statistically 
significant benefit measured against a minimal baseline risk as the accepted “standard of 
care”, irrespective of the baseline risk within particular setting.   
 
Identifying the appropriate intervention once relevant disease is diagnosed requires careful 
analysis, weighing the relative risk posed to the individual and society against the possible 
benefit, risk and cost of available treatment.  The challenge posed by the concept of relevant 
disease, is to identify the sub-population at highest risk in order to focus cost effective 
interventions appropriately. 
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Chapter 3. 
The burden of disease  
 
The contribution of children to the total tuberculosis caseload is poorly documented, 
especially in endemic areas where the emphasis is mainly on the diagnosis and treatment of 
sputum smear-positive disease.  Observational studies in children are often hospital-based, 
and the considerable selection bias inherent to hospital-based studies prevents extrapolation 
of results to the community level.  The reliability of epidemiological data on childhood 
tuberculosis is further limited by the difficulty of establishing an accurate diagnosis.  We 
documented the routine criteria used to diagnose childhood tuberculosis in an endemic area, 
as well as the contribution of children to the overall disease burden recorded in the TB 
treatment register.  We also evaluated the accuracy of community-based surveillance data 
and calculated the actual disease burden in children from an endemic area.   
 
1. Theart AC, Marais BJ, Gie RP, Hesseling AC, Beyers N. Criteria used for the 
diagnosis of childhood tuberculosis at primary health care level in a high-
burden, urban setting. Int J Tuberc Lung Dis 2005; 9: 1210-1214 
This retrospective descriptive study describes the burden of childhood tuberculosis and the 
routine diagnostic criteria used in a high-burden setting, by retrospective analysis of TB 
treatment register data from two primary health care clinics.  Children (<15 years) contributed 
20.6% of all cases notified in the TB treatment register.  The diagnosis of childhood 
tuberculosis demonstrated good agreement with current guidelines, but depended almost 
exclusively on the subjective interpretation of the chest radiograph.  Chest radiography is 
rarely available in resource-limited settings. 
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2. Marais BJ, Hesseling AC, Gie RP, Schaaf HS, Beyers N. The burden of 
childhood tuberculosis and the accuracy of community-based surveillance data 
in a high-burden setting.  Int J Tuberc Lung Dis 2006; 10: 259-263 
Inadequate surveillance and diagnostic difficulties compromise the quality of epidemiologic 
data on childhood tuberculosis.  This prospective study employed comprehensive, 
community-based surveillance to document the actual burden of childhood tuberculosis in an 
endemic area.  The tuberculosis incidence calculated from the TB treatment register was 
441/100 000/year for children, and 845/100 000/year for adults.  Fifty-four (12.3%) children, 
treated for tuberculosis, were not recorded in the TB treatment register, including 21/28 (75%) 
children with tuberculous meningitis and/or disseminated (miliary) disease.   Eighty-five 
(19.4%) children, included in the TB treatment register were judged not to have had 
tuberculosis.  When this information was taken into account, the corrected tuberculosis 
incidence in children was calculated to be 407/100 000/year.   
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Criteria used for the diagnosis of childhood tuberculosis
at primary health care level in a high-burden, urban setting
A. C. Theart, B. J. Marais, R. P. Gie, A. C. Hesseling, N. Beyers
S U M M A R Y
Desmond Tutu TB Centre, Stellenbosch University, Cape Town, Western Cape, South Africa
BACKGROUND: Children contribute a significant pro-
portion of the total tuberculosis (TB) case load in high-
burden settings and present a major diagnostic challenge.
OBJECTIVE: To document the criteria used at primary
health care level to diagnose childhood TB in a high-
burden, urban setting.
METHODS: This retrospective descriptive study was
conducted at two primary health care clinics in Cape
Town, South Africa. Information on all children (15
years of age) entered into the TB register from January
2002 through December 2003 was retrieved for analysis.
RESULTS: During the study period, 1277 cases of TB
were entered into the TB register, of which 268 (21.0%)
were children. Information on 256 (95.5%) children
was available for analysis. The majority (206, 80.5%)
had intrathoracic TB, of whom 107 (51.5%) had un-
complicated lymph node disease, 79 (38.3%) compli-
cated lymph node disease, 8 (3.9%) a pleural effusion
and 12 (5.8%) adult-type cavitating disease. According
to modified WHO criteria, the diagnosis of TB was con-
firmed in 27 (10.5%), probable in 193 (75.4%) and sus-
pect in 36 (14.1%).
DISCUSSION: The diagnostic criteria used at primary
health care level demonstrated good agreement with cur-
rent guidelines, but depended heavily on chest radio-
graph interpretation.
KEY WORDS: criteria; diagnosis; childhood; tuberculosis
THE DEVELOPING WORLD carries the brunt of the
tuberculosis (TB) epidemic.1 In these countries, chil-
dren represent a significant proportion (up to 40%)
of the total TB burden.2 In South Africa, like most
high-burden countries, the National Tuberculosis Pro-
gramme (NTP) focuses on adults with sputum smear-
positive disease, and childhood TB receives little pub-
lic health emphasis. It is extremely difficult to assess the
true impact of TB on child health, because although
children with TB are recorded in the TB register, this in-
formation is not routinely reported to the NTP. The re-
liability of epidemiological data on childhood TB is fur-
ther limited by the difficulty of accurate diagnosis.3,4
Childhood TB presents a major diagnostic chal-
lenge as, unlike adults, children usually have pauci-
bacillary disease and bacteriological confirmation is
rarely achieved.5–7 Several guidelines exist for the
clinical diagnosis of TB in childhood, but these are
poorly validated.8 Both the limited availability of re-
liable epidemiological data and the severe TB-related
morbidity and mortality that children may suffer9
provide compelling reasons to assess the burden of
childhood TB and the criteria used for diagnosis at
primary health level in a high-burden setting. A recent
post-mortem study from Zambia showed that TB ri-
vals acute pneumonia as the most common respiratory
cause of death in African children 6 months of age.10
In addition to the risk posed to the individual child, ad-
olescent children (10 years of age) often develop
adult-type cavitating disease,9,11 which poses a signif-
icant risk of disease transmission to the community.12
There is limited data on the criteria used for the di-
agnosis of childhood TB at primary health care level,
outside the academic or research setting. A recent au-
dit from Malawi reported on diagnostic practices in
referral hospitals,13 but primary health care facilities
were excluded. A previous study from South Africa
evaluated the diagnostic practices in primary health
care clinics,14 but this was done in the pre-DOTS era
and before the implementation of TB registers.
The aim of this study was to document the criteria
used, at primary health care level, to diagnose child-
hood TB in a high-burden, urban South African setting.
METHODS
This was a retrospective descriptive study where data
were collected by folder review.
Correspondence to: Dr Ben J Marais, Centre for TB Research and Education, Stellenbosch University, PO Box 19063, Tyger-
berg, 7505, Cape Town, South Africa. Tel: (27) 21 9389177. Fax: (27) 21 9389138. e-mail: bjmarais@sun.ac.za 
Article submitted 10 December 2004. Final version accepted 5 April 2005.
[A version in French of this article is available from the Editorial Office in Paris and from the Union website www.iuatld.org]
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Study population
The study was conducted at two primary health care
clinics in Cape Town, South Africa, that were not in-
volved in TB-related research during the study period.
All children (15 years of age) entered into the clinic’s
TB register from January 2002 through December
2003 were eligible for inclusion.
Data collection and analysis
According to the NTP, children under 5 years of age
in household contact with an adult sputum smear-
positive source case and all children with symptoms
of TB should be evaluated with a tuberculin skin test
(TST) and chest X-ray (CXR). If TB is diagnosed, the
child’s name is entered into the TB register and all rele-
vant data such as possible contact with an adult source
case, relevant symptoms, TST and CXR results, as
well as treatment adherence, are recorded in the TB
treatment folder. The TST used in the clinics is the
transcutaneous, multipuncture Tine test, while refer-
ral hospitals use the intradermal Mantoux test. Chil-
dren are only tested for human immunodeficiency
virus (HIV) infection if there is clinical suspicion of
HIV disease.
The TB register was used to identify all children di-
agnosed and/or treated for TB at the primary health
care clinic. The TB treatment folders were retrieved
and used as the data source for this study. Demo-
graphic information, clinical findings and treatment
adherence were recorded. A Tine test result of 
grade 2 and/or a Mantoux test result of 10 mm
were regarded as positive (Tine  grade 1 or Man-
toux 5 mm if the child was HIV-infected).15 Suspi-
cious symptoms were broadly defined as documented
cough and/or weight loss, because relevant symptoms
were not recorded in detail. Intrathoracic disease was
classified using the interpretation of the CXR recorded
in the TB treatment folders, according to a recently
proposed radiological classification of intrathoracic
TB in childhood.16 Modified World Health Organi-
zation (WHO) guidelines were used to categorise
children with TB.14,17 All children who received anti-
tuberculosis chemotherapy were regarded as suspects,
those with radiological signs of TB were regarded as
probable cases and those with bacteriological confir-
mation were regarded as confirmed cases.
Ethical approval was obtained from the University
of Stellenbosch, the City of Cape Town Health Depart-
ment and from the relevant local health authorities.
RESULTS
During the study period, 1277 cases of TB were noti-
fied, of whom 268 (21.0%) were children. The folders
of 256 (95.5%) children were available for evalua-
tion. Their demographic features are summarised in
Table 1. There was an equal sex distribution, but the
majority of cases (170, 66.4%) were 5 years of age.
Of the 26 (10.2%) children tested for HIV infection,
15 (5.9%) tested positive.
The specific disease manifestations documented
are summarised in Table 2. The majority of the chil-
dren (206, 80.5%) had intrathoracic disease, of
whom 107 (51.5%) had uncomplicated lymph node
disease, 79 (38.3%) had lymph node disease compli-
cated by visible alveolar consolidation, airway com-
pression and/or segmental/lobar collapse, 8 (3.9%)
had a pleural effusion and 12 (5.8%) had adult-type
disease. No cases of disseminated (miliary) disease
were recorded. All documented pleural effusions oc-
curred in children 5 years of age—two in the 5–9
year and six in the 10–14 year age group. The 12 chil-
dren with adult-type cavitating disease were all 10
years of age, and eight (66.7%) were sputum smear-
Table 1 General demographics and characteristics of children 
notified with TB at the primary health care level
n (%)
Total population* 30 940
All TB cases notified in a 2-year period 1 277
Calculated TB incidence 2 063/100 000/year
Children notified with TB (% of all
notifications) 268 (20.6)
Children included in the study (% of child
notifications) 256 (92.1)
Sex
Male 127 (49.6)
Female 129 (50.4)
Age distribution, years
5 170 (66.4)
5–9 52 (20.3)
10–14 23 (9.0)
Age not recorded 11 (4.3)
HIV exposed, but not tested 6 (2.3)
HIV tested 26 (10.2)
HIV-positive 15 (5.9)
* National census data, 2001.
TB  tuberculosis; HIV  human immunodeficiency virus.
Table 2 Specific disease manifestation documented
in children notified with TB
TB manifestation n (%)
Intrathoracic TB 206 (80.5)
Specific radiological entities
Uncomplicated lymph node disease 107 (51.9)
Complicated lymph node disease 79 (38.4)
Pleural effusion 8 (3.9)
Disseminated (miliary) disease 0 (0.0)
Adult-type disease 12 (5.8)
Cervical lymph node involvement 9 (3.5)
Tuberculous meningitis 2 (0.7)
Osteoarticular involvement 2 (0.7)
Hip involvement 1 (50.0)
Vertebral involvement 1 (50.0)
GA culture, CXR normal 2 (0.7)
Insufficient information to classify 35 (13.7)
Total 256 (100)
TB  tuberculosis; GA  gastric aspirate; CXR  chest radiograph.
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positive. Exclusive cervical lymph node involvement
was noted in nine (3.5%) children. Tuberculous men-
ingitis (TBM) was recorded in two (0.1%) children,
both 2 years of age. Osteo-articular involvement in-
cluded TB of the hip in one child and lumbar verte-
bral collapse with a gibbus in another. In 37 (14.4%)
children, the information recorded was insufficient
for accurate disease classification.
Table 3 reflects the main criteria used in the diag-
nosis of intrathoracic TB. Exposure to an adult spu-
tum smear-positive source case was documented in
more than 50% of children in all age groups. A TST
result was recorded in 173 (83.4%) children, of
whom 109 (63.0%) tested positive, indicating Myco-
bacterium tuberculosis infection. The Tine test was
used in the majority (83.1%) of cases. Of the 15 chil-
dren with known HIV infection, a TST result was
recorded in 12 and only one (6.7%) had a positive re-
action (Tine grade 2). A suggestive CXR was reported
in all children with intrathoracic TB, apart from six
of the eight sputum smear-positive children who did
not receive a CXR. Sputum smear testing was the
only confirmatory test performed at the primary
clinic, and this was only done in children 10 years of
age with productive cough. Gastric aspirates for culture
are routinely performed at the referral hospitals, but it is
uncertain how many children received these tests. Bac-
teriological confirmation was achieved in a total of 23
(11.2%) children.
The majority of the children (208, 81%) com-
pleted 6 months of directly observed chemotherapy.
Treatment was stopped in three cases due to a revi-
sion of the diagnosis by the attending physician, 13
(5.1%) were transferred to another clinic and four
(1.6%) died on treatment. Treatment was interrupted
in 28 (10.9%) children. Three of the four children
who died were 1 year of age; all four were HIV ex-
posed. HIV infection was confirmed in three cases.
The exact cause of death was known in only one
child, who died from diarrhoeal disease.
The diagnosis of TB was made at the primary clinic
level in 156 (60.9%) children, 86 (33.6%) were referred
to a secondary and 14 (5.5%) to a tertiary level hospital
for diagnosis (Table 4). The majority of the children
(222, 86.7%), irrespective of where the diagnosis was
made, met modified WHO criteria for probable (193,
75.4%) or confirmed (27, 10.5%) TB. In 34 (13.3%)
suspect cases, insufficient information prevented classi-
fication into either the probable or confirmed category.
DISCUSSION
The criteria used for the diagnosis of TB, at all levels
of health care, were in accordance with modified WHO
guidelines. This finding is similar to that of a previous
study from Cape Town, South Africa, conducted in
the pre-DOTS era.14 The diagnosis depended heavily
on accurate CXR interpretation, but the reality is that
CXR is often unavailable in high-burden settings. Al-
though the interpretation of the chest radiograph may
be difficult, its sensitivity and specificity increases
when viewed in conjunction with relevant epidemio-
logical and clinical information, and it remains the
mainstay test to diagnose childhood TB.
As bacteriological confirmation was attempted in
only 30–40% of children, the reported yield of
10.5% is probably a gross underestimation of the
expected yield. No gastric aspirate or induced spu-
tum samples were collected for culture at any of the
primary health care clinics. Induced sputum, using
Table 4 Criteria used for the diagnosis of tuberculosis in 
children, categorised according to modified WHO guidelines14
Tuberculosis category
Suspect
n (%)
Probable
n (%)
Confirmed 
n (%)
Unknown
n (%)
Primary clinic 156 (100) 134 (85.9) 10 (6.4) 12 (7.7)
Secondary hospital 86 (100) 53 (61.6) 16 (18.6) 17 (19.8)
Tertiary hospital 14 (100) 8 (57.2) 1 (7.1) 5 (35.7)
Total 256 (100) 195 (76.2) 27 (10.5) 34 (13.3)
WHO  World Health Organization; suspect  all children who received anti-
tuberculosis chemotherapy were regarded as suspect cases; probable  sugges-
tive chest radiograph; confirmed  bacteriological confirmation, either smear-
or culture-positive; unknown  insufficient information to be categorised.
Table 3 Criteria used for the diagnosis of children notified with intrathoracic TB within different age groups
Exposed
fraction
n (%)
TST-positive 
fraction
n (%)
Suspicious Sx 
fraction 
n (%)
Suggestive CXR
fraction
n (%)
Confirmed TB
Age group,
years
Total
n (%)
ZN
n
Cult 
n
2 75 (36.4) 49/75 (65.3) 33/65 (50.8) 58/75 (77.3) 75/75 (100) 0 4
2–4 63 (30.6) 41/63 (65.1) 40/62 (64.5) 55/63 (87.3) 63/63 (100) 0 6
5–9 39 (18.9) 26/39 (68.4) 28/33 (84.8) 30/39 (78.9) 39/39 (100) 0 4
10–14 22 (10.7) 9/22 (56.3) 3/7 (42.9) 21/22 (95.5) 16/16 (100) 8 0
Unknown 7 (3.4) 3/7 (42.9) 5/5 (100) 4/7 (57.1) 7/7 (100) 0 1
Total 206 (100) 118/206 (57.3) 109/173 (63.0) 168/256 (65.6) 200/200 (100) 8 15
The results are expressed as the fraction of the children in whom the information was recorded. No denominator is provided for confirmed TB, because we were
unable to establish in how many children bacteriological tests were done.
TB  tuberculosis; exposed  documented exposure to a sputum smear-positive source case; TST positive  tuberculin skin test (Tine test  grade 2 or Mantoux
test 10 mm); suspicious Sx  symptoms suspicious of TB (cough and/or weight loss); suggestive CXR  reported chest radiograph signs indicative of TB; con-
firmed TB  Mycobacterium tuberculosis isolated from sputum or gastric aspirates; ZN  sputum smear-positive for acid-fast bacilli by Ziehl-Neelsen stain;
Cult  M. tuberculosis confirmed on culture.
37
Stellenbosch University  http://scholar.sun.ac.za 
Diagnosis of childhood tuberculosis 1213
hypertonic saline nebulisation, holds promise as a di-
agnostic tool,18 but its safety and utility has not been
validated in a primary health care setting, and its low
yield remains a concern. Sputum samples were col-
lected for routine microscopy in children 10 years
of age with productive cough. It is notable that eight
children, i.e., more than a third of the children with
TB 10 years of age, were sputum smear-positive. It
seems appropriate to encourage the routine collection
of sputum for smear in all TB suspects 10 years of
age. This can be done with relative ease at the primary
health care level.
Childhood TB contributed to more than 20% of
the total TB caseload. This is consistent with previous
reports from this high-burden setting.19 The propor-
tion of TB contributed by children, especially those
diagnosed with recent primary infection and uncom-
plicated lymph node disease, will be influenced by the
diligence with which active contact tracing and
screening is performed. The fact that no cases of dis-
seminated (miliary) disease and only two cases of TBM
were reported is not a true reflection of how commonly
these disease entities occur, because these children are
not routinely diagnosed or treated at the primary
clinic. They are referred to hospital for diagnosis and
usually complete their treatment under hospital super-
vision and not in the community, which probably ex-
plains why they were not recorded in the clinic’s TB
register. The fact that the percentage of children in the
unknown category (Table 4) increased from primary
through secondary to tertiary level also suggests that
information from referral hospitals is not getting
back to the records held by primary care clinics.
HIV testing was only done if the attending physi-
cian clinically suspected HIV disease, which explains
why 57.7% of those tested were found to be infected.
It is not possible to comment with confidence on the
HIV prevalence amongst these children, because only
a very select number were tested. Only one HIV-
infected child had a positive TST, but the poor sensi-
tivity of the TST to detect M. tuberculosis infection in
this population is well documented.20,21 In South Af-
rica, primary clinics use the multi-puncture, transcu-
taneous Tine test because of concerns regarding the
cost, need for refrigeration and operator dependence
of the Mantoux intradermal test. Previous studies
conducted in South Africa have shown good compar-
ison between the two tests,22,23 but the sensitivity of
the Tine test has been seriously questioned even in
immune-competent children.24
Despite limitations imposed by the study’s retro-
spective design on the quality of the available data,
this had the important advantage of providing a ‘real-
life’ picture of what happens in a primary health care
setting, without interference caused by ongoing re-
search. Incomplete and inappropriate clinical infor-
mation limited the value of the available data and it
seems important to adapt the routine collection of
data in children with TB to ensure that all the relevant
clinical information is captured. The study setting
had an extremely high incidence of TB, and it is un-
certain how well these results will translate to areas
with a lower incidence.
In conclusion, children contribute significantly to
the total TB caseload in high-burden communities.
The criteria used for the diagnosis of childhood TB at
primary health care level showed good agreement
with current diagnostic guidelines, but were heavily
dependent on chest radiography. The interpretation
of CXRs is problematic, and its limited availability in
most high-burden settings underscores the need for
validated diagnostic guidelines that are applicable in
these settings. Ultimately, improved service delivery
to children with TB will depend on sufficient public
health emphasis and political commitment.
Acknowledgements
We thank the primary health care clinics involved, Dr I Toms (City
of Cape Town Health Department) and the local health authorities
for their kind assistance. This manuscript is in partial fulfilment of
a MMed and PhD thesis.
References
1 Raviglione M C, Snider D E, Kochi A. Global epidemiology of
tuberculosis. JAMA 1995; 273: 220–226.
2 Donald P R. Childhood tuberculosis: out of control? Curr
Opin Pulm Med 2002; 8: 178–182.
3 Walls T, Shingadia D. Global epidemiology of paediatric tuber-
culosis. J Infect 2004; 48: 13–22.
4 Nelson L J, Wells C D. Global epidemiology of childhood
tuberculosis. Int J Tuberc Lung Dis 2004; 8: 636–647.
5 Eamranond P, Jamarillo E. Tuberculosis in children: reassess-
ing the need for improved diagnosis in global control strate-
gies. Int J Tuberc Lung Dis 2001; 5: 594–603.
6 Osborne C M. The challenge of diagnosing childhood tuberculo-
sis in a developing country. Arch Dis Child 1995; 72: 369–374.
7 Starke J R. Childhood tuberculosis: a diagnostic dilemma. Chest
1993; 104: 329–330.
8 Hesseling A C, Schaaf H S, Gie R P, Starke J R, Beyers N. A
critical review of diagnostic approaches used in the diagnosis
of childhood tuberculosis. Int J Tuberc Lung Dis 2002; 6: 1038–
1045.
9 Marais B J, Gie R P, Schaaf H S, et al. The natural history of
childhood intra-thoracic tuberculosis: a critical review of the
pre-chemotherapy literature. Int J Tuberc Lung Dis 2004; 8:
392–402.
10 Chintu C, Mudenda V, Lucas S, et al. Lung diseases at necropsy
in African children dying from respiratory illnesses: a descrip-
tive necropsy study. Lancet 2002; 360: 985–990.
11 Weber H C, Beyers N, Gie R P, et al. The clinical and radiolog-
ical features of tuberculosis in adolescents. Ann Trop Paediatr
2000; 20: 5–10.
12 Curtis A B, Ridzon R, Vogel R, et al. Extensive transmission of
Mycobacterium tuberculosis from a child. N Engl J Med 1999;
341: 1491–1495.
13 Weismuller M M, Graham S M, Claesens N J M, et al. Diag-
nosis of childhood tuberculosis in Malawi: an audit of hospital
practice. Int J Tuberc Lung Dis 2002; 6: 432–438.
14 Stolz A P, Donald P R, Strebel P M, Talent J M T. Criteria for
the notification of childhood tuberculosis in a high-incidence
area of the Western Cape Province. South Afr Med J 1990; 77:
385–386.
38
Stellenbosch University  http://scholar.sun.ac.za 
1214 The International Journal of Tuberculosis and Lung Disease
15 Donald P R, Fourie P B, Grange J M. Tuberculosis in child-
hood. Pretoria, South Africa: J L van Schaik, 1999: p 126.
16 Marais B J, Gie R P, Schaaf H S, et al. A proposed radiologic
classification of childhood intra-thoracic tuberculosis. Pediatr
Rad 2004; 33: 886–894.
17 Shingadia D, Novelli V. Diagnosis and treatment of tuberculosis
in children. Lancet Infect Dis 2003; 3: 624–632.
18 Zar J Z, Hanslo D, Apolles P, Swingler G, Hussey G. Induced
sputum versus gastric lavage for microbiological confirmation
confirmation of pulmonary tuberculosis in infants and young
children: a prospective study. Lancet 2005; 365: 130–134.
19 van Rie A, Beyers N, Gie R P, et al. Childhood tuberculosis in
an urban population in South Africa: burden and risk factor.
Arch Dis Child 1999; 80: 433–437.
20 Madhi S A, Huebner R E, Doedens L, et al. HIV-1 co-infection
in children hospitalised with tuberculosis in South Africa. Int J
Tuberc Lung Dis 2000; 4: 448–454.
21 Palme I B, Gudetta B, Bruchfeld J, et al. Impact of human im-
munodeficiency virus 1 infection on clinical presentation, treat-
ment outcome and survival in a cohort of Ethiopian children
with tuberculosis. Pediatr Infect Dis J 2002; 21: 1053–1061.
22 Freiman I, Hartman E, Abkiewics C. A comparative study of
tuberculin tine and Mantoux tests. S Afr Med J 1976; 50: 5–
7.
23 Swingler G H, Miller M S H, Beatty D W. The Mantoux test
versus the tine test. S Afr Med J 1983; 63: 179–180.
24 Lunn J A, Johnson A J. Comparison of the tine and Mantoux
tuberculin tests. B Med J 1978; 1: 1451–1453.
R É S U M É
CONTEXTE : Dans les contextes à haute prévalence, les
enfants contribuent une proportion significative de l’en-
semble du fardeau des cas de tuberculose (TB) et
représentent un défi diagnostique majeur.
OBJECTIF : Documenter les critères utilisés au niveau des
soins de santé primaires pour diagnostiquer la TB infan-
tile dans un contexte urbain à haute prévalence.
MÉTHODES : Cette étude descriptive rétrospective a été
menée dans deux polycliniques de soins de santé pri-
maires à Cape Town en Afrique du Sud. Les informa-
tions concernant tous les enfants (âge 15 ans) présents
dans le registre de la TB de janvier 2002 à décembre
2003 ont été relevées pour analyse.
RÉSULTATS : Au cours de la période d’étude, 1.227 cas
de TB ont été inscrits dans le registre de la TB ; 268 d’en-
tre eux (21,0%) étaient des enfants. Une information a
été disponible pour l’analyse chez 256 (95,5%) enfants.
Chez la majorité d’entre eux (206, 80,5%), la TB était
intrathoracique ; parmi ceux-ci, 107 (51,5%) souffraient
d’une maladie ganglionnaire non compliquée, 79 (38,3%)
d’une atteinte ganglionnaire avec complication, 8
(3,9%) d’un épanchement pleural et 12 (5,8%) d’une
maladie du type adulte avec excavation. Selon les critères
modifiés de l’OMS pour le diagnostic de la TB, celle-ci
est classée comme confirmée dans 27 cas (10,5%), proba-
ble dans 193 (75,4%) et soupçonnée dans 36 cas (14,1%).
DISCUSSION : Les critères de diagnostic utilisés au niveau
des soins de santé primaires s’avèrent en bonne concor-
dance avec les directives actuelles, mais ils dépendent
largement de l’interprétation des clichés thoraciques.
R E S U M E N
MARCO DE REFERENCIA : Los niños representan una
gran proporción de la carga de morbilidad global por
tuberculosis (TB) en medios con alta incidencia y plan-
tean una dificultad diagnóstica importante.
OBJETIVO : Verificar los criterios utilizados para el diag-
nóstico de la TB infantil al nivel primario de atención de
salud en un medio urbano con alta carga de morbilidad
por TB.
MÉTODOS : Fue este un estudio retrospectivo descriptivo
llevado a cabo en dos consultorios de atención primaria
en Ciudad del Cabo, Sudáfrica. Para el análisis se obtuvo
información sobre todos los niños (15 años) consigna-
dos en el registro de TB entre enero de 2002 y diciembre
de 2003.
RESULTADOS : Durante el periodo del estudio, se
declararon 1277 casos al registro de TB, de los cuales
268 fueron niños (21,0%). Para el análisis se contó con
información sobre 256 niños (95,5%). La mayoría (206 ;
80,5%), presentaron TB intratorácica y de ellos 107
(51,5%) tuvieron afectación ganglionar sin complicación,
79 (38,3%) afectación ganglionar complicada, 8 (3,9%)
derrame pleural y 12 (5,8%) tuvieron enfermedad de tipo
adulto, con cavernas. Según los criterios modificados de
la OMS, TB fue confirmada en 27 pacientes (10,5%),
probable en 193 (75,4%) y presunta en 36 (14,1%).
DISCUSIÓN : Se observó que los criterios diagnósticos
utilizados en el nivel primario de atención de salud están
acordes con las recomendaciones vigentes, pero dependen
en gran medida de la interpretación de la radiografía de
tórax.
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The burden of childhood tuberculosis and the accuracy
of community-based surveillance data
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BACKGROUND: Inadequate surveillance and diagnostic
difficulties compromise the quality of epidemiological
data on childhood tuberculosis (TB).
OBJECTIVE: To document the incidence of childhood
TB and to evaluate the accuracy of community-based
surveillance data in a high-burden setting.
METHODS: This prospective observational study was
conducted from February 2003 to October 2004 at five
primary health care clinics in Cape Town, South Africa.
Comprehensive surveillance was done to ensure that all
children 13 years of age treated for TB were included.
RESULTS: During the study period, 443 children (13
years of age) received anti-tuberculosis treatment, of
whom 389 (87.8%) were recorded in the TB treatment
register. The TB incidence calculated from the TB treat-
ment register was 441/100 000/year amongst children
and 845/100 000/year amongst adults. Fifty-four chil-
dren treated for TB were not recorded in the TB treat-
ment register, including 21/28 (75%) children with se-
vere disease.
DISCUSSION: Children 13 years of age contributed
13.7% of the total TB burden, but experienced more
than half (52.2%) the TB incidence recorded in adults.
Community-based surveillance data excluded the major-
ity of children with severe disease. The accuracy of sur-
veillance data is an important consideration when de-
scribing the epidemiology of childhood TB or measuring
the success of public health interventions.
KEY WORDS: childhood tuberculosis; burden; surveil-
lance; epidemiology
THE CONTRIBUTION of children to the total tuber-
culosis (TB) caseload is poorly documented, espe-
cially in countries with a high burden of disease.1,2
Official epidemiological data may not reflect the true
burden of childhood TB in these countries, due to the
inadequacy of existing surveillance systems and the
difficulty of diagnosing TB in children. National Tuber-
culosis Programmes (NTPs) focus almost exclusively
on the diagnosis and treatment of sputum smear-
positive disease,1,3 which excludes the vast majority
of children with TB.4–6 For these reasons, the Interna-
tional Union Against Tuberculosis and Lung Disease
(IUATLD) stated in 1991 that reliable information on
the incidence of childhood TB can only be obtained in
industrialised countries.1,7
Observational studies in children with TB are often
hospital-based, which results in considerable bias, pre-
venting accurate extrapolation to the community
level. The paucity of accurate epidemiological data,1,4
together with the significant TB-related morbidity
and mortality suffered by children in high-burden set-
tings,8 underline the need to obtain a more compre-
hensive picture of childhood TB at the community
level in high-burden settings.
The aim of this study was to document the inci-
dence of childhood TB and to evaluate the accuracy
of community-based surveillance data in a high-burden
setting.
METHODS
This was a prospective observational study conducted
from 1 February 2003 to 31 October 2004 in Cape
Town, Western Cape Province, South Africa.
Study population
The study setting included five local clinics in Cape
Town, served by Tygerberg Children’s Hospital as the
referral hospital. Local clinics provide primary health
care services in the community, and coordinate the di-
agnosis and treatment of TB patients. All children
13 years of age started on anti-tuberculosis treatment
during the 21-month study period were included. Pae-
diatric services were accessible only to children 13
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years of age, and therefore children were defined as
those 13 years instead of the customary 15 years of
age. Two of the five local clinics were sites for on-
going epidemiological research, where a concurrent
household contact study (with supervised tracing of
household contacts 5 years of age) continued dur-
ing the study period.
The study communities rarely utilise private medi-
cal services, and children diagnosed with TB are rou-
tinely referred to the local clinic, where they receive
fully supervised treatment free of charge. The inci-
dence of all TB in Cape Town was 678 per 100 000
population,9 while the prevalence of human immuno-
deficiency virus (HIV) infection amongst women at-
tending public antenatal clinics in the Western Cape
Province was 13.1% (95% confidence interval [CI]
8.5–17.7%),10 in 2003.
Data collection and analysis
According to the South African NTP guidelines,11 all
children with suspect symptoms, as well as those 5
years of age in household contact with a sputum
smear-positive source case, should be routinely evalu-
ated for TB with a tuberculin skin test (TST) and a
chest radiograph (CXR). Once a diagnosis of TB is
made and anti-tuberculosis treatment is commenced,
the child’s name is entered into the TB treatment reg-
ister maintained at the clinic, which provides the only
data source for community-based surveillance data.
For research purposes, a comprehensive prospec-
tive surveillance system was put in place to identify all
children started on anti-tuberculosis treatment during
the study period, irrespective of whether they were re-
corded in the clinic TB treatment register. The inves-
tigator visited each clinic on a weekly basis to evalu-
ate children with suspect symptoms (as defined by the
NTP)11 and those newly diagnosed with TB. In addi-
tion, a study nurse documented all children started on
anti-tuberculosis treatment at the referral hospital.
Two independent experts evaluated the CXRs of all
children treated for TB to assess the accuracy of the
diagnosis. Children were categorised as ‘not TB’ if
they met all three of the following criteria: 1) both ex-
perts agreed that the chest radiograph CXR was not
suggestive of TB; 2) no bacteriological confirmation
was obtained; and 3) no extra-thoracic TB was docu-
mented. All children treated for TB who had radio-
logical signs suggestive of TB, bacteriological confir-
mation or extra-thoracic manifestations of TB were
categorised as ‘probable TB’. Severe disease was de-
fined as disseminated (miliary) disease12 and/or central
nervous system (CNS) involvement.
Unadjusted data from the 2001 national census
were used for the calculation of TB incidence rates.
One clinic was excluded from these calculations, as
the population served by this clinic had increased
considerably since 2001, due to new housing develop-
ments and informal settlements. The populations served
by the other four clinics are stable, as reflected by com-
parable 1996 and 2001 census data and the fact that
these areas are completely built-up, with no recent
housing developments or space for informal settle-
ments. TB incidence was calculated by using the an-
nualised number of entries (excluding those trans-
ferred in) recorded in the clinic TB treatment register
during the 21-month study period as the numerator,
and age-specific population figures for the area as the
denominator. The corrected TB incidence in children
was calculated by subtracting the number of children
categorised as ‘not TB’ from the total number treated
to determine the numerator, and using area- and age-
specific population data as the denominator.
Ethics approval was obtained from the Institutional
Review Board of Stellenbosch University, the City of
Cape Town Health Department and local community
health committees.
RESULTS
During the study period, a total of 443 children were
treated for TB, of whom 389 (87.8%) were recorded
in the TB treatment register (Figure). The files of four
patients were lost. Table 1 shows the demographics
and clinical characteristics of all 439 children whose
records were evaluated. The sex distribution was
equal; 223 (52.6%) children were 3 years of age,
and 283 (64.5%) were tested for HIV infection, of
whom 25 (8.8%) were HIV-infected.
Eighty-five (19.4%) children were categorised as
‘not TB’. Three had disease caused by non-tuberculous
mycobacteria (NTM): one immune-competent child
had a regional Mycobacterium bovis bacille Calmette-
Guérin (BCG) abcess in the right axilla, and the other
two were HIV-infected with M. bovis BCG and an
unspecified NTM, respectively, cultured from their
gastric aspirates. Fifty-five were asymptomatic house-
hold contacts of an adult index case, while 27 pre-
Figure Flow chart of all children 13 years of age treated for
TB during the 21-month study period. ‘Not TB’  both experts
agreed that CXR was not suggestive of TB, no bacteriological
confirmation was obtained and no extra-thoracic TB was docu-
mented. Probable TB  all children treated for TB who had ra-
diological signs suggestive of TB, bacteriological confirmation
or extra-thoracic manifestations of TB. TB treatment register 
the clinic TB treatment register, which is the only data source
used to compile community-based surveillance data. TB 
tuberculosis; CXR  chest X-ray.
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sented with suspect symptoms or possible contact
outside the household. Ten of the 25 (40.0%) HIV-
infected children were categorised as ‘not TB’, com-
pared to 26/253 (10.2%) non-HIV-infected children
(odds ratio [OR] 5.82, 95%CI 2.17–15.56, P  0.001).
Table 2 reflects the burden of childhood TB in the
study area. During the 21-month study period 2830
people were treated for TB, of whom 389 (13.7%)
were children 13 years of age. The proportion of
children 13 years of age was 18.0% (107/593) in
the two clinics where active contact tracing was well-
supervised, compared to 12.4% (278/2237) in the
clinics where no supervised contact tracing took place
(OR 1.55, 95%CI 1.21–1.99, P  0.001). The TB
incidence amongst adults, using routine surveillance
data, was 845/100000/year, compared to 441/100 000/
year in children 13 years of age. The corrected TB
incidence in children was 407/100 000/year.
Table 3 reflects the TB manifestations documented
in the 54 children who were treated for TB but not re-
corded in the clinic TB treatment register. In total, 21/
28 (75.0%) children with severe disease were not re-
corded in the clinic TB treatment register, comprising
9/12 (75.0%) with disseminated (miliary) disease, 7/10
(70.0%) with CNS involvement and 5/6 (83.3%) with
both disseminated disease and CNS involvement.
DISCUSSION
In this high-burden setting, children 13 years of age
contributed 13.7% of the total TB caseload, which
compares remarkably well with the 15% contribu-
tion estimated for children 15 years of age in low-
income countries.13 This indicates that although results
from this hyperendemic area may not be generalis-
able, it is reasonable to suspect a similar situation in
other endemic areas. Efforts should be increased to
measure the burden of childhood TB with greater
accuracy in endemic areas.
A striking observation was the high incidence of
childhood TB in the study community. Although chil-
dren 13 years of age contributed 13.7% of the total
Table 1 Demographics and clinical characteristics
of all children 13 years of age treated for TB
Children treated for TB n (%)
Total analysed (4 of 443 records lost) 439
Sex
Male 217 (49.4)
Female 222 (50.6)
Age, years
3 231 (52.6)
3–5 96 (21.9)
5–9 76 (17.3)
10–13 36 (8.2)
Route
Actively traced contact of an adult index case 140 (31.9)
Presented with suspect symptoms 299 (68.1)
HIV
Tested 283 (64.5)
Infected 25/283 (8.8)
Proportion categorised as ‘not TB’ 85/439 (19.4)
Non-HIV-infected 26/253 (10.2)
HIV status unknown 49/161 (30.4)
HIV-infected 10/25 (40.0)
’Not TB’  both experts agreed that CXR was not suggestive of TB, no bacterio-
logical confirmation was obtained, and no extra-thoracic TB was documented.
TB  tuberculosis; HIV  human immunodeficiency virus; CXR  chest X-ray.
Table 2 The burden of childhood TB in the study area using community-based surveillance 
data, and data corrected for both misdiagnosis and absence from the clinic 
TB treatment register*
Community-based surveillance data n (%)
Total number recorded in the TB treatment register 2830
Proportion of children 13 years of age 289/2830 (13.7)
Proportion of children recorded in the TB treatment register in clinics
with supervised household contact tracing 107/593 (18.0)
without supervised household contact tracing 282/2237 (12.6)
Total population (unadjusted national census data from 2001)† 120 216
Proportion of children 13 years of age† 30 607/120 216 (25.5)
All-TB incidence‡ in
the total population† 742/100 000/year
adult population (13 years of age)† 845/100 000/year
children (13 years of age)† 441/100 000/year
Corrected TB incidence§ in children 13 years of age† 407/100 000/year
* TB treatment register  this refers to the clinic TB treatment register, which is the only data source used to compile
community-based surveillance data.
† Data from one local clinic where the unadjusted national census data from 2001 were considered to be unreliable
were excluded from both the numerator and the denominator.
‡ The all-TB incidence was calculated by 1) using the annualised number of entries (excluding transfers in) recorded in
the TB treatment register during the 21-month study period as the numerator; 2) using area- and age-specific popu-
lation figures as the denominator, and 3) expressing this ratio as the number of TB cases/100 000/year.
§ The corrected TB incidence in children was calculated by subtracting the number of children categorised as ‘not TB’
from the total number treated to determine the numerator and using area- and age-specific population data as the
denominator.
TB  tuberculosis.
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TB caseload, they experienced a TB incidence that
was 52.2% (441 vs. 845/100 000/year) of the adult
(13 years of age) incidence, using data from the
clinic TB treatment register. The incidence of child-
hood TB remained high (407/100 000/year) despite
correcting for children with ‘not TB’, who received
treatment inappropriately. The proportion of paedi-
atric cases was influenced by the diligence with which
active contact tracing was performed, as demon-
strated by the significant difference in the proportion
of child cases recorded in the clinics where active con-
tact tracing was well-supervised, compared to those
without supervised contact tracing.
The fact that significantly more HIV-infected chil-
dren were categorised as ‘not TB’ reflects the tremen-
dous diagnostic difficulties experienced in this group.14
Preventive chemotherapy is advised in HIV-infected
children infected with M. tuberculosis or exposed to
an adult index case, once active TB has been excluded.15
However, because adherence to unsupervised preven-
tive chemotherapy is known to be poor16 and radio-
logical signs are difficult to interpret,14 concerned cli-
nicians often prefer to give fully supervised therapy to
children whom they perceive to be at high risk of de-
veloping TB, such as HIV-infected children exposed
to an adult index case.
The study is limited by the fact that contact tracing
was not well-supervised in all five clinics; however, all
children who presented with suspect symptoms were
screened. In addition, children with severe TB may
have died without presenting to a health care facility,
but access to local clinics and hospitals is good within
the study area, which makes this unlikely. Despite
these limitations, this study provides the best achiev-
able estimate of the true burden of childhood TB in
this high-burden setting.
The most important observation was the frequent
omission of severe cases and the gross under-repre-
sentation (7/28, 25%) of children at the severe end of
the disease spectrum in the clinic TB treatment regis-
ter, although the total number of children recorded
was a slight over-representation of the true TB burden
due to misdiagnosis (389 vs. 358, 108.7%). All 54
children who were not recorded in the clinic TB treat-
ment register were diagnosed at the referral hospital,
from where the majority were transferred to a TB hos-
pital due to the severity of their disease or to social
problems to complete their treatment under hospital
supervision. Those discharged from the referral hos-
pital on anti-tuberculosis treatment were not always
captured in the clinic TB treatment register, although
treatment was continued.
The current policy is that all children discharged
from hospital on anti-tuberculosis treatment should
be recorded in the clinic TB treatment register, but
this policy needs to be re-emphasised to health care
personnel. Children who complete their full duration
of treatment in a TB hospital are currently entered
into a hospital-held register, but these data are not re-
layed back to the local clinic. The most feasible solu-
tion in the study setting is that data from the hospital-
held register should be transferred to the appropriate
clinic register at the time of electronic data entry. The
electronic register should then provide all-inclusive
community-based data. However, current international
TB surveillance categories preclude the identification
of these more serious forms of TB, a limitation that
we think needs to be addressed to determine the true
burden of childhood TB.
In conclusion, children with severe forms of TB are
inaccurately reflected in community-based surveil-
lance data. The accuracy of surveillance data must be
taken into consideration when reporting on the epide-
miology of childhood TB or when determining the
effectiveness of public health interventions.
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R É S U M É
CONTEXTE : La qualité des données épidémiologiques
concernant la tuberculose (TB) infantile est compromise
par une surveillance inadéquate et par les difficultés de
diagnostic.
OBJECTIF : Documenter l’incidence de la TB de l’enfant
et évaluer la précision des données de surveillance basées
sur la collectivité dans un contexte à haute prévalence.
MÉTHODES : Cette étude prospective d’observation a été
menée entre février 2003 et octobre 2004 dans cinq
polycliniques de soins de santé primaires à Cape Town,
Afrique du Sud. Une surveillance complète a été menée
pour s’assurer que tous les enfants âgés de moins de 13
ans et traités pour TB avaient bien été inclus.
RÉSULTATS : Au cours de la période d’étude, 443 en-
fants âgés de 13 ans ont reçu un traitement antituber-
culeux. Parmi ceux-ci, 389 (87,8%) avaient été inscrits
dans le registre de traitement de la TB. L’incidence de la
TB, calculée à partir du registre de traitement de la TB,
a été de 441/100.000 par an parmi les enfants et de 845/
100.000 par an parmi les adultes. Cinquante-quatre en-
fants traités pour TB n’étaient pas inscrits dans le regis-
tre de traitement de la TB, et parmi ceux-ci se trouvaient
21 des 28 (75%) enfants atteints de TB grave.
DISCUSSION : Les enfants âgés de 13 ans ont représenté
13,7% du fardeau total de TB. L’incidence chez les en-
fants est supérieure à la moitié (52%) de celle enregistrée
chez les adultes. Les données de surveillance basées sur
la collectivité n’ont pas inclus la majorité des enfants at-
teints d’une maladie grave. La précision des données de
surveillance est une considération importante lorsqu’il
s’agit de décrire l’épidémiologie de la TB de l’enfant ou de
mesurer les succès des interventions de santé publique.
R E S U M E N
MARCO DE REFERENCIA : La calidad de los datos epide-
miológicos sobre la tuberculosis (TB) infantil se dete-
riora debido a la vigilancia inadecuada y a las dificulta-
des diagnósticas.
OBJETIVO : Verificar la incidencia de TB en la infancia y
evaluar la precisión de los datos de vigilancia epidemi-
ológica de base comunitaria, en un entorno con alta
carga de morbilidad por TB.
MÉTODOS : Fue este un estudio observacional prospec-
tivo realizado entre febrero de 2003 y octubre de 2004
en cinco consultorios de atención primaria de salud en
Ciudad del Cabo, Sudáfrica. Se llevó a cabo una vigilan-
cia exhaustiva para verificar la inclusión de todos los
niños 13 años tratados por TB.
RESULTADOS : Durante el período del estudio 443 niños
13 años recibieron tratamiento antituberculoso, de los
cuales 389 (87,8%) se declararon al registro de trata-
miento de la TB. La incidencia de TB calculada con base
en el registro fue de 441/100 000 por año en los niños
y de 845/100 000 por año en los adultos. Cincuenta y
cuatro niños tratados por TB no fueron declarados al
registro de tratamiento de la TB ; entre ellos 21 de los 28
niños con una enfermedad grave (75%).
DISCUSIÓN : La tuberculosis en niños 13 años repre-
sentó el 13,7% de la carga total de morbilidad por TB.
Sin embargo, los niños presentaron una incidencia de
TB correspondiente al 52,2% de la incidencia de los
adultos. Los datos de vigilancia de base comunitaria ex-
cluyeron la mayoría de niños con enfermedad grave. La
precisión de los datos de vigilancia constituye una con-
sideración importante cuando se describe la epidemi-
ología de la TB infantil y cuando se evalúa el éxito de las
intervenciones de salud pública.
44
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Chapter 4. 
 
The spectrum of disease 
 
Childhood tuberculosis is often reported as a single disease entity, although it represents a 
diverse spectrum of pathology.  Accurate classification of intra-thoracic disease in children is 
important, due to its prognostic significance.  We propose a radiologic classification of intra-
thoracic tuberculosis in children, and discuss the pathogenic differences that underlie the 
different disease manifestations.  Thereafter, we documented the complete spectrum of 
disease in children treated for tuberculosis in an endemic area and demonstrated that 
bacteriologic confirmation may be achieved in the majority of children with intra-thoracic 
tuberculosis.  We also described the clinical presentation and diagnosis of tuberculous 
cervical lymphadenitis, which is the most common extra-thoracic manifestation of tuberculosis 
in children.   
 
1. Marais BJ, Gie RP, Schaaf HS, Starke JR, Hesseling AC,Donald PR, Beyers N. A 
proposed radiologic classification of childhood intra-thoracic tuberculosis. 
Pediatr Rad 2004; 33: 886-894 
One of the obstacles in childhood tuberculosis is the lack of standard descriptive terminology 
to classify the diverse spectrum of disease.  Accurate disease classification is important for 
optimal case definition and management, and to facilitate scientific communication.  This 
review proposes a radiologic classification of intra-thoracic tuberculosis in children, based on 
the underlying disease pathology and the principles of pathological disease progression. 
 
2. Marais BJ, Donald PR, Gie RP, Schaaf HS, Beyers N. Diversity of disease 
manifestations in childhood pulmonary tuberculosis. Ann Trop Paed 2005; 25; 
79-86 
Many factors can influence the dynamic host-pathogen balance, but host immunity is a crucial 
factor.  This is illustrated by the vulnerability of immune-compromised individuals to develop 
tuberculosis and by the age-related spectrum of disease witnessed in immune-competent 
children.  This review focuses on the age-related spectrum of disease in children with 
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tuberculosis and on the importance of understanding the ontogeny of the host immune 
response towards M.tuberculosis.  It offers a hypothesis to explain the unique anatomical 
localization of adult-type tuberculosis and its sudden emergence around puberty. 
 
3. Marais BJ, Gie RP, Hesseling AC, Beyers N. Adult-type pulmonary tuberculosis 
in children aged 10-14 years. Pediatr Inf Dis J 2005; 24: 743-744 
This case series reported 8 children, 10-14 years of age, who were treated for tuberculosis at 
their local primary health care clinic in a 3-month period, after routine sputum testing was 
extended to all children older than 10 years of age with suspected tuberculosis.  Of the 8, 7 
had adult-type disease and were sputum smear-positive.   Children with adult-type disease 
pose a significant transmission risk, especially in congregate settings such as schools.  This 
case series emphasized the existence of adult-type disease in children and the fact that it can 
be diagnosed by sputum smear-microscopy.   
  
4. Marais BJ, Gie RP, Schaaf HS, Hesseling AC, Enarson DA, Beyers N. The 
spectrum of disease in children treated for tuberculosis in a highly endemic 
area. Int J Tuberc Lung Dis 2006. In press 
Children contribute a significant proportion of the global tuberculosis caseload; particularly in 
endemic areas where little is known about their spectrum of disease.  This prospective 
descriptive study documents the complete disease spectrum, and relevant age-related 
differences, in children treated for tuberculosis in a highly endemic area.  Children suffered 
significant morbidity, with most severe disease recorded in very young and/or HIV-infected 
children.  In HIV-uninfected children; disseminated (miliary) disease (9/11, 81.8%) and 
tuberculous meningitis (10/13, 76.9%) occurred predominantly in children less than 3 years of 
age.  In HIV-infected children, disease manifestations that reflect poor organism containment 
such as complicated Ghon focus and disseminated (miliary) disease, were significantly more 
common (6/25, 24.0%) than in HIV-uninfected children (12/414, 2.9%) (OR 10.9, 95% CI 3.2-
35.9).   
 
Stellenbosch University  http://scholar.sun.ac.za 
 47
5. Marais BJ, Hesseling AC, Gie RP, Schaaf HS, Enarson DA, Beyers N. 
Bacteriologic yield in children with intra-thoracic tuberculosis. Clin Infect Dis 
2006. In press 
This report represents a sub-analysis of the disease spectrum study (referred to above) and 
documents the proportion of children treated for intra-thoracic tuberculosis, in whom 
bacteriologic confirmation was achieved.  In total, bacteriologic confirmation was achieved in 
122/196 (62.2%) children in whom specimens were collected.  The lowest bacteriologic yield 
was recorded in children with uncomplicated lymph node disease (24/69, 34.8%).  
Bacteriologic confirmation was achieved in an unexpected high proportion of children treated 
for intra-thoracic tuberculosis, which indicates a need to re-assess the value of bacteriology-
based approaches to diagnose childhood tuberculosis, particularly in endemic areas where 
children often present with advanced disease. 
 
6. Marais BJ, Wright C, Gie RP, Hesseling AC, Schaaf HS, Enarson D, Beyers N. 
Tuberculous lymphadenitis as a cause of persistent cervical lymphadenopathy 
in children from a tuberculosis endemic area. Ped Inf Dis J 2006; 25: 142-146 
Cervical lymphadenitis is the most common form of extra-pulmonary tuberculosis in children.  
This prospective descriptive study documented the clinical presentation of tuberculous 
lymphadenitis at the primary health care level, and its relative contribution as a cause of 
persistent cervical adenopathy in children from a tuberculosis endemic area.  A total of 158 
children were evaluated of whom 35 (22.2%) were diagnosed with tuberculous lymphadenitis.  
In children with a persistent cervical mass ≥2x2cm, without a visible local cause or response 
to antibiotics, tuberculous lymphadenitis was diagnosed in 31/33 (93.3%); sensitivity 88.6%, 
specificity 98.4%, positive predictive value 93.4%.  The use of a simple clinical algorithm 
identified tuberculous lymphadenitis with a high degree of accuracy, while fine needle 
aspiration (FNA) provided a rapid and definitive diagnosis in the majority of children.  
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Abstract One of the obstacles in
discussing childhood tuberculosis
(TB) is the lack of standard
descriptive terminology to classify
the diverse spectrum of disease.
Accurate disease classification is
important, because the correct
identification of the specific disease
entity has definite prognostic sig-
nificance. Accurate classification
will also improve study outcome
definitions and facilitate scientific
communication. The aim of this
paper is to provide practical
guidelines for the accurate radio-
logical classification of intra-tho-
racic TB in children less than
15 years of age. The proposed
radiological classification is based
on the underlying disease and the
principles of pathological disease
progression. The hope is that the
proposed classification will clarify
concepts and stimulate discussion
that may lead to future consensus.
Keywords Tuberculosis'
Lung' Mediastinum'
Classification' Children
Introduction
Inhalation is the predominant route of Mycobacterium
tuberculosis (M. tuberculosis) infection [I, 2]. Infection
is indicated by a significant tuberculin skin test (TST) [3].
A positive M. tuberculosis- specific lymphocyte stimu-
lation test also indicates infection in an experimental
setting [4]. Primary infection is followed by a sequence of
events which in nearly every instance leads to the
development of a Ghon complex and the dissemination
of bacilli throughout the body [2]. Identification of the
radiological changes associated with primary tubercu-
losis (TB) infection may be difficult, and in the absence
of information on clinical symptoms, the point at which
these changes should be looked upon as a manifestation
of disease is uncertain. In general, the pathological
changes associated with TB in children are non-cavitary
and pauci-bacillary. Therefore, the diagnosis of intra-
thoracic TB in childhood depends largely on the inter-
pretation of the chest radiograph [5].
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Fig. 1 Progression of pathol-
ogy in intra-thoracic TB fol-
lowing primary pulmonary
infection in childhood
I PRIMARY PULMONARY INFECTION I
•GHON COMPLEX
Local progression may occur at one or
both major elements of the Ghon
complex with/without disease spread
Disease spread with:Disease progression due to:
~ ~
Airway involvement with:
Poor containment
Mainly <2 years of age or immune
compromised children
or
'Excessive' containment
Mainly >10 years of age
Parenchymal cavitation with
intra-bronchial spread and:
Bronchopneumonic
consolidation
DISEASE PROGRESSION
Progression may terminate
at any particular point
Pleural effusion
and/or
Pericardial effusion
and/or
Disseminated
(miliary) disease
Partial obstruction
or
Partial obstruction, check-valve
effect and hyperinflation
or
Total obstruction and collapse
Lympho-bronchial disease with
intra-bronchial spread and:
Alveolar consolidation
Allergic consolidation
and/or
Caseating consolidation
Bronchopneumonic
consolidation
Caseating consolidation with
parenchymal cavitation, intra-
bronchial spread and:
Bronchopneumonic
consolidation
One of the obstacles in childhood TB is the lack of
standard descriptive terminology to classify the spectrum
of disease. Accurate disease classification is important,
because the identification of specific disease entities has
definite prognostic significance [5].Accurate classification
will improve study outcome definitions, facilitate study
comparison and improve scientific communication. It will
also improve understanding of the underlying disease and
its implications for patient care. The aim is to provide
practical guidelines for the accurate radiological classifi-
cation of different intra-thoracic manifestations of TB in
children less than IS years of age.
Materials and methods
The natural history of disease and associated pathologic
descriptions from the pre-chemotherapy era provided the
scientific basis for the proposed radiological classification
[1-3,5-19]. A summary of the pathological progression of
disease, deduced from the pre-chemotherapy literature, is
provided to illustrate the principles that were applied
(Fig. I). More recent relevant reports, as well as the
combined personal experience of the authors regarding
the radiological manifestations of childhood TB, were
included to provide a comprehensive picture. The pro-
posed classification represents a compromise between
descriptive accuracy and practical utility.
Principles of the pathological progression of disease
A thorough understanding of disease pathology is
essential, because the chest radiograph is merely a 2-D
reflection of the underlying pathology.
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Primary pulmonary infection occurs when an unin-
fected person inhales an infectious droplet, which
successfully establishes infection in a terminal airway or
alveolus [1-3, 5-7]. A localized pneumonic process,
referred to as the primary parenchymal (Ghon) focus,
results. From the Ghon focus, bacilli usually drain via
local lymphatics to the regional lymph nodes. The upper
lobes drain to the ipsilateral-para tracheal nodes, while
the rest of the lung drains to the perihilar nodes, with
dominant lymph flow from left to right [3]. The combi-
nation of the Ghon focus, local lymphangitis and
regional lymph node involvement is called the Ghon
complex [1-3, 5-7, 20, 21]. Some pleural reaction over-
lying a peripheral Ghon focus may form part of the
Ghon complex [21]. The formation of the Ghon complex
is often subclinical and a random chest radiograph fol-
lowing primary infection is often normal or reveals only
a single component (usually hilar adenopathy) [2, 3, 21,
22].
Disease progression may occur at the site of organism
deposition (Ghon focus), within the regional lymph
nodes, or following disease spread [1-3, 5-7]. Disease
spread may occur following lymphatic drainage with
haematogenous dissemination or after local penetration
across anatomical boundaries [1-3, 5-7]. Penetration
may occur into an adjacent anatomical space or struc-
ture, into an airway with additional intra-bronchial
spread or into a blood vessel with haematogenous dis-
semination.
The Ghon focus represents the first site of possible
disease progression. Poor containment at the site of
organism deposition may lead to progressive caseation.
Discharge of the caseated material into a bronchus re-
sults in the formation of a parenchymal cavity [1-3, 5-7].
Infants [1-3, 5, 23, 24] and immunocompromised chil-
dren [25-29] are most vulnerable to cavitation of the
Ghon focus due to poor disease containment. A change
in the immune response around puberty may result in
'excessive' organism containment, but this is a detri-
mental response leading to ultimate poor containment.
Increased parenchymal damage results in cavities, where
organisms multiply efficiently [7-10]. The exact patho-
logical mechanism, as well as the relative contribution of
recent primary infection, re-infection and re-activation is
uncertain, but in older children (> 10 years of age)
adult-type cavitating disease is the dominant disease
manifestation following recent primary infection [7-10,
30].
The second site of possible disease progression is
within the regional lymph nodes, which enlarge due to
central caseation and surrounding inflammatory oedema
[1- 3, 6, 7]. Lymph node disease is most common fol-
lowing primary infection before 5 years of age [1-3, 5].
This, in addition to the small airway size, makes young
children the most vulnerable group to develop lympho-
bronchial TB [1-3, 12,31]. The term lympho-bronchial
50
TB refers to a whole spectrum of airway involvement
and associated complications that may arise following
lymph node disease [30]. Extra-luminal compression re-
sults from enlarged lymph nodes and associated
inflammatory oedema [1-3, 5-7]. Intra-luminal
obstruction results from polyps or granulomatous tissue
that. develop secondary to inflammatory changes in the
bronchial wall, or from caseous material deposited on
eruption of a caseated lymph node into the airway [1-3,
5-7]. Partial airway obstruction may cause a check-valve
effect with distal hyperinflation [7, 13]. Total airway
obstruction results in resorption of distal air with alve-
olar collapse [23]. The ultimate volume of the affected
segment depends on the underlying alveolar pathology
[1- 3, 5-7, I5].
Intra-bronchial spread may occur from a parenchy-
mal cavity with a high organism load [3, 7], or after
eruption of a caseated lymph node with variable
organism load, into a bronchus [3, 5-7, 31]. Patchy
bronchopneumonic consolidation affecting multiple
lung segments may result after intra-bronchial spread
from a parenchymal cavity [3, 5-7]. Lymph node erup-
tion into a bronchus with distal aspiration of caseous
material usually results in dense alveolar consolidation
of a single segment or lobe [1-3, 5-7], but patchy
bronchopneumonic consolidation is also a possibility.
Variation in the dose and virulence of the bacilli aspi-
rated, the degree of airway obstruction and the immune
competence of the host determine the resultant pathol-
ogy [I, 7, IS]. The pathology may range from a pure
hypersensitivity response, historically referred to as
epituberculosis, to destructive caseating pneumonia [7,
IS, 32]. Bulging fissures and cavitation indicates ca-
seating pneumonia or possible secondary bacterial
infection [I, 3, 33].
Disease spread may also occur after penetration into
an adjacent anatomical space or structure [3, 6, 7]. A
unilateral pleural effusion points to direct spread from a
subpleural Ghon focus, while bilateral pleural effusions
may indicate bilateral Ghon foci or haematogenous
dissemination [3, 7, 17]. Pleural effusion develops mainly
in children older than 5 years following recent primary
infection [2, 3]. The accumulation of a lymphocyte-rich
straw-coloured fluid containing few organisms repre-
sents a hypersensitivity response, but rarely tuberculous
empyema may develop, depending on the dose and vir-
ulence of bacilli that enter the pleural space and the
immune status of the host [I, 3, 7]. A pericardial effusion
usually develops when a subcarinal lymph node erupts
into the pericardial space, but it displays the same range
of pathology as pleural effusions [3, 7]. Diseased lymph
nodes may infiltrate other intra-thoracic structures with
visible signs on the chest radiograph, e.g. the oesopha-
gus, the phrenic nerve and the thoracic duct [3, 6, 7].
Two main types of haematogenous spread are dif-
ferentiated, but dissemination represents a condition of
Stellenbosch University  http://scholar.sun.ac.za 
, 51
889
infinite gradation. Following dissemination, bacilli
lodge in small capillaries where they may progress
locally and give rise to further haematogenous spread
[1-3, 7]. The first type (occult spread) occurs com-
monly after primary infection. It rarely progresses to
disseminated disease, except in very young « 2 years
of age) [1-3] and immunocompromised children [25,
26]. The second type occurs rarely and only after
disease progression, when a caseous focus erodes into
a blood or lymph vessel [I, 3, 7]. It frequently pro-
gresses to disseminated disease, irrespective of the
child's age or immune status [I, 3].
Proposed radiological classification
of intra-thoracic tuberculosis
The diverse spectrum of disease is classified into separate
principal disease entities, according to the underlying
pathology (Fig. 1). Active radiographic surveillance
following recent TST conversion indicates that elements
of the Ghon complex are often visible following recent
primary infection [19]. In isolation, elements of the
Ghon complex can be viewed as radiographic proof of
recent primary infection. The presence of clinical
symptoms indicative of disease together with radio-
graphic evidence of recent primary infection, or any
other radiographic sign attributable to current disease,
identifies intra-thoracic TB in childhood. The radio-
graphic picture may be used to classify intra-thoracic TB
according to the principal disease entities and the com-
plications visible (Table 1).
Principal disease entities
The principal disease entities are arranged according to
anatomical location, following the rationale of disease
progression outlined (Fig. I). The Ghon focus involves
the lung parenchyma, but is part of the Ghon complex
and ,will be accompanied by lymph node disease in the
majority of cases. Adult-type disease also affects the lung
parenchyma, but does not form part of the Ghon com-
plex and is usually seen in isolation.
Lung parenchyma
Ghon focus
The Ghon focus forms part of the Ghon complex and is
rarely seen in isolation. It is variable in size and may
show an overlying pleural reaction (Figs. 2, 3) [21].
Complications include local progression with cavity
formation and resultant intra-bronchial spread with
bronchopneumonic consolidation [I, 23-25, 29].
Adult-type disease
The initial presentation of adult-type disease may be
with cloudy opacification in an apical lung segment,
before coalescence and parenchymal breakdown (Fig. 4)
[1,21]. Usually the cavities already exist on presentation.
surrounded by alveolar consolidation and fibrosis [3, 30,
34]. The apical and posterior segments of the upper lobe
and the apical segment of the lower lobe are most
Table I Proposed radiological classification of childhood intra-thoracic TB
Principal disease entity
Lung parenchyma
Ghon focus
Adult-type disease
Lymph node
Lymph node disease
Pleural effusion
Pericardia I effusion
Disseminated (miliary) disease
Local complications
With cavitation
Obstruction
With bronchial and/or
tracheal compression
With hyperinflation or collapse
Infiltration
With tracheo- or brancho-oesophageal
fistula
With chylothorax
With diaphragmatic palsy
With tuberculous empyema
With pneumothorax
Complications following intra-bronchial spread
And branchopneumonic consolidation
With alveolar consolidation (-and cavitation/-and
bronchopneumonic consolidation)
With bronchopneumonic consolidation
Identify the principal disease entity. Then specify the principal
disease entity according to the visible radiographic complications.
More than one principal disease entity may be present at the same
time or develop in succession. Some radiological manifestations
may be difficult or impossible to classify accurately. Extremely rare
entities (e.g. congenital TB) were not included in this classification
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Fig. 2 Radiological classification: Ghon focus. Pathological
description: large uncomplicated Ghon focus in the left lower lobe
Fig. 3 Radiological classification: Ghon focus with cavitation and
bilateral bronchopneumonic consolidation. Pathological descrip-
tion: poorly contained Ghon focus with cavitation leading to
bilateral bronchopneumonia
commonly affected. Complications include progressive
cavity formation and intra-bronchial spread with bron-
chopneumonic consolidation [9, 17, 34].
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Fig. 4 Radiological classification: adult-type disease with unilateral
cavitation and unilateral bronchopneumonic consolidation. Path-
ological description: adult-type disease with alveolar consolidation
and multiple cavities in the left upper lobe, leading to intra-
bronchial spread with segmental bronchopneumonia in the right
upper lobe. The calcified mediastinal glands on the left suggest
previous primary infection
Lymph node disease
Regional lymphadenopathy (perihilar or paratracheal) is
considered the radiological hallmark of primary infec-
tion in childhood (Figs. 5,6,7,8) [17, 35, 36]. Initially,
lymph nodes show poor delineation ('flaring') due to
adjacent parenchymal involvement, but they become
better circumscribed on resolution [17]. AP and lateral
views are required for optimal lymph node visualization
[22, 36], but it may remain difficult to visualize enlarged
lymph nodes with certainty [37-39]. Complications in-
clude the full spectrum of lympho-bronchial disease.
Airway compression may be better visualized with high-
kilovolt exposure. A hyperlucent area with volume in-
crease indicates hyperinflation (partial obstruction with
check-valve effect), while segmental or lobar volume loss
indicates alveolar collapse (total obstruction). With no-
dal eruption into an airway and associated alveolar
consolidation, the relative contribution of hypersensi-
tivity and caseating pneumonia can only be assessed in
hindsight. A pure hypersensitivity response is rare and
consolidation shows complete resolution without per-
manent sequelae [IS]. Caseating pneumonia causes
parenchymal destruction with cavitation and excessive
fibrosis on resolution [15, 33]. Rare local complications
visible on chest radiography include broncho- or tra-
cheo-oesophageal fistula formation, diaphragmatic pal-
sy and chylothorax.
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Fig. 5 Radiological classification: lymph node disease (AP view).
Pathological description: right hilar lymph node enlargement. Note
the haziness ('flare') that surrounds the lymph node suggesting
recent infection without signs of resolution
Fig. 6 Radiological classification: lymph node disease (lateral
view). Pathological description: the lateral chest radiograph
confirms the enlarged hilar nodes, as indicated by the arrolV
Pleural effusion
The amount of fluid is highly variable; it typically
obliterates 30-60% of the affected hemithorax [17], but a
massive fluid collection may occur causing mediastinal
shift (Fig. 9) [3, 17]. Complications include a co-existent
- 53
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Fig. 7 Radiological classification: lymph node disease with bron-
chial compression and unilateral hyperinflation. Pathological
description: lymph node enlargement with compression of the left
main bronchus resulting in a check-valve effect with air trapping in
the left lung. This causes unilateral hyperinflation, shifting the
mediastinum to the right
Fig. 8 Radiological classification: lymph node disease with bron-
chial and tracheal compression, with lobar alveolar consolidation
and cavitation. Pathological description: lymph node enlargement
with compression of both the trachea and left main bronchus.
Expansile alveolar consolidation of the left upper lobe and lingula
due to caseating pneumonia, causes mediastinal shift to the right. A
small cavity is visible in the left upper lobe
pneumothorax or a persistent loculated fluid collection.
indicative of tuberculous empyema [3, 40].
Pericardial effusion
The heart shadow may be enlarged with a suggestive
globular appearance [3]. Cardiac ultrasound confirms
the diagnosis.
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Fig. 9 Radiological classification: unilateral pleural effusion. Path-
ological description: large uncomplicated right-sided pleural effu-
sion. No underlying pathology is visible
Fig. 10 Radiological classification: lymph node disease plus dis-
seminated disease. Pathological description: large right-sided
para tracheal glands shifting the trachea to the left, with haemat-
ogenous disease dissemina tion
Disseminated (miliary) disease
Initial mottling may be invisible, only becoming visible
after local progression (Fig. 10) [1,17,41-43]. Mottling
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may vary in size depending on the degree of local pro-
gression [I], from typical even-sized miliary lesions
« 2 mm) to atypical poorly defined patches. The lesions
are bilateral and evenly distributed into the periphery of
the lung, although limited dissemination via a pulmo-
nary artery may rarely occur [3, 44]. Disease dissemi-
nation may be a complication of another pre-existing
disease entity, or it may occur in isolation.
How to use the disease classification
A summary of the proposed classification is provided to
guide the radiological evaluation (Table I). First iden-
tify the principal disease entities present. More than one
entity may be present at the same time or develop in
succession. Then specify each principal disease entity
according to the radiographically visible complications.
The extent of disease can be quantified using 'segmen-
tal', 'lobar', 'unilateral' or 'bilateral', where applicable.
The correct use of the proposed classification has been
illustrated with the examples provided (Figs. 2, 3, 4, 5, 6,
7,8,9, 10).
Radiological distinction between the different types
of cavitating disease may be difficult and is guided by the
age of the child. Cavitation from a progressive Ghon
focus is rare and occurs in very young (mainly < 2 years
of age) or immunocompromised children. Cavitation
from adult-type disease usually involves the apical seg-
ments of the lung and occurs in older children (mainly
> 10 years of age). Cavitation due to caseating pneu-
monia occurs secondary to Iympho-bronchial disease
with segmental alveolar consolidation. It affects younger
children (mainly < 5 years of age). With extensive
bilateral involvement, distinction between advanced
disseminated disease and bilateral bronchopneumonia
may be problematic, but uniform bilateral involvement
usually indicates haematogenous dissemination [17].
However, with HIV-associated immune compromise,
lymphocytic interstitial pneumonitis (LIP), malignancies
and opportunistic infections may cause additional
diagnostic confusion [45, 46].
Consequences of previous pulmonary tuberculosis
Calcification
Areas of caseation (e.g. inside a Ghon focus or a dis-
eased lymph node) frequently calcify. This may be the
only sign of previous primary infection. Calcification
may occur from 6 months to 4 years after infection,
tending to occur earlier in young children [3, 9, 17]. In
the absence of current disease, calcification points to a
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previous well-contained infection. It indicates, but is not
a guarantee of, clinical quiescence [I, 5, 17].
Parenchymal destruction with fibrosis
A check-valve effect causes distal volume increase and
hyperinflation. Extensive parenchymal destruction cau-
ses a bullous appearance with volume loss due to asso-
ciated fibrosis (l, 3, 47]. Fibrosis and contraction may
influence the position of the hilum and lead to eventual
collapse of the bullae [I, 17].
Bronchiectasis
Excessive airway and surrounding parenchymal damage,
may cause permanent bronchiectatic dilatation [18, 19].
Recurrent bacterial infections may complicate bronchi-
ectasis, especially if the lower lobes are affected [3, 5, 17].
Consequences of immune reconstitution
Immune reconstitution was historically described fol-
lowing nutritional rehabilitation or termination of high-
dose steroid treatment [3]. Recent descriptions followed
the introduction of highly active anti-retroviral therapy
(HAART) in HIV-infected Immune compromised
patients [48, 49]. Immune reconstitution results in
increased inflammation.
References
Airway compression
Airway compression may worsen due to increased
inflammation surrounding diseased lymph nodes. In-
creased airway compression may be directly visible on
the chest radiograph, or indicated indirectly by seg-
mental hyperinflation or collapse.
Alveolar consolidation
In areas of previous uncontained parenchymal disease
progression, excessive inflammation may result in dense
alveolar consolidation and eventual parenchymal
breakdown [49].
Conclusions
The diversity of disease manifestations in childhood TB
necessitates the use of standard descriptive terminology.
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Diversity of disease in childhood pulmonary tuberculosis
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Abstract Many factors can influence the dynamic balance that exists between the host and the pathogen (M.
tuberculosis), but the host immune response seems to be the most important. This is illustrated by the vulnerability
of immune-compromised individuals to develop tuberculosis and by the age-related spectrum of disease witnessed
in immune-competent children. This age-related spectrum of disease reflects the ontogeny of the host immune
response towards M. tuberculosis. Renewing our focus on the ontogeny of the immune response in children might
provide valuable insights to direct future research regarding tuberculosis prevention, vaccine development and
treatment.
Background
Childhood covers the interval from birth to
adolescence (defined as 0–15 years of age).
It is a period of dynamic growth and
maturation during which the natural
response to infection undergoes profound
change as the immune system develops. Few
diseases illustrate this evolution of the
immune response better than the diverse
and changing spectrum of pathology seen in
childhood tuberculosis.1
A recently proposed radiological classifi-
cation of childhood intra-thoracic tubercu-
losis highlights this disease diversity and its
relevance to prognosis and treatment.2
Understanding the age-dependent differ-
ences in the immune response to Mycoba-
cterium tuberculosis infection is crucial for
improved case management and for direct-
ing future research.
The aim of this paper is to explore the
pathological mechanisms that underlie the
diversity of disease manifestations observed
in childhood intra-thoracic tuberculosis.
General infectious disease principles are
outlined and discussed for tuberculosis in
general, before applying them to separate
intra-thoracic disease manifestations in
particular.2
Principles of Disease
Dynamic balance
The clinical manifestation of an infectious
disease depends on the balance between the
organism’s pathogenicity and the host’s
immune competence. In tuberculosis, an
important dynamic dimension is added to
this balance because initial organism con-
tainment rarely ensures organism eradica-
tion.3 Persistence of dormant bacilli inside
sequestered foci (latent infection) provides
an ‘ever-present’ risk of reactivation when-
ever the balance shifts in favour of the
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organism. In addition to the risk of reactiva-
tion following previous primary infection,
high levels of transmission implies an addi-
tional risk of re-infection in high-burden
settings.4,5 The delicate and dynamic
balance that is established between the
pathogen and the host can be influenced
by numerous variables (Fig. 1).
The pathogen
Variables related to the pathogen include
the number of organisms inhaled (size of the
infecting dose), the virulence of the organ-
isms and their ability to resist eradication
(persistence).
Variation in the infecting dose of M.
tuberculosis seems negligible. Lung deposi-
tion studies indicate that only the tiniest
aerosol droplets containing ,5 bacilli are
likely to reach the terminal airways and
establish a pulmonary focus of infection.6–8
Larger droplets are either not inhaled (since
they are less likely to remain suspended in
the air) or are deposited in the proximal
airways where infection is effectively
resisted.8–10 Epidemiological evidence and
experimental evidence from laboratory ani-
mals11,12 suggests that the intensity
of exposure influences the risk of both
infection and disease. It is well established
that variables such as duration of exposure
and number of infectious particles in the
ambient air influence the risk of infection.
However, natural infection in humans seems
a fairly uniform event with little variation in
the infecting dose which is generally thought
to be a single aerosol droplet containing ,5
bacilli. Other variables, including multiple
infections or increased virulence of the
infecting organisms, might explain the
increased tendency to progress to disease
following high-intensity exposure such as
exposure in the home to a sputum smear-
positive source case. Primary infection is
usually visualised as a single parenchymal
(Ghon) focus,1 but exposure to multiple
infective doses might increase the likelihood
that a single infective dose is ultimately
successful in establishing infection and/or
disease. Variation in the virulence of the
infecting organisms could be another expla-
nation, as the phenotypic virulence might
differ according to the sputum smear-status
of the source case, while the proximity of the
source case will determine the influence of
environmental factors such as exposure to
ultraviolet irradiation or drying.8,9 Genetic
variation in organism virulence is well
documented13,14 but it is unlikely that
FIG. 1. Factors underlying different manifestations of pulmonary tuberculosis.
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strain differences can explain the consistent
epidemiological finding that household
contacts of sputum smear-positive source
cases are more likely to progress to disease
following infection.
Persistence describes the ability of the
pathogen to evade eradication and to remain
dormant for extended periods of time.
Several mechanisms that might enable M.
tuberculosis to persist both intracellularly
(inside macrophages) and extracellularly
(inside the caseous centres of granulomas)
have been described.15,16 The presence of
dormant M. tuberculosis bacilli is not harmful
to the host unless circumstances favour their
reactivation, which explains why progressive
immune compromise poses such a high risk
of reactivation disease.
Host immunity
Total host immunity includes a combina-
tion of innate and acquired immune
responses together with local pulmonary
defences, which seem more important than
was previously appreciated. Compromised
organism clearance, decreased mucosal
immunity and a favourable micro-
environment at the point of organism
deposition might all contribute to an
increased risk of infection and disease. The
importance of these local pulmonary influ-
ences is demonstrated by the co-morbidity
that exists between pulmonary tuberculosis
and silicosis17 or tobacco smoking.18,19
The protection provided by the innate
immune response seems limited because
bacilli grow unrestrained within naive macro-
phages and occult haematological dissemina-
tion occurs frequently during the 1st 4–6
weeks after primary infection.20–23 Acquired
cellular immunity is of crucial importance to
contain the organism and prevent uncon-
trolled disease progression.20–23 In the
absence of immune compromise, age is the
dominant variable that determines the effec-
tiveness of acquired cellular immunity to
contain the organism. This is illustrated by
the striking age-related risk of developing
tuberculosis following primary infection and
by the age-related differences seen between
particular disease manifestations (Fig. 2).1
Very young children (,2–3 yrs of age) with
immature immune systems are at high risk of
developing progressive disease while children
aged 3–10 years are the least likely to
progress to disease after primary infec-
tion.1,24,25 After this ‘golden period’, there
FIG. 2. Age-related manifestations of pulmonary tuberculosis in immune-competent children. 1. Complicated
Ghon focus and/or disseminated disease. 2. Complicated lymph node disease. 3. Pleural effusion. 4. Adult-type
disease.
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is a sudden increase in the risk of progressing
to disease following recent primary infection
during adolescence (.10 years of age).1,24–28
The possible reasons for this sudden
increase in risk around puberty are dis-
cussed in more detail under the heading
Adult-type disease. In young children, dis-
ease is mainly related to regional lympha-
denopathy and organism dissemination,
while adolescent disease is differentiated
by the tendency to develop adult-type
pulmonary cavitation.1,28,29 Apart from
the age and immune status of the child
at the time of infection, the time since
infection is another important variable that
influences the particular disease manifes-
tation, as illustrated by the time-table of
tuberculosis in children1,23 (Fig. 3).
Description of Specific Disease Entities
Uncomplicated Ghon focus and/or lymph node
disease2 (risk group: children ,5 years of age)
With primary pulmonary infection, a loca-
lised pneumonic process develops at the site
of organism deposition, referred to as the
Ghon focus.1,24 From the Ghon focus bacilli
drain via local lymphatics to the regional
lymph nodes and together these constitute
the elements of the primary (Ghon) com-
plex.1,24 The formation of the primary
complex is often subclinical25,27 and detec-
tion usually follows active surveillance after
recent exposure.1 In the absence of radio-
graphic complications or clinical symptoms
indicative of disease, the presence of the
primary complex may be viewed as proof of
recent primary infection but not necessarily
disease.1,2,27
Complicated Ghon focus and/or disseminated
disease2 (risk groups: children ,2–3 years of
age/all immune-compromised children)
Very young (immune immature) and
immune-compromised children often have
sub-optimal cellular immune responses that
result in poor disease containment.1,30–32
Unrestrained multiplication of bacilli at the
point of organism deposition can cause
progressive parenchymal damage with even-
tual cavitation of the Ghon focus. Poor
containment, particularly within the regio-
nal lymph nodes, can also lead to dissemi-
nated disease, the most dangerous of which
is tuberculous meningitis. Disseminated
disease rarely occurs in older immune-
competent children and then usually as a
result of advanced disease.1
Complicated lymph node disease2 (risk group:
children ,5 years of age)
Lymph node disease can be complicated by
a spectrum of airway complications appro-
priately referred to as lympho-bronchial
FIG. 3. Schematic timeline following primary pulmonary infection with M. tuberculosis. Adapted from the TB
time-table first described by Wallgren.23 O: Incubation; I: Tuberculin skin test conversion; II: Ghon focus and/or
disseminated (miliary) disease; III: Lymph node disease (,5y)/pleural effusion (.5 y); IV: Adult-type disease
(.10 y).
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tuberculosis.33 Children ,5 years of age
tend to show exuberant lymph node enlar-
gement following primary infection which,
in addition to the small size of their airways,
predisposes them to lympho-bronchial dis-
ease. Extra-luminal compression results
when an airway is compressed by enlarged
lymph nodes and the associated inflamma-
tory oedema.1 Intra-luminal obstruction can
result from polyps, granulomatous tissue or
caseous material within the airway; partial
airway obstruction can lead to a check-valve
effect with distal hyperinflation whereas
total obstruction results in distal atelecta-
sis.1,2 Intra-bronchial spread occurs when
caseous material is aspirated from a diseased
lymph node that has herniated into the
airway. Depending on the dose and viru-
lence of the aspirated bacilli, the degree of
airway obstruction and the immune compe-
tence of the host, the resultant lung pathol-
ogy can range from a pure hypersensitivity
response (historically referred to as epitu-
berculosis) to destructive, caseating pneu-
monia.1 Diseased lymph nodes can also
infiltrate other intra-thoracic structures such
as the pericardium, the oesophagus, the
phrenic nerve and the thoracic duct.1,24
Pleural effusion2 (risk group: children .5 years
of age)
A limited pleural reaction may overlie a
peripheral Ghon focus and is viewed as part
of the primary complex, but large effusions
are less common. It occurs mainly in
children .5 years of age and indicates
recent primary infection.1 Unilateral pleural
effusions result when a few organisms
spread from a sub-pleural focus into the
pleural cavity; bilateral pleural effusions
indicate either bilateral pulmonary foci or
haematogenous dissemination.1,26 A hyper-
sensitivity response triggers accumulation of
the typical straw-coloured fluid that con-
tains very few bacilli1,25 but, depending on
the dose and virulence of bacilli that enter
the pleural space as well as the immune
competence of the host, caseating tubercu-
lous empyema can rarely develop.1,24
Adult-type disease2 (risk group: children .10
years of age)
Adult-type disease is a phenomenon that
suddenly appears around puberty and is
distinguished by cavitation that occurs pre-
dominantly in the lung apices. Although the
apices are especially vulnerable, the posterior
segments of the upper lobes and the
superior segments of the lower lobes are
also frequently involved. The natural his-
tory of the disease indicates that this type
might rapidly follow (within 6–12 months)
primary infection (as documented by tuber-
culin skin test conversion),1,28 and the
majority of adolescents who develop
adult-type disease do so within 2 years of
primary infection.1,27 This suggests that
adult-type disease in adolescents most
frequently follows inappropriate contain-
ment of a recent primary infection rather
than reactivation of an old, well-contained
infection, although reactivation remains an
ever-present possibility following primary
infection. Two hypotheses, summarised as
preferential organism deposition and pre-
ferential organism growth, have been
proposed to explain the typical anatomical
distribution and the particular vulnerability
of the lung apices.
Preferential deposition
On inhalation, airflow is directed towards
the dependent lung zones, which should
favour organism deposition in the lung
bases.34 However, it has been suggested
that preferential deposition of tubercle
bacilli in the apical lung segments might
occur owing to air trapping during an
episode of coughing1,24 or preferential hae-
matogenous spread (so-called ‘Simon
foci’).1,3 However, radiographically visible
Ghon foci in children show no predilection
for the upper lobes and, as expected, the
dependent zones of the right lung (middle
Diversity of pulmonary TB 83
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and lower lobes) are the most frequently
involved.1,27 Thus the hypothesis of prefer-
ential deposition is not supported by clinical
observation and, most importantly, it does
not explain the distinct absence of adult-
type disease before puberty.
Preferential growth
In isolation, the hypothesis of preferential
organism growth also fails to explain the
absence of adult-type disease until puberty
but it might do so when viewed in conjunc-
tion with the changes that occur in the
immune response around puberty. The
importance of the host’s immune response
is clearly illustrated by the marked differ-
ence in disease manifestations seen in
different animal hosts infected with the
same strain of M. tuberculosis.35 Although
immune maturation occurs throughout
childhood, major changes relating to the
effective containment of primary M. tuber-
culosis infection seem to occur around 2
years of age and around puberty (.10 yrs of
age) when hormonal changes might be an
important factor in the altered pathogenesis.
Some elements of the acquired cellular
immune response seem to become a two-
edged sword during adolescence;35,36 while
it is essential for disease containment,
excessive tissue necrosis aids the develop-
ment of parenchymal cavities.35
Although the exact immune mechanisms
responsible for tissue necrosis in humans are
not well described,37 it seems reasonable to
deduce from clinical observation that a
change towards more destructive contain-
ment occurs around puberty. This destruc-
tive immune response might allow the
organism to take full advantage of a favour-
able micro-environment. The growth of M.
tuberculosis is enhanced in an oxygen-rich
environment. Oxygen tension is highest in
the lung apices owing to high ventilation/
perfusion (V/Q) ratios,34 which will encou-
rage more vigorous growth and multiplica-
tion of M. tuberculosis in these areas. With
progressive parenchymal damage the local
V/Q ratio and oxygen tension will rise
higher, creating an even more favourable
micro-environment to be exploited by viable
bacilli. Apart from the relatively high oxygen
tension, poor blood flow and decreased
lymph formation may also contribute to
the vulnerability of the lung apices.34 Thus
the combination of destructive attempts at
organism containment together with
increased organism survival and multiplica-
tion in the lung apices might initiate a
positive feedback loop that results in a
vicious circle of escalating parenchymal
destruction. This hypothesis would explain
the sudden emergence of adult-type tuber-
culosis around puberty as well as its
anatomical localisation.
Conclusion
Although the exact immune mechanisms
underlying the different intra-thoracic man-
ifestations of tuberculosis in childhood
remain incompletely understood, the evi-
dence available allows a pragmatic under-
standing of disease pathology. The
maturation of host immunity is an important
variable that influences the ultimate disease
manifestation in children. Variation in both
the pheno- and genotypic pathogenicity of
the organism might also influence the
dynamic host–pathogen balance, but its
clinical relevance is poorly documented. To
improve our understanding of the mechan-
isms that underlie different disease manifes-
tations in childhood tuberculosis, renewed
focus on the ontogeny of the host immune
response towards infection with M. tubercu-
losis is required.36 The knowledge gained
might be essential for directing future
research into preventing and treating tuber-
culosis and developing a vaccine.
Acknowledgments
We thank the United States Agency for
International Development (USAID) for
84 B. J. Marais et al.
62
Stellenbosch University  http://scholar.sun.ac.za 
funding the researcher. This paper is in
partial fulfilment of a PhD thesis
References
1 Marais BJ, Gie RP, Schaaf HS, et al. The natural
history of childhood intra-thoracic tuberculosis—a
critical review of the literature from the pre-
chemotherapy era. Int J Tuberc Lung Dis 2004;
8:392–402.
2 Marais BJ, Gie RP, Schaaf HS, et al. A proposed
radiologic classification of childhood intra-thoracic
tuberculosis. Pediatr Radiol 2004; 33:886–94
3 Rich A. The Pathogenesis of Tuberculosis, 2nd edn.
Springfield, IL: Charles C. Thomas, 1951; 314–
880.
4 Van der Spuy GD, Warren RM, Richardson M,
Beyers N, Behr MA, van Helden PD. Use of genetic
distance as a measure of ongoing transmission of
Mycobaterium tuberculosis. J Clin Microbiol 2003;
41:5640–4.
5 Van Rie A, Warren R, Richardson M, et al.
Exogenous reinfection as a cause of recurrent
tuberculosis after curative treatment. N Engl J
Med 1999; 341:1174–9.
6 Riley RL. Airborne infection. Am J Med 1974;
57:466–75.
7 Balasubramanian V, Wiegeshaus EH, Taylor BT,
Smith DW. Pathogenesis of tuberculosis: pathway
to apical localization. Tuberc Lung Dis 1994;
74:168–78.
8 Dannenberg AM. Immune mechanisms in the
pathogenesis of pulmonary tuberculosis. Rev Infect
Dis 1989; 11(Suppl 2):S369–78.
9 Riley RL. Airborne infection. Am J Med 1974;
57:466–75.
10 Rieder HL. The Epidemiologic Basis of Tuberculosis
Control, 1st edn. Paris, France: International Union
against Tuberculosis and Lung Disease, 1999.
11 Converse PJ, Dannenberg AM, Estep JE, et al.
Cavitary tuberculosis in rabbits by aerosolized
virulent tubercle bacilli. Infect Immun 1996;
64:4776–87.
12 Marais BJ, Gie RP, Schaaf HS, et al. The clinical
epidemiology of childhood pulmonary tuberculosis:
a critical review of literature from the pre-
chemotherapy era. Int J Tuberc Lung Dis 2004;
8:278–85.
13 Lopez B, Aguilar D, Orozco H, et al. A marked
difference in pathogenesis and immune response
induced by different Mycobacterium tuberculosis
genotypes. Clin Exp Immunol 2003; 133:30–7.
14 Manabe YC, Dannenberg AM, Tyagi SK, et al.
Different strains of Mycobacterium tuberculosis cause
various spectrums of disease in the rabbit model of
tuberculosis. Infect Immun 2003; 71:6004–11.
15 Zahrt TC. Molecular mechanisms regulating per-
sistent Mycobacterium tuberculosis infection. Microbes
Infect 2003; 5:159–67.
16 Boom WH, Canaday DH, Fulton SA, Gehring AJ,
Rojas RE, Torres M. Human immunity to M.
tuberculosis: T cell subsets and antigen processing.
Tuberculosis 2003; 83:98–106.
17 Cowie RL. The epidemiology of tuberculosis in
gold miners with silicosis. Am J Resp Crit Care Med
1994; 15:1460–2.
18 Alcaide J, Altet MN, Plans P, et al. Cigarette
smoking as a risk factor for tuberculosis in young
adults: a case—control study. Tuber Lung Dis 1996;
77:112–16.
19 Gajalakshmi V, Peto R, Kanaka TS, Jha P. Smoking
and mortality from tuberculosis and other diseases
in India: a retrospective study of 43000 adult male
deaths and 35000 controls. Lancet 2003; 362:1243–
4.
20 Dannenberg AM. Roles of cytotoxic delayed-type
hypersensitivity and macrophage-activating cell-
mediated immunity in the pathogenesis of tubercu-
losis. Immunobiology 1994; 191:461–73.
21 Wallgren A. Primary pulmonary tuberculosis in
childhood. Am J Dis Child 1935; 49:1105–36.
22 Orme IM, Andersen P, Boom WH. T cell response
to Mycobacterium tuberculosis. J Infect Dis 1993;
167:1481–97.
23 Wallgren A. The time-table of tuberculosis. Tubercle
1948; 29:245–51.
24 Miller FJW, Seal RME, Taylor MD. Tuberculosis in
Children. London, UK: Churchill, 1963.
25 Lincoln EM, Sewell EM. Tuberculosis in Children.
New York, NY: McGraw Hill, 1963.
26 Bentley FJ, Grzybowski S, Benjamin B. Tuberculosis
in Childhood and Adolescence. The National
Association for the Prevention of Tuberculosis.
London, UK: Waterlow, 1954; 466–82.
27 Gedde-Dahl T. Tuberculous infection in the light
of tuberculin matriculation. Am J Hyg 1951;
56:139–141.
28 Davies PDB. The natural history of tuberculosis in
children. Tubercle 1961; 42(Suppl):1–40.
29 Weber HC, Beyers N, Gie RP, Schaaf HS, Fish T,
Donald PR. The clinical and radiological features of
tuberculosis in adolescents. Ann Trop Paediatr 2000;
20:5–10.
30 Freiman I, Geefhuysen J, Solomon A. The radi-
ological presentation of pulmonary tuberculosis in
children. S Afr Med J 1975; 49:1703–6.
31 Madhi SA, Huebner RE, Doedens L, Aduc T,
Wesley D, Cooper PA. HIV-1 co-infection
in children hospitalized with tuberculosis in
South Africa. Int J Tuberc Lung Dis 2000;
4:448–54.
32 Palme IB, Gudetta B, Bruchfeld J, Muhe L,
Giesecke J. Impact of human immunodeficiency
virus-1 infection on clinical presentation, treatment
Diversity of pulmonary TB 85
63
Stellenbosch University  http://scholar.sun.ac.za 
outcome and survival in a cohort of Ethiopian
children with tuberculosis. Pediatr Infect Dis J 2002;
21:1053–61.
33 Beyers JA. The radiological features of primary
pulmonary tuberculosis. S Afr Med J 1979; 55:994–7.
34 Murray JF. Bill Dock and the localization of
pulmonary tuberculosis: how bed rest might have
helped consumption. Am J Respir Crit Care Med
2003; 168:1029–33.
35 Dannenberg AM, Collins FM. Progressive pulmon-
ary tuberculosis is not due to increasing numbers of
viable bacilli in rabbits, mice and guinea pigs, but
due to a continuous host response to mycobacterial
products. Tuberculosis 2001; 81:229–42.
36 Pabst HF. Ontogeny of the immune response as a
basis of childhood disease. J Pediatr 1980; 97:
519–34.
37 Rook AW, Bloom BR. Mechanisms of pathogenesis
in tuberculosis. In: Bloom BR, ed. Tuberculosis:
Pathogenesis, Protection and Control. Washington,
DC: American Society for Microbiology, 1994;
485–501.
86 B. J. Marais et al.
64
Stellenbosch University  http://scholar.sun.ac.za 
The Pediatric Infectious Disease Journal • Volume 24, Number 8, August 2005
65
Pulmonary Tuberculosis in Children
groins and the neck. It appears predominantly in situations of
peripheral insulin resistance, such as endocrine diseases, obesity and
some malignant tumors.7 It is used as a skin marker for insulin
resistance, although this association has been called into question in
recent endocrinologic studies8 The pathophysiologic mechanism of
this skin alteration consists of direct or indirect activation of the
insulin-like growth factor-I receptor of fibroblasts and keratinocytes
by elevated concentrations of circulating insulin, with subsequent
proliferation of these epidermal cells. The skin alterations consist of
hyperkeratosic and hyperpigmented plaques with velvet texture and
brown coloration. The metabolic changes induced by antiretroviral
therapy can lead to a state of insulin resistance, '.2 which may result
in acanthosis nigricans, as shown in the present case.
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ADULT-TYPE PULMONARY TUBERCULOSIS IN
CHILDREN 10-14 YEARS OF AGE
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Abstract: We report 8 children (10-14 years of age) who were
diagnosed with tuberculosis at their local primary health care clinic
from July to September 2004, after routine sputum testing was
extended to all children older than 10 years of age with suspected
tuberculosis. This case series emphasizes that older children develop
adult-type cavitating disease, which can be diagnosed by sputum
smear microscopy, in contrast to younger children for whom smear
microscopy has very little diagnostic value.
Key Words: adolescent children, adult-type pulmonary
tuberculosis
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Because of the rising burden of tuberculosis worldwide, theWorld Health Organization took the unprecedented step
of declaring a global tuberculosis emergency in 1993. Children
constitute a significant proportion of the tuberculosis caseload, up to
40% in high burden settings, and experience considerable tubercu-
losis-related morbidity and mortality.'.2 Childhood tuberculosis is
regarded as a paucibacillary disease that is difficult to diagnose and
that poses little risk of Mycobacterium tuberculosis transmission.
However, children older than 10 years of age develop a different
spectrum of disease compared with younger children, with the majority
developing adult-type cavitating disease that is sputum smear-posi-
tive.3.4This emphasizes the importance of correct disease classification
in childhood tuberculosis, both for prognosis and estimation of the
transmission risk,5We report 8 children (10-14 years of age) who were
diagnosed with tuberculosis at their local primary health care clinic in
Cape Town, South Africa during a period of3 months (July-September
2004); after routine sputum testing was extended to all children older
than 10 years of age with suspected tuberculosis.
CASE SERIES
During the 3-month period, 92 cases of tuberculosis were
recorded in total. Children (younger than 15 years of age) consti-
tuted 22.8% (21 of 92) of the total disease burden. All sputum
smear-positive disease occurred in those 10 years of age or older. In
total, 65 (70.6%) cases were sputum smear-positive, of whom
7(10.8%) were children 10-14 years of age. One child in this age
group, with a large pleural effusion and blistering tuberculin skin
test, were sputum smear-negative. The male-female ratio was 2:6,
and none of these children was infected with human immunodefi-
ciency virus. The majority (6 of 8, 75.0%) reported known contact
with a sputum smear-positive source case in the preceding 6-18
months (Table I). All of the children were still at school.
Table I describes the clinical presentation and disease char-
acteristics of the 8 cases. Two children reported erythema nodosum
(probably indicative of primary M. tuberculosis infection) in the
preceding year. Two children had a tuberculous pleural effusion, of
whom I had additional parenchymal cavitation and was sputum
smear-positive. Both presented with intense, localized pleuritic chest
pain, accompanied by fever. Most children without pleural effusion
(4 of 6, 66.7%) reported vague and poorly localized chest pain. The
children with sputum smear-positive disease had high organism loads
as reflected by their sputum smear grading. Complete symptom reso-
lution occurred within 2 months of treatment in 7 (87.5%) cases, using
the standard initial four-drug treatment of isoniazid, rifampin, pyrazin-
amide and ethambutol in a combined fixed dose tablet. Treatment
adherence during the intensive phase was excellent (>90% of pre-
scribed doses in all cases). Sputum smear conversion was documented
in all 7 sputum smear-positive cases after 2 months of treatment. At this
time, only I child reported incomplete symptom resolution, although
she did show significant symptomatic and radiologic improvement.
This was attributed to the extent of disease at diagnosis, and her
treatment was continued with the standard short course (6 months)
treatment regimen.
DISCUSSION
Despite the methodologic limitations, this case series high-
lights a few clinical observations with important public health implica-
tions. It illustrates that tuberculosis in children 10-14 years of age
frequently presents like adult tuberculosis,6 and that the majority of
these children can be diagnosed with routine sputum smear microscopy
at the primary health care level. It is well-known that adolescent girls
are at higher risk to develop tuberculosis after recent primary infection
than are boys.3.4Erythema nodosum may represent a marker of recent
primary M. tuberculosis infection, identifying those with a particularly
high risk of progression to tuberculosis in the coming months.?
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Abstract: Two extremely premature infants died as a result of
congenital Candida glabrata infection, and their placentas and
umbilical cords were free of macroscopic Candida nodules. Because
non-Candida albicans Candida infections are less likely to produce
necrotic foci, we should not exclude Candida infections in the
absence of macroscopic nodules on the placenta and umbilical cord.
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CONGENITAL CANDIDA GLABRATA INFECTION
WITHOUT SPECIFIC NODULES ON THE PLACENTA
AND UMBILICAL CORD
It is difficult to establish the exact time of M. tuberculosis
infection, but it is striking that 75% of children had known contact
with a sputum smear-positive source case in the preceding 6-18
months. This correlates with the natural history of disease, which
indicates that adolescent children are at high risk to develop adult-
type tuberculosis within 1-2 years after primary infection.3.7 There-
fore all contacts of sputum-smear positive source cases, especially
adolescent girls, should be informed about their risk to develop
tuberculosis, even if their initial screening tests are negative. Per-
sistent, nonremitting symptoms should be reported without delay,
and tuberculosis should be excluded. Delayed diagnosis poses a
significant transmission risk to the community, especially fellow
pupils" and household members.
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Abstract 
Background 
Children contribute a substantial proportion of the global tuberculosis caseload, particularly in 
endemic areas, where little is known about their spectrum of disease.  The aims of this study 
were to document the complete disease spectrum, and relevant age-related differences, in 
children treated for tuberculosis in a highly endemic community.  
Methods 
A prospective descriptive study was conducted from February 2003 through October 2004 at 
five primary health care clinics in Cape Town, South Africa; including all children (<13 years 
of age) treated for tuberculosis.    
Results   
439 children received anti-tuberculosis treatment.  The spectrum of disease included; 85 
(19.4%) “not TB”, 307 (86.7%) intra-thoracic, and 72 (20.3%) extra-thoracic tuberculosis, of 
whom 25 (5.7%) had co-existing intra-thoracic disease.  In HIV-uninfected children; 
disseminated (miliary) disease (9/11, 81.8%), and TBM (10/13, 76.9%), were predominantly 
documented in children <3 years of age. In HIV-infected children, complicated Ghon focus 
and disseminated (miliary) disease were significantly more common 6/25 (24.0%) than in HIV-
uninfected children 12/414 (2.9%) (OR 10.9, 95% CI 3.2-35.9); without age-related 
differences.  
Conclusion 
This study describes the complete disease spectrum observed in children treated for 
tuberculosis, in a highly endemic area.  Children suffered significant morbidity with most 
severe disease recorded in very young and/or HIV-infected children.   
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Background 
Children contribute a substantial proportion of the global tuberculosis caseload.1-3 Reliable 
epidemiologic data is rarely available from endemic areas,2,3  where children experience high 
tuberculosis-related morbidity and mortality.4 Childhood tuberculosis is often reported as a 
single disease entity, although it represents a diverse spectrum of pathology with important 
prognostic significance, which warrants accurate classification.5 Previous observational 
studies on childhood tuberculosis were mostly retrospective or hospital-based,6,7 but due to 
the selection bias inherent to these study designs, the disease spectrum recorded is not 
representative of the disease spectrum at community level. To quantify the tuberculosis-
related morbidity suffered by children in endemic areas, and to evaluate the relative 
contribution made by different disease entities, require a prospective study that documents 
the full spectrum of disease in children, at community level.  
 
The natural history of disease, described in the pre-chemotherpy literature, documented the 
different disease entities observed in children with tuberculosis.8 It identified clear age-related 
differences and specific high-risk groups, namely very young (<3 years of age) and/or 
immune compromised children.8,9 Children less than 2 years of age were documented to be 
at high risk to progress to disease within the first 12 months following primary infection.  This 
observation indicates that it is prudent to regard all children less than 3 years of age to be at 
high risk.  However, it is unknown how relevant these historic observations are to assist our 
understanding of the current tuberculosis situation in highly endemic areas.     
 
The aims of this study were to document the complete disease spectrum, and relevant age-
related differences, in children treated for tuberculosis in a highly endemic community. 
 
Methods 
A prospective descriptive study was conducted from 1 February 2003 through 31 October 
2004 in Cape Town, Western Cape Province, South Africa.   
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Study setting 
The incidence of all tuberculosis in Cape Town was 678/100 000,10 and the prevalence of 
human immunodeficiency virus (HIV) infection in women attending public antenatal clinics in 
the Western Cape Province was 13.1% (95% CI  8.5-17.7%), in 2003.11 
 
Five primary health care clinics, which utilize the same referral hospital (Tygerberg Children’s 
Hospital) were selected. These clinics serve impoverished urban communities, providing both 
primary health care services and supervised anti-tuberculosis treatment. The study population 
rarely utilizes private medical services and children diagnosed with tuberculosis are routinely 
referred to the primary health care clinic, to report their tuberculosis and provide supervised 
anti-tuberculosis treatment.  Paediatric services are only accessible to children less than 13 
years of age.     
 
According to South African National Tuberculosis Programme (NTP) guidelines,12 all children 
with suspect symptoms and those less than 5 years of age in household contact with a 
sputum smear-positive source case, should be evaluated with a tuberculin skin test (TST) and 
chest radiograph (CXR).   Children diagnosed with tuberculosis are entered into the 
tuberculosis treatment register and receive supervised anti-tuberculosis treatment free of 
charge.  
 
Study population  
All children (<13 years of age) who commenced anti-tuberculosis treatment during the study 
period were included.  A prospective surveillance system ensured identification of all children 
treated for tuberculosis.  The investigator visited each clinic on a weekly basis to evaluate 
children newly started on anti-tuberculosis treatment at the primary health care clinic, while a 
study nurse documented those started on anti-tuberculosis treatment at the referral hospital.  
 
Chest radiograph (CXR) 
Standard chest radiographs (antero-posterior and lateral views) were reviewed by 2 
independent experts, blinded to all clinical information. Findings were documented on a 
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standard report form.  Classification was done according to the most severe disease entity 
reported, using a recently proposed radiological classification of childhood intra-thoracic 
tuberculosis, which differentiates Ghon focus (uncomplicated or complicated), primary 
complex, lymph node disease (uncomplicated or complicated), pleurisy, pericarditis, 
disseminated (miliary) disease and adult-type disease.5 A Ghon focus described the typical, 
localized pneumonic process that occurs at the site of primary infection within the lung.5 A 
primary complex described the presence of both a Ghon focus and uncomplicated lymph 
node disease (regional hilar adenopathy).5 Complicated lymph node disease described visible 
lymphadenopathy in conjunction with either airway compression (compression), or 
parenchymal consolidation other than a Ghon focus (consolidation).5   
 
HIV testing 
Screening for HIV infection was done by rapid testing (Determine Rapid HIV test, Abbott) or 
ELISA (Vironostika HIV Uniform II, Organon Teknika).  Children diagnosed with possible HIV-
infection were referred to the HIV family clinic at Tygerberg Children’s Hospital for 
confirmatory tests (PCR in children <18 months and a second ELISA test in older children), 
and clinical management.   
 
Sample collection and culture 
An attempt was made to collect at least one culture specimen before treatment initiation; 
pulmonary specimens included gastric aspirates and/or induced/uninduced sputum; extra-
pulmonary specimens included pleural or cerebro-spinal fluid, fine needle aspiration and/or 
biopsy specimens.  Culture samples were inoculated into liquid medium using either the 
BACTEC or MGIT systems (Becton Dickinson, Sparks, MD, USA).  Positive cultures were 
confirmed to be Mycobacterium tuberculosis by routine polimerase chain reaction (PCR) 
speciation.13  
 
Definitions 
“Not TB” was defined as meeting all 3 of the following criteria; 1) agreement by both 
independent experts that the chest radiograph indicated “certain not TB”, and 2) no 
bacteriologic or histologic confirmation, and 3) no documented extra-thoracic tuberculosis. 
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Intra-thoracic tuberculosis was defined as any intra-thoracic manifestation of tuberculosis, 
identified by one or both of the experts. Extra-thoracic tuberculosis was defined as any extra-
thoracic manifestation of tuberculosis; with/without concomitant CXR signs suggestive of 
intra-thoracic tuberculosis. Bacteriologic confirmation was defined as the presence of acid-
fast bacilli in histologic or sputum specimens and/or culture confirmation of M.tuberculosis.   
Age groups were defined as; <3 years, 3-4 years, 5-9 years and >10 years, according to the 
most relevant age-related risk groups identified by the natural history of disease.8 
 
Parents/legal guardians gave written informed consent for study participation.  Separate 
consent was obtained for HIV testing, together with routine pre- and post-test counselling. 
Ethics approval was obtained from the Institutional Review Board of Stellenbosch University, 
the City of Cape Town Health Department and local health committees.  
 
Results 
During the study period, 439 children (<13 years of age) were treated for tuberculosis.  
Demographics and HIV results are reflected in table 1; 283 (64.5%) children were tested for 
HIV of whom 25 (8.8%) were HIV-infected.  
 
Table 2 reflects the complete disease spectrum in all 439 children who were treated for 
tuberculosis; 85 (19.4%) were categorized as “not TB”, 307 (69.9%) as intra-thoracic and 72 
(16.4%) as extra-thoracic tuberculosis, of whom 25 (5.7%) had co-existing intra-thoracic 
disease. The 85 children categorized as “not TB”, were commenced on anti-tuberculosis 
treatment by the attending physician, due to known M.tuberculosis exposure together with a 
positive TST and/or a subjective opinion of possible hilar adenopathy on the chest radiograph. 
The study team did not interfere with the attending physician’s decision to treat. In total, 
bacteriologic confirmation was achieved in 150/276 (54.3%) children in whom specimens 
were collected; in 0/36 with “not TB”, in 122/196 (62.2%) with intra-thoracic tuberculosis and 
in 33/49 (67.3%) with extra-thoracic tuberculosis.  Bacteriologic confirmation was achieved in 
both respiratory and non-respiratory specimens in 5 children.   
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In children with intra-thoracic tuberculosis, uncomplicated lymph node disease was 
documented in 147(47.9%) children.  Complicated lymph node disease occurred in 87 
(28.3%), including; parenchymal consolidation in 62 (20.2%), of whom 9 had expansile 
tuberculous pneumonia, with cavities reported in 7, and airway compression in 25 (8.1%), of 
whom 10 had visible compression, 12 segmental or lobar collapse and 3 hyperinflation. 
Pleural effusions were documented in 24 (7.8%) children; 2 had massive fluid collections with 
mediastinal shift.   Cardiac tamponade was documented in 1 child, while a second child had a 
small pericardial effusion against a background of disseminated (miliary) disease.  Fifteen 
(4.9%) children had disseminated (miliary) disease; 4 with co-existing hilar adenopathy, 1 with 
pericardial effusion and 2 with tuberculous meningitis (TBM). The bacteriologic yield achieved 
in children with different intra-thoracic disease entities is described elsewhere (data not 
shown).    
 
The most common disease entities identified in the 72 children with extra-thoracic 
tuberculosis were cervical lymphadenitis (35, 48.6%) and tuberculous meningitis (TBM) (14, 
19.4%).  Only 1 (1.4%) child had involvement of a lymph node outside the cervical area 
(unilateral involvement of an inguinal lymph node).  CNS involvement occurred in 16 (22.2%) 
children, of whom 14 had TBM (6 with stage 1, 7 with stage 2 and 1 with stage 3 disease) and 
2 had tuberculomas of the brain; 1 was an HIV-infected child in whom the tuberculoma 
represented a CNS relapse after completing 6 months of directly supervised TBM therapy in 
hospital.  In children with extra-thoracic tuberculosis, bacteriologic confirmation (culture or 
microscopy) was achieved in 33/49 (67.3%), with the lowest yield in those diagnosed with 
TBM (1/10, 10.0%).  Computed tomography (CT) or magnetic resonance imaging (MRI), 
provided supportive evidence in 18/21(85.7%) children with extra-thoracic tuberculosis, 11/14 
with TBM, 2/2 with tuberculomas of the brain, 1/1 with abdominal tuberculosis and 4/4 with 
tuberculous spondilitis.  Disseminated (miliary) disease and/or TBM was recorded in 26/439 
(5.9%) children; 12 with miliary disease, 11 with TBM, and 3 with both miliary disease and 
TBM. 
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Osteo-articular tuberculosis was recorded in 11 (15.3%) children, involving mainly the 
vertebra and single weight bearing joints (4 vertebral, 3 hip, 2 knee), 1 had mastoiditis and 
another had osteitis of the cranium.  No cases of urogenital tuberculosis were recorded. Skin 
manifestations included 2 children with papulonecrotic tuberculide (PNT), 5 with erythema 
nodosum and 1 with a superficial cold abscess on the back.  Six children categorised as 
extra-thoracic tuberculosis had no bacteriologic or radiologic evidence of tuberculosis; 3 had a 
presumptive diagnosis of stage 1 TBM, based on cerebrospinal fluid (CSF) findings alone, 
and 3 had erythema nodosum in combination with a TST response >20mm.  Co-existing intra-
thoracic tuberculosis was documented in 25/72 (34.7%) children with extra-thoracic 
tuberculosis.   
 
Table 3 reflects the disease entities documented in all high-risk children; HIV-uninfected 
children less than 3 years of age and HIV-infected children of all ages.  In HIV-uninfected 
children; disseminated (miliary) disease (9/11, 81.8%), and TBM (10/13, 76.9%), especially 
TBM stage 2 and 3 (7/8, 87.5%), were predominantly documented in children less than 3 
years of age.  Complicated Ghon focus and/or disseminated (miliary) disease were 
significantly more common in HIV-infected children 6/25 (24.0%), compared to HIV-uninfected 
children 12/414 (2.9%) (OR 10.9, 95% CI 3.2-35.9). No age-related differences were noted in 
HIV-infected children. 
 
Figure 1 reflects age-related differences in specific disease entities, documented in all 
children treated for tuberculosis, excluding those with HIV-infection.  The figure illustrates 
differences between high-risk (<3 years) and low-risk children (3 years), with additional 
emphasis on the changes that occur after 10 years of age.  Of all children with disseminated 
(miliary) disease and/or tuberculous meningits stage 2 or 3, 16/19 (84.2%) were less than 3 
years of age. Complicated Ghon focus with cavitation was reported in 1 infant. Intra-thoracic 
lymph node disease was most common in children less than 3 years of age, but it was 
documented with frequency until 5 years of age; 123/144 (85.4%) children with uncomplicated 
lymph node disease and 54/71 (76.0%) children with complicated lymph node disease were 
less than 5 years of age.  Pleural effusions were most frequently documented in children 3-9 
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years of age (14/23, 60.9%).  Adult-type disease was not reported in any child less than 8 
years of age, the majority (10/14, 71.4%) being older than 10 years. Spondilitis occurred 
predominantly in children 3-5 years (3/4, 75%), while peripheral tuberculous lymphadenitis 
occurred with equal frequency in all age groups, except that no infants were affected.   
 
Discussion 
This study provides a comprehensive overview of the disease spectrum seen in children 
treated for tuberculosis in a highly endemic area.  A striking observation was the high 
morbidity suffered by children; 207/439 (47.1%) had disease manifestations other than 
uncomplicated lymph node disease, while 26/439 (5.9%) were diagnosed with disseminated 
(miliary) disease and/or TBM.  The severity of disease suffered by children in this community 
may be largely attributable to high levels of transmission, which results in the infection of 
many children at a young and vulnerable age.  Levels of transmission in this community, at 
least in the areas where it has been measured, is high.14 Active tracing and prophylaxis of 
children exposed to an adult index case is often neglected due to resource constraints and 
the high burden of adult tuberculosis.  Provision of effective preventative chemotherapy may 
have prevented disease in many children, but it is well documented that a substantial 
proportion of transmission in highly endemic areas, such as the study community, occurs 
outside the household.15 Thus many children, especially those older than 2-3years of age, 
become infected and develop disease following exposure in the community,16  without known 
exposure inside the household.  
 
Young (<3 years of age) children who are immunologically immature, and HIV-infected 
(immune compromised) children, were prone to develop disease manifestations indicative of 
poor organism containment, such as cavitation of the Ghon focus and disseminated (miliary) 
disease. This is consistent with recent observations that HIV-infected children, 17-18 and very 
young HIV-uninfected children,19-21 are prone to develop cavitation and disseminated (miliary) 
disease. Overall, HIV infection had little impact on the disease spectrum observed in this 
community, as few children were HIV-infected; however, a bigger impact can be expected in 
settings where the prevalence of HIV infection in children is higher.  The age-related disease 
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profiles documented show remarkable consistency, when compared to observations from the 
pre-chemotherapy literature.8,9 Immune maturation seems less relevant in HIV-infected 
children, as no age-related differences were observed in these children.   
 
Study limitations include the fact that we may have missed children with severe tuberculosis 
who died without presenting to a health care facility, but access to local clinics and hospitals 
is good within the study area, which makes this unlikely.  The small number of HIV-infected 
children reduces our ability to comment on this sub-group and to show statistically significant 
differences.  However, the fact that the majority of children, including all those with a clinical 
suspicion of HIV disease, were tested for HIV, is a major strength.  Children not tested for HIV 
were mainly infants whose mothers tested HIV-negative during pregnancy, and older children 
(>8 years of age) who refused assent, but were otherwise healthy.  Despite these limitations, 
we believe the spectrum and severity of disease recorded approximates the reality in highly 
endemic settings.   
 
In conclusion, this study provides a comprehensive picture of the disease spectrum observed 
in children treated for tuberculosis in a highly endemic area.  The age-related differences 
observed correlate well with disease descriptions from the pre-chemotherapy literature.  Very 
young and HIV-infected children were at highest risk to develop severe disease, which 
emphasizes the need for preventative chemotherapy in these particular groups, while timely 
and accurate diagnosis of disease is important in all children.  
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Table 1 
Demographics and disease characteristics in all children treated for tuberculosis 
(n=439) 
 
 
Gender 
  Male 
  Female 
 
Age  
    < 3yrs 
     3-5yrs 
     5-9yrs  
    10-13yrs  
      
HIV  
Tested 
Infected 
 
Household contact reported 
Diagnosed after active contact tracing 
Number (%) 
 
217 (49.5) 
222 (50.6) 
 
 
231(52.6) 
95 (21.6) 
77 (17.6) 
36 (8.2) 
 
 
283 (64.5) 
25/283 (8.8) 
 
257 (58.5) 
140 (31.9) 
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Table 2 
The disease spectrum and bacteriologic confirmation achieved in all children treated 
for tuberculosis (n=439) 
 
 
TB manifestation 
 
Total (%) 
N=439 
 
Bacteriologic 
Confirmation* 
  
Not TB 
 
Intra- thoracic TB 
Ghon focus 
  Uncomplicated 
  Complicated 
 
Primary complex 
 
Lymph node disease 
Uncomplicated 
Complicated 
    Compression 
    Consolidation  
 
Pleurisy 
Pericarditis 
Disseminated  
Adult-type   
 
Extra-thoracic TB 
Peripheral lymphadenitis 
  Cervical 
  Other 
 
Central nervous system TB 
  Meningits 
  Tuberculoma 
 
Abdominal TB 
 
Osteo-articular TB 
  Spondylitis 
  Other 
 
Skin 
 
[Intra+Extra thoracic TB] 
 
 
85 (19.4) 
 
307 (69.9) 
 
1/307 (0.3) 
3/307 (1.0) 
 
15/307 (4.9) 
 
 
147/307 (47.9) 
 
25/307 (8.1) 
62/307 (20.6) 
 
24/307 (7.8) 
1/307 (0.3) 
15/307 (4.9) 
14/307 (4.6) 
 
72 (16.4) 
 
35/72 (48.6) 
1/72 (1.4) 
 
 
14/72 (19.4) 
2/72 (2.8 
 
1/72 (1.4) 
 
 
4/72 (5.6) 
7/72 (9.7) 
 
8/72 (11.1) 
 
25 (5.7) 
 
0/36 
 
122/196 (62.2) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
33/49 (67.3) 
 
27/27(100) 
1/1 (100) 
 
 
1/10 (10.0) 
N/A 
 
1/1 (100) 
 
 
N/A 
2/7 (28.6) 
 
2/3 (66.7) 
 
17/21 (80.1) 
 
TB – Tuberculosis 
N/A – no bacteriologic confirmation attempted 
Not TB - a chest radiograph that is not suggestive of tuberculosis (confirmed by two 
independent child TB experts), no bacteriologic or histologic proof and no extra-thoracic 
disease recorded  
*Bacteriologic confirmation – Culture confirmed M.tuberculosis or acid-fast bacilli seen on 
microscopy, as a proportion of those in whom specimens were collected 
[Intra+extra thoracic TB] - Children with intra- and extra-thoracic TB were included in both 
groups  
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Table 3 
The disease spectrum documented in all high-risk children; HIV-uninfected less than 3 
years of age and HIV-infected children 
 
 
TB manifestation 
All children 
Number (%) 
N=439 
HIV-uninfected 
<3 years of age 
N=231 
HIV-infected 
 
N=25 
  
Not TB 
 
Intra- thoracic TB 
Ghon focus 
  Uncomplicated 
  Complicated 
 
Primary complex 
 
Lymph node disease 
Uncomplicated 
Complicated 
    Compression 
    Consolidation  
 
Pleurisy 
Pericarditis 
Disseminated (miliary) disease 
Adult-type disease 
 
Extra-thoracic TB 
Peripheral lymphadenitis 
  Cervical 
  Other 
 
Central nervous system TB 
  Meningits 
  Tuberculoma 
 
Abdominal TB 
 
Osteo-articular TB 
  Spondylitis 
  Other 
 
Skin 
 
[Intra+Extra thoracic TB] 
 
 
85 (19.4) 
 
307 (69.9) 
 
3/307 (1.0) 
1/307 (0.3) 
 
15/307 (4.9) 
 
 
147/307 (47.9) 
 
25/307 (8.1) 
62/307 (20.6) 
 
24/307 (7.8) 
1/307 (0.3) 
15/307 (4.9) 
14/307 (4.6) 
 
72 (16.4) 
 
35/72 (48.6) 
1/72 (1.4) 
 
 
14/72 (19.4) 
2/72 (2.8) 
 
1/72 (1.4) 
 
 
4/72 (5.6) 
7/72 (9.7) 
 
8/72 (11.1) 
 
25 (5.7) 
 
59 (25.5) 
 
161 (69.7) 
 
1 (0.4) 
1 (0.4) 
 
11 (4.8) 
 
 
88 (38.1) 
 
15 (6.5) 
34 (14.7) 
 
2 (0.8) 
0  
9 (3.9) 
0 
 
19 (8.2) 
 
6 (2.6) 
0 
 
 
10 (4.3) 
1 (0.4) 
 
0 
 
 
1 (0.4) 
0 
 
1 (0.4) 
 
9 (3.9) 
 
 
8 (32.0) 
 
16 (64.0) 
 
0 
2 (8.0) 
 
0 
 
 
4 (16.0) 
 
0  
5 (20.0) 
 
1 (4.0) 
0 
4 (16.0) 
0 
 
2 (8.0) 
 
0 
0 
 
 
1 (4.0) 
1 (4.0) 
 
0 
 
 
0 
0 
 
0 
 
1 (4.0) 
 
TB – Tuberculosis 
HIV-uninfected – This includes all HIV-uninfected children and those not tested. 
[Intra+extra thoracic TB] - Children with intra- and extra-thoracic TB were included in both 
groups.  
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Abstract 
This report documents the bacteriologic yield in children who received treatment for 
intrathoracic tuberculosis in an area where it is highly endemic.  All children (<13 years) 
treated for probable or confirmed intrathoracic tuberculosis at five primary health care clinics 
in Cape Town, South Africa were included.  A total of 307 children were included in the study, 
and bacteriologic confirmation was achieved in 122/196 (62.2%) children from whom 
specimens were collected. The lowest bacteriologic yield was recorded in children with 
uncomplicated lymph node disease (24/69, 34.8%).   In this highly endemic setting, 
bacteriologic confirmation was achieved in an unexpected high proportion of children treated 
for intra-thoracic tuberculosis, which indicates a need to re-assess the value of bacteriology-
based diagnostic approaches in these settings. 
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Background 
The diagnosis of childhood tuberculosis is complicated by the absence of a practical gold 
standard, as the collection of bacteriologic specimens is difficult and culture yields are 
considered to be low.1 It has reported that Mycobacterium tuberculosis is isolated from less 
than 30-40% of children with probable tuberculosis, while sputum smear microscopy is 
positive in less than 10-15% 2,3  
 
Bacteriologic confirmation is rarely attempted in children from highly endemic areas, due to 
resource limitations and the expected low yield.  However, bacteriologic confirmation may 
have particular value in these settings, where epidemiologic indicators such as known 
exposure to and/or proven infection with M. tuberculosis contribute little diagnostic value.  In 
addition to providing a definitive diagnosis, isolation of M. tuberculosis offers opportunities for 
drug susceptibility testing and molecular investigation. The aim of this study was to document 
the proportion of children given treatment for intra-thoracic tuberculosis in an area of high 
endemicity, in whom bacteriologic confirmation was achieved.   
 
Methods 
A prospective community-based observational study was conducted from 1 February 2003 
through 31 October 2004 in Cape Town, South Africa.   
 
Study population 
Five primary health care clinics, all utilizing the same referral hospital (Tygerberg Children’s 
Hospital), were selected. People living in the study area rarely access private medical 
services, and children diagnosed with tuberculosis are routinely referred to their local primary 
health care clinic for treatment.  Paediatric services are only accessible to children less than 
13 years of age.   
 
All children (<13 years) from the study area, initiated on anti-tuberculosis treatment during the 
study period, were screened by the investigator.  The investigator visited each clinic on a 
weekly basis to evaluate children newly started on anti-tuberculosis treatment at the primary 
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health care clinic, while a study nurse documented those started on anti-tuberculosis 
treatment in hospital. The chest radiographs of all children were reviewed and those with 
radiographic signs suggestive of intra-thoracic tuberculosis were included in the study. 
 
Chest radiograph (CXR) 
All children received standard anteroposterior and lateral chest radiographs.  Chest 
radiographs were reviewed by the same 2 independent experts. Findings were documented 
on a standard report form. All children with radiographic signs suggestive of intra-thoracic 
tuberculosis (even if this was indicated by only 1 of the 2 independent experts) were included.  
Disease classification was done according to the most severe disease entity reported; using a 
recently proposed radiological classification of childhood intra-thoracic tuberculosis.4 Those 
without any radiographic signs suggestive of intrathoracic tuberculosis were excluded. 
 
Sample collection and culture 
In all children, an attempt was made to collect at least one respiratory specimen for 
mycobacterial culture.  However, in children diagnosed at the referral hospital, multiple 
specimens were collected as part of a separate hospital-based study that aimed to compare 
the bacteriologic yield achieved with different specimen collection methods. Specimens 
collected included; gastric aspirates and/or nasopharyngeal aspirates and/or 
induced/uninduced sputum, and/or pleural fluid aspiration.  Samples were routinely inoculated 
into liquid broth using either the BACTEC or MGIT systems (Becton Dickinson, Sparks, MD, 
USA).  M.tuberculosis was confirmed by polymerase chain reaction (PCR) speciation.  
 
Definitions 
Routine specimens were defined as the first 2 gastric aspirate and/or uninduced sputum 
specimens collected.  Bacteriologic confirmation was defined as culture confirmation of M. 
tuberculosis and/or the presence of acid-fast bacilli on sputum microscopy.  
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Parents gave separate written informed consent for study participation and HIV testing.  
Ethics approval was obtained from the Institutional Review Board of Stellenbosch University, 
the City of Cape Town Health Department and local health committees.  
 
Results 
During the study period, 439 children received anti-tuberculosis treatment (data on the 
complete cohort is described elsewhere),5 of whom 307 had radiographic signs suggestive of 
intra-thoracic tuberculosis.  The gender distribution was equal (152, 49.5% male). The age 
distribution was; 230 (74.9%) <5 years, 53 (17.3%) 5-9years, and 24 (7.8%) >10 years.  The 
majority of children were tested for HIV (211, 68.7%), of whom 17 (8.1%) were HIV-infected.   
 
Table 1 reflects the intra-thoracic disease manifestations documented and the proportion in 
whom bacteriologic confirmation was achieved.  Uncomplicated lymph node disease was the 
most frequently documented intrathoracic disease manifestation (147, 47.9%).  Adult-type 
disease was documented in 14 (4.6%) children and bacteriologic confirmation was achieved 
in all 14.  This is the only group of children in whom sputum smear microscopy was 
performed; 7/10 (70%) children in whom sputum smears were performed were sputum 
smear-positive.   
 
Overall, bacteriologic confirmation was achieved in 122/196 (62.2%) children, in whom 
specimens were collected; in 102/183 (55.7%) when only routine specimens were included in 
the analysis. The bacteriologic yield in children with intrathoracic disease manifestations other 
than uncomplicated lymph node disease was 98/127 (77.2%); significantly higher than the 
yield (22/69, 34.8%) in those with uncomplicated lymph node disease [odds ratio (OR) 6.3, 
95% confidence interval (CI) 3.2-12.8].  The significance persisted when only routine 
specimens were included in the analysis [81/114 (71.0%) versus 21/69 (30.4%), OR 5.6, 
95%CI 2.8-11.4].  
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Discussion 
Bacteriologic confirmation was achieved in the majority of children treated for intrathoracic 
tuberculosis in this highly endemic area. Possible reasons for this unexpected high yield are; 
1) the selection criteria applied, as children without any radiographic sign suggestive of intra-
thoracic tuberculosis were excluded; 2) the diligence with which specimens were collected 
and cultured, as the high yield persisted despite excluding non-routine specimens from the 
analysis; 3) the community-based approach, as hospital-based studies tend to accumulate 
more children with alternative diagnoses and radiographic signs that are difficult to interpret; 
4) the fact that many children presented with advanced intra-thoracic disease, as the minority 
were classified as uncomplicated lymph node disease.   
 
Although uncomplicated lymph node disease, often considered the typical manifestation of 
childhood tuberculosis, was the most common disease entity, it was documented in only 
47.9% of children.  The fact that the bacteriologic yield was the lowest in this group, may 
explain the low bacteriologic yields reported from non-endemic areas where active contact 
tracing programmes are usually well-established.  Therefore, the majority of children are 
diagnosed at a very early stage with uncomplicated lymph node disease,6 and few present 
with advanced disease.  
 
To our knowledge, the bacteriologic yield achieved in children treated for intra-thoracic 
tuberculosis in an area of high endemicity has not been reported before. However, similar and 
even higher bacteriologic yields have been reported in select patient groups; such as children 
with lymph node disease complicated by expansile tuberculous pneumonia,7 and infants who 
frequently develop rapidly progressive disease.8,9 These studies support the observation that 
the bacteriologic yield is primarily influenced by the type of radiographic disease manifestation 
recorded.  Radiographic disease manifestations show clear age-related patterns in children.10 
In this study the bacteriologic yield did differ according to age, but the age-related effect 
disappeared when the specific radiologic disease manifestation was taken into account, which 
illustrates the importance of accurate disease classification.4 
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The main study limitations were the fact that bacteriological confirmation was not attempted 
with equal vigor in all children.  The multiple specimens collected at the referral hospital may 
have introduced sampling bias. We attempted to correct for possible sampling bias by 
restricting the analysis to routine samples only.  However, more rigorous evaluation of the 
association between disease severity and bacteriologic yield, and the comparison between 
different specimen collection methods, will require accurate disease classification and 
standardized procedures for specimen collection. 
 
In this highly endemic area, bacteriologic confirmation was achieved in an unexpected high 
proportion of children treated for intra-thoracic tuberculosis.  This finding indicates a need to 
re-assess the value of bacteriology-based approaches to diagnose intra-thoracic tuberculosis 
in children, particularly in endemic areas where they frequently present with advanced 
disease.   
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Table 1 
The documented radiologic disease manifestations in children treated for intrathoracic 
tuberculosis and the proportion with bacteriologic confirmation 
 
 
Disease manifestation 
 
Number (%)   
 
Bacteriologic confirmation* 
  
Ghon focus 
 
Primary (Ghon) complex 
 
Lymph node disease  
Uncomplicated 
Complicated 
    Airway compression 
    Parenchymal consolidation  
 
Pleurisy 
Pericarditis 
Disseminated (miliary) disease 
Adult-type disease  
 
TOTAL 
 
4 (1.3) 
 
15 (3.6) 
 
 
147 (47.9) 
 
25 (8.1) 
62 (20.6) 
 
24 (7.8) 
1 (0.3) 
15 (4.9) 
14 (4.6) 
 
307 (100) 
 
4/4 (100) 
 
5/9 (55.6) 
 
 
24/69 (34.7) 
 
10/18 (55.6) 
40/49 (81.6) 
 
10/17 (58.8) 
1/1 (100) 
14/15 (93.3) 
14/14 (100)# 
 
122/196 (62.2) 
 
*Bacteriologic confirmation – the numerator is the number of children in whom bacteriologic 
confirmation (positive M. tuberculosis culture and/or the presence of acid-fast bacilli on 
sputum) was achieved, and the denominator is the number of children in whom specimens 
were collected 
#Three of these 14 children had positive results for sputum smears only, as no cultures were 
performed. 
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ORIGINAL STUDIES
Tuberculous Lymphadenitis as a Cause of Persistent
Cervical Lymphadenopathy in Children From a
Tuberculosis-Endemic Area
Ben J. Marais, MRCP (Paed), FCP (Paed), MMed,* Colleen A. Wright, MMed, FCPath, FRCPath, FIAC,†
H. Simon Schaaf, MMed, MD (Paed),* Robert P. Gie, FCP (Paed),* Anneke C. Hesseling, MBChB, MSc,*
Don A. Enarson, MD,‡ and Nulda Beyers, FCP (Paed), MSc, PhD*
Background: Cervical lymphadenitis is the most common form of
extrapulmonary tuberculosis in children, although its relative con-
tribution as a cause of persistent cervical adenopathy is not well-
documented. The aim of this study was to determine the relative
contribution of tuberculous lymphadenitis as a cause of persistent
cervical adenopathy in a tuberculosis-endemic setting and to docu-
ment its clinical presentation at the primary health care level.
Methods: A prospective descriptive study was conducted from
February 2003 through October 200 at 5 primary health care clinics
in Cape Town, South Africa. The study included all children
younger than 13 years presenting with persistent cervical adenopa-
thy to the local primary health care clinic.
Results: A total of 158 children were evaluated of whom 35 (22.2%)
were diagnosed with tuberculous lymphadenitis. Bacteriologic con-
firmation was achieved in 27 of 35 (77.1%) children; all 35 re-
sponded to standard antituberculosis treatment. The majority of
those without tuberculous lymphadenitis (105 of 123, 85.4%) had a
visible superficial lesion in the area drained by the affected nodes. In
children with persistent lymphadenopathy 2  2 cm, tuberculosis
lymphadenitis was diagnosed in 31 of 33 (93.9%); specificity was
98.4%, sensitivity was 88.6% and the positive predictive value was
93.4%.
Conclusion: Children commonly present with persistent cervical
adenopathy to the primary health care clinic. The use of a simple
clinical algorithm provided an accurate diagnosis of tuberculous
lymphadenitis in the study setting. Fine needle aspirations provided
a rapid and definitive diagnosis in the majority of children and will
have added diagnostic value in settings where alternative diagnoses
are more likely.
Key Words: tuberculosis, lymphadenitis, children, persistent
cervical adenopathy
(Pediatr Infect Dis J 2006;25: 142–146)
Peripheral tuberculous lymphadenitis predominantly in-volves the cervical lymph nodes1–5 and is the most com-
mon form of extrapulmonary tuberculosis in children from
tuberculosis-endemic areas.1,2 However, its relative contribu-
tion as a cause of persistent cervical adenopathy in these
communities is not well-documented.
Cervical lymphadenitis, caused by Mycobacterium tu-
berculosis, is generally considered to have its origin in the
lymphatic spread of organisms from a primary pulmonary
focus, but in a minority of cases it can originate from a
primary focus in the mouth, tonsils, oropharynx or tissues of
the head and neck.6 Other mycobacteria can also cause
cervical lymphadenitis; the relative contribution of different
mycobacteria is influenced by the control of bovine tubercu-
losis,7 the use of BCG vaccination,8 the presence of environ-
mental mycobacteria and the prevalence of tuberculosis
within a particular setting.7
The diagnosis of tuberculosis in children is often dif-
ficult, given that symptoms and signs might be nonspecific,
the collection of bacteriologic specimens problematic and
bacteriologic yields low.9,10 In children with peripheral tu-
berculous lymphadenitis, however, clinical signs are usually
apparent, and fine needle aspiration (FNA) provides excellent
bacteriologic yields.11–13 Although the diagnostic value of
FNA has been demonstrated in resource-limited settings,11–13
to date it remains underutilized as a routine diagnostic mo-
dality in most endemic areas.
The aim of this study was to determine the relative
contribution of tuberculous lymphadenitis as a cause of per-
sistent cervical adenopathy in children from a tuberculosis-
endemic area and to document its clinical presentation at the
primary health care level.
METHODS
A prospective descriptive study was performed from
February 2003 through October 2004 in Cape Town, the
Western Cape Province, South Africa.
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Setting. The study was conducted at 5 primary health care
clinics served by one referral hospital. The incidence of all
tuberculosis in Cape Town was 678/100,000,14 and the preva-
lence of human immunodeficiency virus (HIV) infection among
women attending public antenatal clinics in the Western Cape
Province was 13.1% (95% confidence interval, 8.5–17.7%), in
2003.15 Bovine tuberculosis is well-controlled within the study
communities, and children receive routine neonatal Calmette-
Gue´rin bacillus (BCG) vaccination. The study communities
rarely use private medical services, and children diagnosed with
tuberculosis are routinely referred to the local primary health
care clinic, where supervised antituberculosis treatment is pro-
vided free of charge. Pediatric services are extended only to
children younger than 13 years of age.
Study Population. All children (younger than 13 years of age)
who presented with persistent cervical adenopathy; defined as
lymph nodes 1  1 cm, persisting for 4 weeks despite a
course of oral antibiotics (usually amoxicillin), were referred
to the investigator for evaluation.
Data Collection and Surveillance. The principal investigator
visited each clinic on a weekly basis to screen referred
children, whereas a study nurse recorded children referred
directly to hospital. The areas surrounding the affected cer-
vical lymph nodes were inspected to exclude a visible super-
ficial lesion within their drainage area (visible local cause),
such as impetigo of the scalp, tinea capitis or traction follic-
ulitis. Those with a visible local cause were given appropriate
therapy and instructed to return if the lymph nodes persisted
or increased in size. Surveillance was continued at all 5
clinics and the referral hospital throughout the study period,
and for an additional 3 months after enrollment was stopped,
to document any child who subsequently returned with symp-
tom deterioration or a possible diagnosis of tuberculosis.
Children with no visible local cause of cervical lymph-
adenopathy received a Mantoux (2 tuberculin units of purified
protein derivative RT23 intradermal) tuberculin skin test
(TST) and a chest radiograph (anteroposterior and lateral).
The Mantoux TST was interpreted as positive if induration
was 10 mm. Two independent experts evaluated the chest
radiographs for intrathoracic signs of tuberculosis. Symptoms
and signs as well as possible tuberculosis contact were
documented. Children diagnosed with tuberculous lymphad-
enitis were offered a rapid HIV test (Determine HIV 1/2;
Abbott) after appropriate counseling. Standard 3-drug antitu-
berculosis treatment was initiated,16 and response to antitu-
berculosis therapy was monitored after a period of 3 months.
In the group not diagnosed with tuberculous lymphadenitis,
symptom resolution in the absence of antituberculosis therapy
was monitored.
Case Definition. Tuberculous lymphadenitis was defined as
cervical lymphadenopathy 1  1 cm persisting for 4
weeks despite a course of oral antibiotics, in the presence of
at least 1 of the following criteria: (1) bacteriologic confir-
mation: isolation of M. tuberculosis from a lymph node, or
microscopically visible acid-fast or autofluorescent bacilli
associated with amorphous necrosis on cytology; or (2) clin-
ical diagnosis: significant therapeutic response (lymph node
size decreased from2 2 cm to1 1 cm after 3 months
of standard antituberculosis treatment). All cultures positive
for M. tuberculosis complex were routinely speciated by
polymerase chain reaction to differentiate M. tuberculosis
from Mycobacterium bovis and M. bovis BCG.17
FNA and/or Biopsy. Of the children enrolled, only those with
a positive TST (10 mm) and/or a suggestive chest radio-
graph and/or a cervical mass 2  2 cm were referred to the
hospital for FNA. FNA was performed in the pediatric out-
patient department with sedation and pain relief (chloral
hydrate 20–50 mg/kg and paracetamol 10–20 mg/kg, admin-
istered orally 30–60 minutes before the procedure). The
largest discrete node was identified by careful palpation of the
cervical mass. Two needle passes were performed with a
23-gauge needle attached to a 10-mL syringe, applying 2 mL
of suction. Aspirated material was placed on standard micro-
scope slides, thinly smeared and air-dried or fixed with
commercial spray fixative for Giemsa and Papanicolou stains,
before flushing the syringe and needle directly into a MGIT
(Becton Dickinson, Cockeysville, MD) mycobacterial culture
bottle. Microscopic evaluation included cytology, acid-fast
staining and autofluorescence.18 Excision biopsies were oc-
casionally performed if children presented with persistent
cervical adenopathy to the referral hospital without a letter
from the investigator or if the FNA was inconclusive.
Statistical Analysis. Descriptive analysis was conducted with
SPSS (version 11.5). The sensitivity and specificity of a
simple clinical algorithm were calculated with the use of
either bacteriologic confirmation and/or the clinical case
definition (see case definition) as the “reference” test.
Parents gave written informed consent for study partic-
ipation and ethics approval was obtained from the Institu-
tional Review Board of Stellenbosch University, the City of
Cape Town Health Department and local health committees.
RESULTS
Persistent Cervical Adenopathy. Of the 167 children who
were identified with persistent cervical adenopathy, 9 (5.4%)
did not return to the clinic for evaluation by the investigator
(Fig. 1). Of the 158 children evaluated, 53 had no visible
cause of whom 40, with either a positive TST or a cervical
mass 2  2 cm, were referred to hospital to establish a
histologic diagnosis. None of the 13 TST-negative children
had radiographic or other clinical signs indicative of possible
tuberculosis, and all children judged not to have tuberculosis
on clinical grounds showed symptom resolution in the ab-
sence of antituberculosis treatment.
Table 1 summarizes the demographics and etiology of
persistent cervical adenopathy in the 158 children who were
evaluated. The majority of children (105, 66.5%) had lymph
nodes 2  2 cm with a visible local cause; 28 returned for
reevaluation within 1 month; the lymphadenopathy resolved
in 18 and decreased to 1  1 cm in 9. Multiple discrete
lymph nodes, 1–2 cm in diameter, remained in 1 child who
was TST-negative and asymptomatic. The lymphadenopathy
showed slow resolution, decreasing to 1  1 cm within 3
months. None of the children with a visible local cause
returned to the clinic with symptom deterioration or with a
possible tuberculosis diagnosis from any hospital, during the
study period.
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Of the 53 (33.5%) children without a visible local cause,
tuberculous lymphadenitis was diagnosed in 35 (66.0%). Of
those with a cervical mass 2  2 cm, tuberculous lymphade-
nitis was diagnosed in 31 of 33 (93.9%). Of the 2 remaining
children, 1 had an unidentified chronic inflammatory process
diagnosed through excision biopsy, and the other developed a
chronic bacterial abscess after repeat courses of oral antibiotics,
requiring eventual incision and drainage. Two children pre-
sented with acute bacterial adenitis; both had a history of
persistent lymph node enlargement that preceded the acute
event. Both these children were TST-positive and were
diagnosed with secondary bacterial infection, as M. tuber-
culosis was cultured after incision and drainage. One had
signs suggestive of tuberculosis on the chest radiograph
and reported a prolonged cough and night sweats, whereas
the other had no additional suspect symptoms or signs
apart from the cervical mass and a positive TST.
Tuberculous Lymphadenitis. Of the 35 children diagnosed with
tuberculous lymphadenitis (Fig. 1), bacteriologic confirmation
was achieved in 27 (77.1%) children. Of the 8 children without
bacteriologic confirmation, 7 failed to attend the referral hos-
pital, and 1 refused permission for FNA. All 8 had a TST
response15 mm and showed excellent response to standard
antituberculosis treatment. In the 27 children with bacterio-
logic confirmation; FNA was performed in 21 children and
formal biopsies in 6. No cases caused by M. bovis, M. bovis
BCG, infection with environmental mycobateria such as
Mycobacterium avium-intracellulare complex or Mycobacte-
rium scrofulaceum or malignancies were identified.
Of the 21 children with tuberculous lymphadenitis in
whom FNA was performed, 16 of 21 (76.2%) were acid-fast
or autofluorescent smear-positive, which allowed rapid and
definitive diagnosis. Culture confirmation was achieved in 19
of 21 (90.5%), of whom 2 had no microscopic features
indicative of tuberculosis. One of the 2 children who were
culture-negative had received antituberculosis treatment be-
fore FNA was performed. Either a positive culture or typical
microscopic features were present in all 21 cases. One of the
2 children, who had no microscopic features indicative of
tuberculosis on FNA, had an excision biopsy performed that
established the diagnosis, before the FNA culture result
became known. No immediate complications relating to the
FNA procedure, apart from minimal bleeding, were noted.
No long term complications, such as sinus formation, were
recorded during the 3-month follow-up period.
Table 2 reflects the lymph node characteristics and
associated findings in the 35 children diagnosed with tuber-
culous lymphadenitis. Using the clinical algorithm of a per-
sistent cervical mass 2  2 cm, without a visible local
cause or response to antibiotics, accurately identified children
with tuberculous lymphadenitis; sensitivity was 88.6%, spec-
ificity was 98.4% and the positive predictive value of this
clinical algorithm was 93.4%.
Tuberculous lymphadenitis occurred in children of all
ages, except in infants. In 18 (51.4%), lymph nodes occurred
in the anterior triangle, with involvement of multiple regions
in 5 (14.3%). Other regions involved were: posterior triangle,
8 (22.9%); submandibular, 2 (5.7%); and supraclavicular, 2
(5.7%). Lymph nodes occurred more regularly on the right
TABLE 1. Demographics and Etiology of Persistent
Cervical Adenopathy in Children (n  158)
No. of Instances
Demographics
Gender
Male 69 (43.7)*
Female 89 (56.3)
Age groups
5 yr 93 (58.9)
5–9 yr 51 (32.2)
10 yr 14 (8.9)
Etiology
Visible local cause 105 (66.5)
Bacterial infection (crusted impetigo) 26 (16.5)
Tinea capitis (with secondary infection) 34 (21.5)
Traction folliculitis 44 (27.8)
Otitis externa 1 (0.6)
No visible local cause 53 (33.5)
Tuberculous lymphadenitis 35 (22.2)
Reactive nodes† 13 (8.2)
Nonspecific inflammation 4 (2.5)
Nonacute bacterial abscess 1 (0.6)
Malignancy 0
*Numbers in parentheses, percent.
†Cervical mass 2  2 cm, tuberculin skin test-negative and natural symptom
resolution.
FIGURE 1. Flow diagram of children referred with persistent cer-
vical adenopathy. Not TB indicates symptom resolution in the
absence of antituberculosis chemotherapy. TB, bacteriologic con-
firmation: isolation ofM. tuberculosis from a lymph node, or mi-
croscopically visible acid-fast or autofluorescent bacilli associated
with caseating necrosis on cytology or clinical diagnosis; significant
therapeutic response (lymph node size decreased from 2  2
cm to 1  1 cm after 3 months of standard antituberculosis
treatment); Not evaluated, did not return to the clinic for evalua-
tion by the investigator; Rx response, clinical diagnosis together
with significant therapeutic response in the absence of FNA or
biopsy-based diagnosis; classified as not TB: 1 chronic inflamma-
tory process diagnosed after excision, 1 nonacute bacterial abscess
diagnosed after incision and drainage.
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side: right, 19 (54.3%); left, 13 (37.1%); bilateral, 3 (8.6%).
Most lymph nodes were multiple, either discreet or matted
(30, 85.7%), either discreet or matted, and solid (28, 80.0%).
All lymph nodes were nontender, either discreet or matted,
except 2 with secondary bacterial infection. A sinus devel-
oped in 2 children, one before presentation and the other after
surgical incision and drainage.
Associated findings in children with tuberculous lymph-
adenitis included a positive TST in 33 of 35 (94.3%). Two
(5.7%) children had a nonreactive TST; 1 was HIV-infected,
the other was severely ill with coexistent pulmonary tuber-
culosis. The TST in the latter patient measured 16 mm when
repeated after 3 months of antituberculosis treatment. Twen-
ty-nine (82.9%) children were tested for HIV, and 1 (3.5%)
was HIV-infected. Contact with an adult index case was
reported in 19 (54.3%), whereas in a further 2 cases, adults
with suspicious symptoms were subsequently diagnosed with
tuberculosis. Constitutional symptoms were present in 21
(60.0%) children, and the chest radiograph was suggestive of
primary pulmonary tuberculosis in 13 (37.1%).
The response to standard antituberculosis therapy was
good, and most children showed considerable improvement,
with reduction in lymph node size to 1  1 cm after 3
months of standard antituberculosis treatment. Three (8.6%)
children deteriorated initially; 1 developed upper airway
obstruction that required surgical lymph node enucleation and
the addition of corticosteroids. All 3 children showed good
response after completing 6 months of standard antitubercu-
losis therapy, although a cervical mass of 1  1 cm re-
mained in 1 child.
DISCUSSION
Children commonly presented with persistent cervical
adenopathy to primary health care clinics in the study setting.
The majority of these children had visible local lesions such
as crusted impetigo, infected tinea capitis or traction follicu-
litis. The hair of most small girls in this community is tightly
braided, which often leads to irritation and bacterial infection
of the hair follicles. This also explains the overrepresenta-
tion of girls in the study population. It is understandable that
none of these conditions responded to a short course of oral
antibiotics, in the absence of etiology-specific systemic
and/or local treatment.
A simple clinical algorithm that identified children with
persistent (4 weeks) cervical lymphadenopathy, no visible
local cause or response to antibiotics and a cervical mass
2  2 cm showed excellent diagnostic accuracy within the
study setting. The addition of a positive TST may be of value
in settings where infection with M. tuberculosis is less com-
mon or where conditions other than tuberculosis, such as
malignant lymph node involvement or other chronic infec-
tions, are more common and may present with a similar
clinical picture. The fact that accurate clinical diagnosis is
possible at the primary health care level might allow the
initiation of antituberculosis treatment without hospital refer-
ral, which should improve access to care for children in
extremely resource-limited settings. However, regular fol-
low-up (at least monthly) is essential so that children who
do not respond to standard antituberculosis treatment are
referred as soon as possible to establish a definitive diag-
nosis. The value of this clinical approach requires further
evaluation.
FNA proved to be a robust and simple technique, which
provided an excellent bacteriologic yield. No significant side
effects were noted. FNA provided a definitive bacteriologic
diagnosis with the ability to speciate M. tuberculosis complex
and to perform drug susceptibility testing. A definitive diag-
nosis is always desirable, but the diagnostic value of FNA
will be even greater in settings where a clinical diagnosis is
expected to be less accurate, such as areas where malignant
lymph node involvement and/or other chronic infections are
more common.11,12
The lymph node characteristics and constitutional symp-
toms recorded in this study correlate well with findings from
Papua New Guinea and India.3,4,19 The most distinctive fea-
tures were the chronic persistent course, the lymph node size
(2  2 cm) and the involvement of multiple, discrete or
matted, lymph nodes. The study also emphasizes the value of
TABLE 2. Clinical Characteristics of Children With
Tuberculous Lymphadenitis (n  35)
No. of Instances
Lymph node characteristics
Persistence (present for 4 wk, no response to
antibiotics)
35 (100)*
Size†
2  2 cm 4 (11.4)
(2–4)  (2–4) cm 25 (71.5)
4  4 cm 6 (17.1)
Character
Single 5 (14.3)
Multiple
Discreet 14 (40.0)
Matted 16 (45.7)
Solid 28 (80.0)
Fluctuant
Without secondary bacterial infection 5 (14.3)
With secondary bacterial infection (red
and warm)
2 (5.7)
Associated findings
Tuberculin skin test
0 mm 2 (5.7)
1–9 mm 0
10 mm 33 (94.3)
15 mm 32 (91.4)
Mean response 19.1 mm (standard deviation
2.9 mm)
Constitutional symptoms
Any symptom 21 (60.0)
Fever 7 (20.0)
Cough 9 (25.7)
Night sweats 8 (22.8)
Fatigue‡ 19 (54.3)
Failure to thrive§ 10 (28.6)
Chest radiograph
Suggestive of tuberculosis 13 (37.1)
Lymph node disease
Uncomplicated 8 (22.8)
With airway compression 1 (2.9)
With parenchymal consolidation 4 (11.4)
*Numbers in parentheses, percent.
†Transverse diameter of the largest cervical mass.
‡Less playful and active since the mass was first noted.
§Crossing at least 1 centile line in the preceding 3 months or having lost10% of body
weight (minimum, 1 kg) over any time interval.
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clinical follow-up and serial measurement of enlarged lymph
nodes if the diagnosis is not apparent.20
Only 1 child with tuberculous lymphadenitis was HIV-
infected. This reflects the low HIV prevalence among chil-
dren in the study setting but might also illustrate a decreased
tendency in HIV-infected children to develop peripheral
tuberculous lymphadenitis, as suggested in a comparative
study from Zambia.21 FNA may have increased diagnostic
value in HIV-infected children, because the relative contri-
bution of tuberculous lymphadenitis to persistent cervical
adenopathy in this group is expected to be smaller.
It is interesting that no environmental mycobacteria
were isolated, although it is reported to be the most common
cause of persistent cervical adenopathy in the developed
world.22 Paucity of disease caused by environmental myco-
bacteria has also been described in other tuberculosis-en-
demic countries, such as India.23,24 This may result from the
protective effect afforded by routine neonatal BCG vaccina-
tion,8 whereas natural infection with M. tuberculosis might
provide additional protection against disease caused by envi-
ronmental mycobacteria.
An important study limitation is that bacteriologic confir-
mation was achieved in only 77.1% of the study patients, as it
was not attempted in 8 children. However, we are confident that
the diagnosis was accurate, given the fact that these 8 children all
had a TST response 15 mm and showed excellent clinical
response to standard antituberculosis treatment.
In conclusion, the use of a simple clinical algorithm
identified tuberculous lymphadenitis with a high degree of
accuracy in the study setting, whereas FNA provided a rapid
and definitive diagnosis in the majority of children.
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Chapter 5. 
Symptom-based screening and diagnosis 
 
The pre-chemotherapy literature indicated the importance of symptoms to assist with the 
differentiation between infection and disease. This implies that symptom-based approaches 
may have value for screening and diagnostic purposes.  We evaluated the potential value of 
simplified (symptom-based) screening to improve access to preventive chemotherapy for 
children exposed to tuberculosis in resource-limited settings.  We then applied a step-wise 
approach to assess the potential value of symptoms to diagnose childhood tuberculosis.  The 
first step was merely to document the prevalence of symptoms traditionally associated with 
tuberculosis, in a random selection of children from an endemic area. The second step was to 
develop optimal symptom definitions and to demonstrate that well-defined symptoms have 
improved diagnostic value compared to poorly defined symptoms.  The final step was to 
validate the value of a novel symptom-based approach, using well-defined symptoms, to 
diagnose pulmonary tuberculosis in children from an endemic area. 
 
1. Marais BJ, Gie RP, Hesseling AC, Schaaf HS, Enarson DA, Beyers N.  
Radiographic signs and symptoms in children treated for tuberculosis: 
possible implications for symptom-based screening in resource-limited 
settings. Ped Infect Dis J 2006; 25: 237-240 
The WHO advises active tracing of children less than 5 years of age who are in household 
contact with a sputum smear-positive index case.  Current guidelines include tuberculin skin 
testing and chest radiography as prerequisite tests for adequate screening, but these tests 
are rarely available in endemic areas.  As a result no preventive chemotherapy is offered to 
exposed children in these settings.  This prospective descriptive study compared disease 
manifestations in two groups of children, those who presented with suspicious symptoms and 
those who were actively traced household contacts of an adult index case.  Significantly more 
actively traced contacts were categorized as “not TB” (OR 7.4, 95%CI 3.8-14.3), or 
demonstrated elements of the primary complex only on chest radiograph (OR 26.2, 95%CI 
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8.6-89.2), compared to children who presented with suspicious symptoms.  Only 20/230 
(8.7%) children diagnosed with intra-thoracic tuberculosis reported no symptoms, all of whom 
demonstrated elements of the primary complex only.  Simplified, symptom-based screening of 
child contacts may be justified to improve access to preventive chemotherapy in resource-
limited settings  
 
2. Marais BJ, Obihara CC, Gie RP, Schaaf HS, Hesseling AC, Lombard C, 
Enarson D, Bateman E, Beyers N. The prevalence of symptoms associated 
with pulmonary tuberculosis in randomly selected children from a high-
burden community.  Arch Dis Child 2005; 90: 1166-1170 
This community-based survey documented the prevalence of symptoms traditionally 
associated with tuberculosis in a random selection of children from a high-burden community. 
Of the 1397 children without tuberculosis, 253 (26.4%) reported a cough during the preceding 
3 months and 66 (6.9%) reported a cough of more than 3 weeks duration.  In addition, 50% of 
children with newly diagnosed tuberculosis reported no symptoms at all.  These observations 
clearly limit the value of poorly defined symptoms to diagnose tuberculosis in children. The 
study emphasized the need for improved symptom and case definitions. 
 
3. Marais BJ, Gie RP, Obihara CC, Hesseling AC, Schaaf HS, Beyers N. Well-
defined symptoms are of value in the diagnosis of childhood pulmonary 
tuberculosis. Arch Dis Child 2005; 90: 1162-1165 
We have demonstrated that poorly defined symptoms have little diagnostic value, but this 
may not be true for well-defined symptoms.  According to the natural history of disease, 
childhood tuberculosis is associated with persistent, non-remitting symptoms.  We conducted 
a small prospective cohort study to evaluate whether the use of well-defined symptoms 
improves diagnostic accuracy.  Of 151 children referred with a cough of >2 weeks duration, 
only 17 (11.2%) reported a persistent, non-remitting cough.  In this small study, a persistent, 
non-remitting cough was an almost universal feature in children with tuberculosis (15/16, 
93.8%), while it was extremely rare in those without tuberculosis (2/135, 1.5%). The study 
demonstrated that accurate symptom definition might add significant diagnostic value.  
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However, formal validation of this novel approach requires a large, prospective community-
based study.   
 
Rationale applied to validate a novel symptom-based diagnostic approach 
There are multiple reasons for current scepticism about the utility of symptom-based 
approaches to diagnose childhood tuberculosis; 1) the poor validation and performance of 
existing clinical algorithms, 2) an appreciation that the symptoms traditionally associated with 
tuberculosis are not uncommon in endemic areas, even in children without tuberculosis, 3) 
literature reports that describe children with “asymptomatic tuberculosis”, 4) a perception that 
childhood tuberculosis may progress rapidly, implying that symptom-based diagnostic 
approaches may be dangerous, and 5) a belief that bacteriologic confirmation remains the 
only way to establish a definitive diagnosis of tuberculosis.   
 
Despite these reservations, we felt confident that a novel symptom-based diagnostic 
approach may hold promise; based on evidence from the pre-chemotherapy literature, 
personal clinical experience and the results of our studies to date.  There have been few 
recent advances in the diagnosis of childhood tuberculosis.  The new T-cell based assays 
were greeted with great enthusiasm, but although these tests indicate M. tuberculosis 
infection with accuracy, they fail to differentiate latent infection from active disease. Accurate 
case definition and the distinction between infection and disease have caused a lot of 
confusion.  The natural history of disease demonstrate that “asymptomatic tuberculosis” 
probably results from inappropriate disease classification, as elements of the primary complex 
became transiently visible on the chest radiograph in the majority of children following recent 
primary infection with M. tuberculosis.  Radiological visibility of elements of the primary 
complex, in the absence of symptoms or radiologically visible complications, should be 
classified as recent primary infection and not disease.  
 
Natural history disease descriptions also enabled accurate risk analysis and stratification 
according to a child’s risk to progress to disease following primary infection with M. 
tuberculosis.   Appropriate risk stratification indicated that the risk of rapid disease 
Stellenbosch University  http://scholar.sun.ac.za 
 100
progression was restricted to high-risk (very young and/or immune compromised) children.  In 
these high-risk children the identification and treatment of latent infection is important and the 
study protocol should ensure the provision of preventive chemotherapy.  In low-risk children 
(immune competent and older than 3yrs of age), who represent the majority of children in the 
community, disease progression was associated with slowly progressive, persistent 
symptoms that provided a potential window of opportunity for symptom-based diagnosis.  
 
Essential study design elements identified were; 1) prospective community-based recruitment 
to limit patient selection, 2) appropriate risk-stratification, 3) the use of accurate case 
definitions that are both independent of the predictor variables tested and inclusive of the full 
disease spectrum seen in children with pulmonary tuberculosis, and 4) the need for 
comprehensive disease surveillance to identify all children from the study community who 
received anti-tuberculosis treatment during the study period, irrespective of study entry.  
Comprehensive disease surveillance is an essential safety check to quantify the potential 
disadvantages of using a novel symptom-based diagnostic approach.  Primary health care 
clinics were identified as the most practical, community-based point of entry into the study.  In 
addition, clinic-based entry would be representative of the situation faced by healthcare 
workers in tuberculosis endemic areas. 
  
The formulation of accurate case definitions provided a major challenge. Bacteriologic 
confirmation is the accepted gold standard.  However, it is limited by a few major concerns; 1) 
the low bacteriologic yields achieved in children with tuberculosis, 2) the fact that culture 
positive children may represent a select group that does not reflect the full disease spectrum, 
and 3) the observation that positive cultures may be obtained in healthy children shortly after 
primary infection.  Chest radiography is often used as a more practical alternative, but it has 
serious limitations as well; 1) radiologic visibility of elements of the primary complex may 
indicate recent primary infection and not necessarily disease, and 2) the subjectivity inherent 
to radiograph interpretation undermines its reliability as an objective endpoint.  It is important 
to mention that the majority of children with tuberculosis have unequivocal radiologic signs.  
The poor inter and intra-personal correlation reported in the literature may be partly due to the 
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fact that expert readers were forced to make a diagnosis in every instance, without having the 
option of indicating uncertainty.   
 
We concluded that the most accurate case definitions are provided by a combination of 
symptomatic presentation and either bacteriologic confirmation or radiographic certainty.  This 
excludes asymptomatic children with either an unexpected positive culture and/or transiently 
visible elements of the primary complex on the chest radiograph.  The following measures 
were identified to ensure that a radiographic diagnosis of tuberculosis do provide a reliable 
endpoint; 1) antero-posterior and lateral views should be taken, 2) all chest radiographs 
should be read by two independent blinded experts, who should first evaluate the quality of 
the radiograph and then document their findings on a standard report form, and 3) the expert 
readers must have the option to indicate uncertainty.  Only when both independent experts 
agree on a certain diagnosis of tuberculosis, should it be accepted as an objective and 
reliable endpoint.  Children without bacteriologic confirmation or radiologic certainty should be 
monitored for natural symptom resolution or response to anti-tuberculosis therapy, before 
assigning the most probable clinical diagnosis. These outcome criteria; 1) “bacteriologically 
confirmed TB”, 2) “radiologically certain TB”, and 3) “probable TB”, in conjunction with 
symptomatic study entry, should provide accurate case definitions that are inclusive of the 
complete disease spectrum.   
 
We proceeded to perform a prospective, community-based study to validate a novel 
symptom-based approach, based on the study rationale outlined.  
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4. Marais BJ, Gie RP, Hesseling AC, Schaaf HS, Enarson D, Beyers N. A novel 
symptom-based approach to diagnose childhood pulmonary tuberculosis: 
a prospective, community-based study. Submitted to Pediatrics 
This final study determined the value of well-defined symptoms to diagnose pulmonary 
tuberculosis in children from a highly endemic area, and assessed its performance within 
relevant risk groups.  Accurate diagnosis of pulmonary tuberculosis, using a simple symptom-
based approach, was possible in most HIV-uninfected children, particularly those 3years of 
age.  Further confirmation is required, but this novel approach offers the exciting prospect of 
extending antituberculosis treatment to children in highly endemic areas with limited 
resources, where they currently have poor access to treatment.  
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ORIGINAL STUDIES
Radiographic Signs and Symptoms in Children
Treated for Tuberculosis
Possible Implications for Symptom-Based Screening
in Resource-Limited Settings
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Anneke C. Hesseling, MBChB, MSc,* H. Simon Schaaf, MMed(Paed), MD(Paed),*
Donald A. Enarson, MD,† and Nulda Beyers, FCP(Paed SA), MSc, PhD*
Background: The World Health Organization advises active tracing
of children younger than 5 years old in household contact with a
sputum smear-positive tuberculosis index case. This study compared
radiographic disease manifestations in 2 groups of children treated
for tuberculosis in an endemic setting: those who presented with
suspicious symptoms; and those actively traced as household con-
tacts of an adult index case.
Methods: We conducted a prospective descriptive study from Feb-
ruary 2003 through October 2004 at 5 primary health care clinics in
Cape Town South Africa, including all children (younger than 5
years old) treated for tuberculosis (TB).
Results: A total of 326 children (younger than 5 years old) received
antituberculosis treatment; 190 (58.3%) presented with suspicious
symptoms, and 136 (41.7%) were actively traced contacts. Children
were categorized as; “not TB” 71 (22%), intrathoracic tuberculosis
230 (70%) and extrathoracic tuberculosis 25 (8%). Significantly
more actively traced contacts were categorized as “not TB” (odds
ratio, 7.4; 95% confidence interval, 3.8–14.3), or demonstrated
elements of the primary complex only on the chest radiograph (odds
ratio, 26.2; 95% confidence interval, 8.6–89.2), compared with
children who presented with suspicious symptoms. Of all children
diagnosed with intrathoracic tuberculosis, 20 of 230 (9%) reported
no symptoms, all of whom demonstrated elements of the primary
complex only.
Conclusions: The majority of actively traced contacts had minimal
disease. Symptom-based screening would have identified all but 9%
of children diagnosed with intrathoracic tuberculosis, all of whom
demonstrated elements of the primary complex only. Further inves-
tigation is required to establish whether symptom-based screening
can be justified to improve access to preventive chemotherapy in
resource-limited endemic settings.
Key Words: symptom-based screening, preventive chemotherapy,
childhood tuberculosis
(Pediatr Infect Dis J 2006;25: 237–240)
Because childhood tuberculosis is often considered to be amild disease with limited epidemiologic impact, the main
reason for treating children is to eradicate the pool of latent
infection from which future reactivation disease can result.
However, children carry a heavy burden of disease in tuber-
culosis-endemic areas,1 and tuberculosis is a major cause of
respiratory tract-related disease and death,2 which indicate
the importance of preventive chemotherapy to reduce the
tuberculosis disease burden in children.
The World Health Organization advises active tracing
and screening of children younger than 5 years old in house-
hold contact with a sputum smear-positive tuberculosis index
case.3 Guidelines for screening include tuberculin skin testing
and chest radiography. These tests are rarely available in
endemic areas with limited resources; as a result, children
exposed to Mycobacterium tuberculosis in these settings are
not offered preventive chemotherapy.
The South African National Tuberculosis Program
(NTP) guidelines state that all children younger than 5 years
old in household contact with a sputum smear-positive index
case should be assessed at the primary health care clinic.4
Routine assessment includes documentation of suspicious
symptoms, a tuberculin skin test (TST) and standard antero-
posterior and lateral chest radiographs. Children diagnosed
with tuberculosis receive standard multidrug treatment, whereas
those in whom active tuberculosis has been excluded receive
isoniazid preventive chemotherapy for 6 months.
This study compared radiographic disease manifesta-
tions in 2 groups of children treated for tuberculosis in an
endemic setting: those who presented with suspicious symp-
toms; and those actively traced as household contacts of an
adult index case. This comparison allowed us to evaluate the
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potential value of symptom-based screening in resource-
limited settings, where chest radiography is unavailable.
METHODS
Study Setting. We conducted a prospective descriptive study,
from February 2003 through October 2004 in Cape Town,
Western Cape Province, South Africa. The study area in-
cluded 5 primary health care clinics served by Tygerberg
Children’s Hospital as the referral hospital. The population
rarely use private medical services, and those diagnosed with
tuberculosis are routinely referred to the local primary health
care clinic where they receive supervised treatment free of
charge. The incidence of all tuberculosis in Cape Town was 678
per 100,000 in 2003,5 and the prevalence of human immunode-
ficiency virus (HIV) infection among women attending public
antenatal clinics in the Western Cape Province was 13.1% (95%
confidence interval (CI), 8.5–17.7%) in 2003.6
Data Collection. All children younger than 5 years of age
who started antituberculosis treatment during the study period
were identified by prospective surveillance. The investigator
visited each clinic on a weekly basis to review children who
had newly started antituberculosis treatment at the primary
health care clinic. Children who started antituberculosis treat-
ment in hospital were recorded by a study nurse and referred
to the same investigator for review.
TST. A TST was performed on the volar aspect of the left
forearm, using either the Mantoux test (intradermal injection
of 2 tuberculin units of M. tuberculosis purified protein
derivative RT 23; Statens Serum Institut, Copenhagen, Den-
mark) or the multipuncture tine test. A positive Mantoux test
was defined as 10 mm (5 mm if the child was HIV-
infected). The tine test was regarded as positive if 2 or more
of the papules showed confluence of induration.
Chest Radiograph (CXR). Chest radiographs were performed
in all children and reviewed by the same 2 independent
experts who were blinded to all clinical information. They
used a standard report form and categorized their findings as
“certain TB,” “uncertain TB” and “certain not TB.” Classi-
fication was done according to the most severe disease
classification reported, with the use of a recently proposed
radiologic classification of childhood intrathoracic tuberculo-
sis.7 Disease entities identified included Ghon focus, primary
complex, lymph node disease (uncomplicated or compli-
cated), pleurisy and disseminated (miliary) disease.
Definitions. Actively traced contacts were defined as children
who did not present because of parental concern regarding
suspicious symptoms but who were screened for tuberculosis
because of known household contact with an adult index
case. Suspicious symptoms were defined according NTP guide-
lines as cough or wheeze for 2 weeks, and/or prolonged or
recurrent unexplained fever and/or failure to thrive.4
“Not TB” was defined as meeting all 3 of the following
criteria: (1) agreement by both independent experts that the
chest radiograph indicated “certain not TB”; (2) no bacteri-
ologic or histologic confirmation; and (3) no documented
extrathoracic tuberculosis. Intrathoracic tuberculosis was de-
fined as a child with signs suggestive of tuberculosis on the
chest radiograph (“certain TB” or “uncertain TB”) identified
by at least 1 independent expert. Extrathoracic tuberculosis
was defined a child treated for an extrathoracic manifestation
of tuberculosis, without CXR signs suggestive of intratho-
racic tuberculosis.
Patients were enrolled after the parents or legal guardians
gave written informed consent for study inclusion. Separate
consent was obtained for HIV testing, with pre- and posttest
counseling. Ethics approval was obtained from the Institutional
Review Board of Stellenbosch University, the City of Cape
Town Health Department and local health committees.
RESULTS
Antituberculosis treatment was given to 326 children
(younger than 5 years of age), of whom 190 (58%) presented
with suspicious symptoms and 136 (42%) were actively
traced contacts. (Fig. 1).
Demographics and disease characteristics are presented
in Table 1. Of the 194 children with a positive TST, Mantoux
tests were done in 159 (82%). The 71 children categorized as
“not TB” were given antituberculosis treatment by the attend-
ing physician because of known M. tuberculosis exposure
together with suspicious symptoms and/or possible hilar ad-
enopathy on the CXR. Significantly more actively traced
contacts were categorized as “not TB” (55 of 136; 40.4%)
than children who presented with suspicious symptoms (16 of
190; 8.4%) odds ratio (OR), 7.4; 95% CI 3.8–14.3.
Table 2 reflects radiographic disease manifestations in
children with intrathoracic tuberculosis. The majority of ac-
tively traced contacts (77 of 81, 95%) had elements of the
primary complex only on CXR, compared with 63 of 149
(42%) children who presented with suspicious symptoms
(OR 26.2; 95% CI 8.6–89.2). Four actively traced contacts
had radiographic signs other than elements of the primary
complex; 3 had complicated lymph node disease, and 1 had
pleurisy. All 4 were symptomatic; 2 reported suspicious
symptoms (as defined), 1 child reported a mild intermittent
cough of recent onset and the child with pleurisy reported
chest pain and fever of recent onset. None of these children
presented to the health care facility because of concern
regarding their symptoms. Only 20 of 230 (9%) children
diagnosed with intrathoracic tuberculosis reported no symp-
toms, all of whom had elements of the primary complex only
on CXR.
FIGURE 1. Flow diagram of all children younger than 5 years
of age treated for tuberculosis.
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DISCUSSION
We believe this study is the first to compare radio-
graphic signs of tuberculosis in actively traced child contacts
and children who presented with suspicious symptoms. Sig-
nificant differences were noted. The majority of actively
traced contacts had elements of the primary complex only on
CXR. This observation might explain the discrepancy in
disease severity reported from endemic and nonendemic
areas, because most children in nonendemic areas are diag-
nosed after active contact tracing. The mild disease and low
bacteriologic yield reported in such children are not unex-
pected.
More importantly, this study provided the opportunity
to evaluate the potential value of symptom-based screening
compared with CXR-based screening of children exposed to
M. tuberculosis. TST results did not influence the decision to
provide preventive chemotherapy as NTP guidelines stipulate
that all household contacts younger than 5 years of age should
receive preventive chemotherapy irrespective of the TST
result. As in other endemic areas,8 the diagnosis of childhood
tuberculosis in the study area depended mainly on clinical
criteria and subjective CXR interpretation.
The majority of children treated for tuberculosis
presented with suspicious symptoms. Only 9% of children
diagnosed with intrathoracic tuberculosis reported no
symptoms, all of whom had elements of the primary
complex only on CXR. The prechemotherapy literature
that documented the natural history of tuberculosis in
children demonstrated that elements of the primary com-
plex become transiently visible in most children after
recent primary infection.9 The complete absence of symp-
toms indicated good containment of the organism, and the
few children who did progress to disease developed symp-
toms.9 Therefore, in the complete absence of symptoms or
any other radiographic sign attributable to current disease,
elements of the primary complex probably reflect recent
primary infection only.7,9
It is important to provide preventive chemotherapy to
children exposed to M. tuberculosis, particularly to those at
high risk to progress to disease (children younger than 3 years
and/or immune compromised children) after primary infec-
tion with M. tuberculosis.9 Current guidelines, which regard
TST and CXR as prerequisite tests for adequate screening,
limit access to preventive chemotherapy in resource-limited
TABLE 1. Demographics and Disease Characteristics Recorded in Children Younger Than 5 Years of
Age Treated for Tuberculosis
Characteristics Totals(N  326)
Presented With Symptoms
(N  190)
Actively Traced Contacts
(N  136) OR
Gender male 166 (51)* 100 (53) 66 (49) 0.9 (0.5–1.4)†
Age 3 yr 231 (71) 126 (66) 105 (77) 1.7 (1.0–2.9)
TST 0.5 (0.3–0.9)
Tested 307 (94) 184 (97) 123 (90)
Positive 194 (60) 145 (76) 81/123 (66)
HIV 1.0 (0.3–3.8)
Tested 183 (56) 148 (78) 35 (26)
Positive 21 (6) 17 (9) 4 (3)
Disease spectrum
Not TB 71 (22) 16 (8) 55 (40) 7.4 (3.8–14.3)
Intra-thoracic TB 230 (70) 149 (79) 81 (60) 0.4 (0.2–0.7)
Extra-thoracic TB 25 (8) 25 (13) 0
*Numbers in parentheses, percent.
†Numbers in parentheses, 95% CI.
TABLE 2. Intrathoracic Disease Manifestations Recorded in Children Younger Than 5 Years of Age
Treated for Tuberculosis
Intrathoracic Disease Manifestation Totals(N  230)
Presented With Symptoms
(N  149)
Actively Traced Contacts
(N  81) OR
Ghon focus 3 (1)* 3 (2) 0
Primary complex 12 (5) 7 (5) 5 (6) 1.5 (0.4–5.7)†
Lymph node disease
Uncomplicated 125 (5) 53 (36) 72 (89) 14.0 (6.2–32.8)
Complicated
Airway compression 18 (8) 17 (11) 1 (1) 0.1 (0.0–0.7)
Parenchymal consolidation 48 (21) 46 (31) 2 (3) 0.1 (0.0–0.3)
Pleurisy 10 (4) 9 (6) 1 (1) 0.2 (0.0–1.5)
Disseminated (miliary) disease 14 (6) 14 (9) 0
*Numbers in parentheses, percent.
†Numbers in parentheses, 95% CI.
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settings where these tests are unavailable. Our findings sug-
gest that symptom-based screening could have considerable
value in these settings given that10% of children diagnosed
with intrathoracic tuberculosis on CXR reported no symp-
toms, all of whom had visible elements of the primary
complex only.
The main study limitation is the fact that it was not
primarily designed to evaluate the value of symptom-based
screening compared with CXR-based screening. We based
our conclusion on an analysis of all children treated for
tuberculosis, which provides an indication of whether chil-
dren with tuberculosis would have been missed by symptom-
based screening. In addition, very few children were HIV-
infected, and not many of the actively traced contacts were
tested for HIV infection.
Further investigation is required to determine whether
symptom-based screening are justified in resource-limited,
endemic settings to improve access to preventive chemother-
apy. A symptom-based approach would provide preventive
chemotherapy to all asymptomatic high risk contacts, while
symptomatic children (cough, wheeze, fever or failure to
thrive) would require further investigation to exclude tuber-
culosis. Whether 6–9 months of isoniazid monotherapy or
shorter durations of multidrug therapy represent the optimal
preventive regimen in these settings also require further
investigation.
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Background: Diagnosis of childhood tuberculosis is problematic and symptom based diagnostic
approaches are often promoted in high burden settings. This study aimed (i) to document the prevalence
of symptoms associated with tuberculosis among randomly selected children living in a high burden
community, and (ii) to compare the prevalence of these symptoms in children without tuberculosis to those
in children with newly diagnosed tuberculosis.
Methods: A cross sectional, community based survey was performed on a 15% random sample of
residential addresses. A symptom based questionnaire and tuberculin skin test (TST) were completed in all
children. Chest radiographs were performed according to South African National Tuberculosis Control
Program guidelines.
Results: Results were available in 1415 children of whom 451 (31.9%) were TST positive. Tuberculosis was
diagnosed in 18 (1.3%) children. Of the 1397 children without tuberculosis, 253 (26.4%) reported a
cough during the preceding 3 months. Comparison of individual symptoms (cough, dyspnoea, chest pain,
haemoptysis, anorexia, weight loss, fatigue, fever, night sweats) in children with and without tuberculosis
revealed that only weight loss differed significantly (OR =4.5, 95% CI 1.5 to 12.3), while the combination
of cough and weight loss was most significant (OR=5.4, 95% CI 1.7 to 16.9). Children with newly
diagnosed tuberculosis reported no symptoms in 50% of cases.
Conclusion: Children from this high burden community frequently reported symptoms associated with
tuberculosis. These symptoms had limited value to differentiate children diagnosed with tuberculosis from
those without tuberculosis. Improved case definitions and symptom characterisation are required when
evaluating the diagnostic value of symptoms.
I
n areas with a high prevalence of tuberculosis, children
contribute a significant proportion of the disease burden
and experience considerable morbidity and mortality
related to tuberculosis.1 2 This is demonstrated by the fact
that pulmonary tuberculosis rivals bacterial pneumonia as a
respiratory cause of death in African children older than
6 months of age.3 The diagnosis of tuberculosis in children is
difficult because bacteriological confirmation is rarely
achieved and is often not even attempted.4–8 Chest radio-
graphy is regarded as a valuable diagnostic tool, but it is often
impossible to identify hilar adenopathy, considered to be the
most consistent sign of primary pulmonary tuberculosis, with
certainty.9 In addition, the distinction between recent
primary infection and active disease is highly problematic.10
Most diagnostic algorithms are partly symptom based, but
these algorithms are poorly validated and lack standard
symptom definitions.11
To our knowledge, no previous study has documented the
prevalence of symptoms associated with tuberculosis in
randomly selected children living in a high burden commu-
nity. In these communities a large number of individuals
become infected with Mycobacterium tuberculosis (M tubercu-
losis) during childhood,12 and symptom based diagnostic
approaches are often promoted to screen children for active
tuberculosis. The literature on tuberculosis related sympto-
matology in children is almost exclusively hospital based,
which does not reflect the prevalence of symptoms in the
general population.
A recent review of studies from the pre-chemotherapy
era documented the natural history of tuberculosis in
childhood.10 It confirmed that immune competent children,
older than 2 years of age, are at low risk of disease
progression following primary infection.10 The presence of
symptoms associated with tuberculosis had definite diag-
nostic value in these low risk children, in whom the principal
diagnostic challenge was to distinguish self contained
infection from progressive disease.10
The aims of this community based study were (i) to
document the prevalence of symptoms associated with
tuberculosis among randomly selected children living in a
high burden community, and (ii) to compare the prevalence
of these symptoms in children without tuberculosis to those
in children with newly diagnosed tuberculosis.
METHODS
A cross sectional community based survey was carried out
between July and December 2002. A questionnaire was
completed and a tuberculin skin test (TST) administered to
each child (,15 years of age). Chest radiographs (CXR) were
performed according to the South African National
Tuberculosis Control Program (NTCP) guidelines.
Study setting
The study area is an established epidemiological field site in
Cape Town, South Africa, comprising two suburbs with a
population of 38 656 (census 1996) and a high burden of
Abbreviations: CI, confidence interval; CXR, chest radiograph; HIV,
human immunodeficiency virus; NTCP, National Tuberculosis Control
Program; OR, odds ratio; TST, tuberculin skin test; TU, tuberculin units
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tuberculosis (average notification rate of new bacteriologi-
cally confirmed cases 320/100 000 per year).13 Childhood
tuberculosis constitutes a high percentage (39%) of the total
caseload.14 The proportion of the population infected with
human immunodeficiency virus (HIV) is relatively low, less
than the average of 8.8% (95% CI 4.9 to 12.7%) calculated for
the Cape Town/Metropole region in 2001.15
Sample selection
A 15% sample of residential addresses was randomly selected,
based on a geographical information system of the area.
Trained field workers enumerated the people at each of the
839 residential addresses selected. Written informed consent
was obtained from the parent or legal guardian. The 218
addresses (26%) that refused consent were systematically
replaced by neighbouring addresses. A CXR was performed in
children less than 5 years of age who had been in household
contact with a sputum smear positive source case or had a
positive TST (induration >15 mm in diameter), and in all
children with suspect symptoms according to World Health
Organisation guidelines (loss of weight, cough .3 weeks,
fever .1 week, or haemoptysis).16
Questionnaire
A standard questionnaire recorded symptoms that are
commonly associated with tuberculosis, experienced during
the preceding 3 months (table 1). The duration of each
symptom (other than haemoptysis) was categorised as less
than 1 week, 1–2 weeks, 2–3 weeks, or more than 3 weeks.
Questionnaires were completed by the parent under super-
vision of a trained field worker. Parents were requested (but
put under no obligation) to confidentially report previous
HIV tests and results.
Tuberculin skin test
Trained field nurses performed TST by intra-dermal injection
of 2 tuberculin units (TU) ofM tuberculosis PPD RT 23 (Statens
Serum Institut, Copenhagen, Denmark) on the volar aspect of
the left forearm. The largest transverse diameter of indura-
tion was measured after 48–72 h.
Chest radiograph
Standard antero-posterior (AP) and lateral views were taken,
using the same x ray machine in all children. A single expert
screened all CXR. A second independent expert was used to
confirm that the radiographical signs were suggestive of
tuberculosis in all children identified with possible tubercu-
losis during the initial screening. Children with confirmed
radiographical signs suggestive of tuberculosis had sputum or
gastric aspirate samples taken for culture.
A probable tuberculosis case was defined as a child with a
‘‘diagnostic’’ CXR, confirmed by two independent observers
(modified WHO guidelines).17 A confirmed tuberculosis case
was defined as a child with bacteriological proof of
tuberculosis. All children with probable or confirmed
tuberculosis were referred to a local clinic for treatment, in
accordance with the NTCP guidelines. Children aged less
than 5 years, in household contact with a sputum smear
positive source case or with a positive TST, were referred for
chemoprophylaxis or treatment of latent infection after active
tuberculosis was excluded. The study was approved by the
Ethics Review Board of Stellenbosch University and by the
Department of Health, City of Cape Town.
Statistical analysis
Data analyses were carried out with SPSS for Windows
version 11.0. The frequencies of symptoms and specific
symptom durations were compared between age groups,
and TST positive and TST negative children, as well as
between those with newly diagnosed tuberculosis and those
without. Comparisons were performed by using the Mantel-
Haenszel x2 test. The two sided Fisher’s exact test was used to
determine the p values.
Table 1 Questionnaire
1) Did your child experience a daily cough in the preceding 3 months?
What was the duration of daily cough?
2) Did your child experience any breathing difficulty in the preceding
3 months?
What was the duration of difficult breathing?
3) Did your child experience any chest pain in the preceding 3 months?
What was the duration of chest pain?
4) Did your child cough up any blood in the preceding 3 months?
5) Did your child experience any deterioration in appetite in the
preceding 3 months?
What was the duration of appetite loss?
6) Did your child lose any weight in the preceding 3 months?
What was the duration of weight loss?
7) Did your child experience any abnormal lethargy/fatigue in the
preceding 3 months?
What was the duration of abnormal fatigue/lethargy?
8) Did your child experience daily or recurrent fever in the preceding
3 months?
What was the duration of daily or recurrent fever?
9) Did your child experience night sweats in the preceding 3 months?
What was the duration of night sweats?
Once a specific symptom was reported the duration was specified as: a)
less than 1 week; b) 1–2 weeks; c) 2–3 weeks; or d) more than 3 weeks.
Table 2 Demographics of all children enrolled
(n = 1415)
Total number (%)
Gender
Male 709 (50.1)
Female 706 (49.9)
Age distribution in years
,2 188 (13.2)
2–4 243 (17.2)
5–9 508 (35.9)
10–14 476 (33.7)
TST positive (>15 mm in diameter) 451 (31.9)
Age distribution of TST positive children in years
,2 35 (2.5)
2–5 42 (3.0)
5–10 164 (11.6)
10–14 210 (14.8)
HH contact with an adult source case ever 201 (14.2)
Recent HH contact with an adult source case 53 (3.7)
CXR done 239 (16.9)
CXR suggestive of tuberculosis 18 (1.3)
The total number of children enumerated was 1593 of whom 1415
(88.8%) were enrolled. CXR, chest radiograph; HH, household; Recent
HH contact, household contact with a sputum smear positive source case,
currently on treatment; TST, tuberculin skin test.
Table 3 Disease characteristics in the children with
newly diagnosed TB (n =18)
Characteristics Number (%)
TST >15 mm in diameter 17 (94.4)
Type of disease on CXR
Elements of the Ghon complex only 15 (83.4)
Parenchymal consolidation (apart from 1 (5.5)
the Ghon focus)
Parenchymal cavities 2 (11.1)
Bacteriological proof (culture positive) 2 (11.1)
TB, bacteriological confirmation or definite radiological signs with proof
of M tuberculosis infection; TST, tuberculin skin test.
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RESULTS
In total, 1593 children were enumerated at the selected
addresses. Questionnaire and TST results, available in 1415
(88.9%) children, were included in the analysis. Table 2
summarises the demographic characteristics of the whole
group. A positive TST was recorded in 451 (31.9%) children.
Seventy five children reported previous HIV testing, with only
one reporting a positive test result. CXR were performed in
239 (16.9%) children, applying current NTCP guidelines. The
main reasons for performing the CXR were as follows: (i) 177
(74.1%) ,5 years of age with household contact ever, (ii) 33
(13.8%) ,5 years of age and with TST >15 mm, and (iii) 29
(12.1%) with suspect symptoms. Eighteen (1.3%) children
were newly diagnosed with probable or confirmed tubercu-
losis. Table 3 summarises the disease characteristics (type of
disease) in these 18 children. Bacteriological confirmation (a
positive M tuberculosis culture) was achieved in two cases
(11.1%). None of the children with newly diagnosed
tuberculosis had clinical signs suggestive of HIV disease.
Table 4 describes the demographics of the 1397 children
without tuberculosis, compared to the 18 children with newly
diagnosed tuberculosis. Most children with newly diagnosed
tuberculosis (14; 77.8%) were less than 5 years of age.
Household contact with a recent sputum smear positive
source case was reported in three (16.7%) children with
newly diagnosed tuberculosis, compared to 50 (3.6%)
children without tuberculosis (OR=5.4; 95% CI 1.5 to
19.2). The TST result was equal to or greater than 15 mm
(median 17 mm; range 0–31 mm) in all but one child with
newly diagnosed tuberculosis.
Table 5 compares the symptoms reported in children
without tuberculosis to those in children with newly
diagnosed tuberculosis. Of the 1397 children without
tuberculosis, 253 (26.4%) reported a cough during the
preceding 3 months. Prolonged symptoms were not uncom-
mon, and 66 (6.9%) reported coughing of more than 3 weeks
duration. No significant differences in symptom prevalence
or symptom duration existed between age groups (,2 years,
2–4 years, 5–9 years, 10–14 years) or between those with and
without TST proof of tuberculosis infection. Significantly
more children with newly diagnosed tuberculosis reported
weight loss in the preceding 3 months (OR=4.5, 95% CI 1.5
to 12.3). None of the other symptoms showed statistically
significant differences between the two groups, even when
the reported duration of symptoms was taken into account.
When children less than 5 years of age were analysed
separately, to correct for possible selection bias in the older
children, the results were similar.
The presence of more than one symptom increased the
odds for tuberculosis, but this reached significance only with
the inclusion of weight loss. The combination of cough and
weight loss was most significant (OR=5.4, 95% CI 1.7 to
16.9). Nine (50%) children with newly diagnosed tubercu-
losis reported no symptoms at all, compared to 910 (65.2%) of
those without tuberculosis (OR=1.9, 95% CI 0.7 to 4.7).
DISCUSSION
This community based survey documents the prevalence of
symptoms associated with pulmonary tuberculosis in the
average child living in a high burden community. The results
Table 4 Demographics of children without TB (n = 1397) compared to children with newly diagnosed TB (n =18)
Demographics No TB (%) TB (%) OR (95% CI) p value
Gender
Male 701 (50.2) 9 (50.0) 1.00 (0.4 to 2.6) 0.998
Female 696 (49.8) 9 (50.0) 1.00 (0.4 to 2.6) 0.998
Age distribution in years
,2 185 (13.2) 3 (16.7)
2–4 232 (16.7) 11 (61.1)
5–9 505 (36.1) 3 (16.7)
10–14 475 (34.0) 1 (5.5) x2 = 11.0 0.001*
HH contact with adult source case ever 195 (14.0) 5 (27.8) 2.31 (0.3 to 20.0) 0.442
Recent HH contact with adult source case 50 (3.6) 3 (16.7) 5.39 (1.5 to 19.2) 0.004**
Positive TST (>15 mm in diameter) 434 (24.0) 17 (94.4) 37.7 (5.0 to 284.4) 0.000
*p trend; **p,0.01.
CI, confidence interval; CXR, chest radiograph; HH, household; OR, odds ratio; Recent HH contact, household contact with a sputum smear positive source case,
currently on treatment; TB, bacteriological confirmation or definite radiological signs with proof of M tuberculosis infection; TST, tuberculin skin test.
Table 5 Symptoms reported in children without TB (n = 1397) during the preceding 3 months compared to symptoms reported
in those with newly diagnosed TB (n = 18)
No TB (%) TB (%) OR (95% CI) p value
Individual symptoms
1) Cough 365 (26.1) 8 (44.4) 2.3 (0.9 to 5.8) 0.080
2) Difficult breathing 150 (10.7) 1 (5.6) 0.5 (0.1 to 3.7) 0.478
3) Chest pain 77 (5.5) 0 (0.0) 1 (0.9 to 1.1) 0.305
4) Haemoptysis 7 (0.6) 0 (0.0) 1 (0.9 to 1.1) 0.763
5) Anorexia 123 (8.8) 4 (22.2) 2.9 (0.9 to 9) 0.052
6) Weight loss** 110 (7.8) 5 (27.8) 4.5 (1.6 to 13) 0.002
7) Fatigue 110 (7.8) 3 (16.7) 2.3 (0.7 to 8.2) 0.172
8) Fever 162 (11.6) 4 (22.2) 2.2 (0.7 to 6.7) 0.164
9) Night sweats 153 (10.8) 3 (16.7) 1.6 (0.4 to 5.7) 0.443
Combined symptoms
Cough and weight loss** 70 (5.0) 4 (22.2) 5.4 (1.7 to 16.9) 0.001
Cough, anorexia, and weight loss** 51 (3.7) 3 (16.7) 5.3 (1.5 to 18.8) 0.004
No symptoms 911 (65.2) 9 (50.0) 1.9 (0.7 to 4.7) 0.182
**p,0.01.
Symptoms 1) to 9): individual symptoms correlate with questions described in table 1. CI, confidence interval; OR, odds ratio; TB, bacteriological confirmation or
definite radiological signs with proof of M tuberculosis infection.
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demonstrate that within this setting, these symptoms are
common in the general paediatric population. Only weight
loss, alone or in combination with other symptoms, was
significantly more common in children with newly diagnosed
tuberculosis. Combinations of symptoms (symptom com-
plexes) were more likely to be associated with tuberculosis
than individual symptoms, but the small number of
tuberculosis cases limited the analysis. This is an inevitable
limitation of community based surveys that document
relatively rare events.18 The detection of 18 new tuberculosis
cases during this survey demonstrate a high prevalence of
undiagnosed childhood tuberculosis within this community
(1272/100 000 of the child population).
The observation that nearly a third of children coughed in
the preceding 3 months may be explained by the fact that
both viral and bacterial infections are common in this
community, especially during the winter months (May to
September). It is also common practice for children to share a
bed with their parents, which may increase parental
awareness of night time symptoms such as cough, fever, or
sweating. Similar to previous observations, some (exactly
50%) of the children with newly diagnosed tuberculosis
reported no symptoms.19–21 Although significant differences
were found between the symptoms reported in children with
tuberculosis and those without, these differences are of
limited diagnostic value and only relevant from an epide-
miological perspective. This is illustrated by the fact that the
symptom complex with the highest significance, cough and
weight loss, had a positive predictive value of only 5%.
The study had several limitations; of most importance is
the fact that CXR were performed on a selective subgroup of
children. Only children under 5 years of age were radiologi-
cally screened following household exposure or a positive TST
and as a result older children with asymptomatic primary
infection may not have been diagnosed. Although this could
have biased the results, the statistical findings in children less
than 5 years of age and in the group as a whole were similar
when comparing symptoms in those with and without
tuberculosis. This potential bias seems unavoidable as both
the WHO and NTCP guidelines recommend that a CXR
should only be performed in older children if they are
symptomatic. It may even be argued that it is unethical to
perform a CXR in an asymptomatic child older than 5 years
of age, as the risk of developing disease following primary
infection is less than 1%.10 The group diagnosed with
tuberculosis during this survey represents a true reflection
of children who would have been diagnosed with tubercu-
losis in a ‘‘real life’’ setting, where resources permit active
contact tracing and adequate investigation.
The majority of children diagnosed with tuberculosis had
signs indicative of recent primary infection only (positive TST
and elements of the Ghon complex on CXR). The natural
history of tuberculosis in children illustrates that following
primary pulmonary infection, transient visibility of the Ghon
complex is common and does not necessarily indicate
disease.10 22 23 The fact that current, internationally accepted
definitions of disease often reflect recent primary infection,
especially in children who are diagnosed after active contact
tracing, does hamper the interpretation. Therefore, it is
important to point out that, although the study indicates that
symptoms have limited diagnostic value, their value for
differentiating active disease from recent primary infection
requires further investigation.
Questionnaire driven surveys are inherently limited by
recall bias and subjectivity. Bias was reduced by the use of
standardised questionnaires and the fact that the diagnostic
tests (TST and CXR) were performed after completion of the
questionnaire. Reported weight loss reflected a subjective
impression and objective weight measurements were not
taken into account, as these were not routinely done in all
children. In addition, the questions used may have been too
imprecise, as the pre-chemotherapy literature identifies
important symptom characteristics, associated with progres-
sive tuberculosis, that were not elucidated in the present
study. These characteristics include persistent, non-remitting
symptoms of recent onset.10 Careful symptom characterisa-
tion may be essential to improve their diagnostic value.
Nearly a third (5, 27.8%) of children with newly diagnosed
tuberculosis reported previous household contact with a
sputum smear positive source case. This is in agreement with
a study from the same community that employed restriction
fragment length polymorphism (RFLP) analysis, providing
proof that 34% of children acquired disease following
infection from a source case within the household.24 In high
burden settings, most infection, particularly in children older
than 2 years of age, is contracted outside the household
within the community.9 13 24
In conclusion, this study illustrates the importance of
community based research. It describes symptomatology
within the general community and highlights the danger of
extrapolating findings from hospital based studies to the
community level. It is essential to know the prevalence of
symptoms within the general community in order to evaluate
the value of any particular symptom based diagnostic
approach. Comparing the symptoms reported in children
without tuberculosis to those in children with newly
diagnosed tuberculosis demonstrates why current symptom
based scoring systems perform poorly in clinical practice.
Most importantly, the study emphasises the need for
improved symptom characterisation and accurate outcome
definitions which will adequately differentiate M tuberculosis
infection from active disease.
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What is already known about this topic
N No previous community based report has described the
prevalence of symptoms traditionally associated with
tuberculosis in randomly selected children from a high
burden community; hospital based reports are limited
by selection bias.
N There is a need to reassess the value of symptom based
approaches for the diagnosis of childhood pulmonary
tuberculosis, especially in high burden settings with
limited resources; current symptom based diagnostic
algorithms are poorly validated.
What this study adds
N This is the first report describing the prevalence of
symptoms traditionally associated with tuberculosis in
the average child from a high burden community.
N This study indicates that poorly defined symptoms,
traditionally associated with tuberculosis, are too
common in children from these communities to be of
real diagnostic value.
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Paternal postnatal depression
M
uch has been written about maternal postnatal depression: it affects the quality of
infant care and may lead to problems with the child’s later social, behavioural,
cognitive, and physical development. By contrast, fathers have been relatively
ignored. Data from the Avon Longitudinal Study of Parents and Children (ALSPAC) in
southwest England have been used to measure the effects on children of paternal depression
in the postnatal period (Paul Ramchandani and colleagues. Lancet 2005;365:2201–5; see also
Comment, ibid: 2158–9).
ALSPAC recruited 85–90% of all women in the Bristol area with an expected date of
delivery between 1 April 1991 and 31 December 1992. Questionnaires were sent 8 weeks
postnatally to 13351 mothers and 12 884 partners. Data on postnatal depressive symptoms
were available for 11 833 mothers and 8431 fathers. Depression (a score of .12 on the
Edinburgh postnatal depression scale (EPDS)) was diagnosed in 1203 mothers (10%) and
303 fathers (4%). Fathers were reassessed at 21 months and behavioural and emotional
problems in the children were assessed at 3.5 years using maternal reports on the Rutter
revised preschool scales.
There was a significant correlation between maternal and paternal EPDS scores. Maternal
postnatal depression increased (by factors of two or three) the likelihood of high total Rutter
scale scores and of high subscale scores for emotion, conduct, and hyperactivity, in the
children. There was a smaller increase in prosocial subscale scores. Paternal depression
increased (by factors of 1.5–2) total, emotional, conduct, and hyperactivity scores. On
controlling for social class, education, and maternal depression, paternal depression was still
associated with high total, conduct and hyperactivity, but not emotional, scores. After
controlling for paternal depression at 21 months after the birth, there was still a significant
association between paternal postnatal depression and high conduct and hyperactivity
subscale scores in the children. While maternal postnatal depression was associated with
increased Rutter scale scores in both sexes, paternal depression was associated with
increased scores only in boys, particularly for conduct problems.
Postnatal depression in fathers seems to have an adverse effect on their sons at age 3K
years, in particular affecting their behaviour.
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Well defined symptoms are of value in the diagnosis
of childhood pulmonary tuberculosis
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Background: The diagnosis of childhood pulmonary tuberculosis presents a major challenge as symptoms
traditionally associated with tuberculosis are extremely common in children from endemic areas. The
natural history of tuberculosis in children shows that progressive disease is associated with symptoms
which have a persistent, non-remitting character. The aims of this study were to investigate whether
improved symptom definition is possible in a clinical setting, and whether use of these well defined
symptoms has improved value in the diagnosis of childhood pulmonary tuberculosis.
Methods: A prospective, community based study was conducted in two suburbs of Cape Town, South
Africa. All children (,13 years) presenting to the local community clinic with a cough of .2 weeks
duration, were referred to the investigator. Parents completed a symptom based questionnaire, whereafter
reported symptoms were characterised in a standard fashion.
Results: Of the 151 children enrolled, 21 (15.6%) reported symptoms with a persistent, non-remitting
character. Tuberculosis was diagnosed in 16 (10.5%) children, all of whom reported these symptom
characteristics. A persistent, non-remitting cough was reported in 15/16 (93.8%) children with
tuberculosis and in 2/135 (1.5%) children without tuberculosis, indicating a specificity of 98.5% (135/
137). Persistent fatigue of recent onset was also sensitive (13/16, 81.3%) and specific (134/135, 99.3%).
Persistent fever and/or chest pain were exclusively reported in children with tuberculosis, but were present
in only 4/16 (25.0%) children with tuberculosis.
Conclusion: The use of well defined symptoms is feasible, even in resource limited settings, and may offer
significantly improved value in the diagnosis of childhood pulmonary tuberculosis.
T
he diagnosis of childhood pulmonary tuberculosis pre-
sents a major challenge, because bacteriological con-
firmation is rarely achieved and radiological signs are
often difficult to interpret.1–3 Various symptom based
diagnostic approaches have been developed, but these were
mostly based on clinical experience and lack proper valida-
tion.4
Hospital based studies have reported widely varying results
regarding the utility of a symptom based approach for the
diagnosis of childhood pulmonary tuberculosis.5–7 However,
the selection bias inherent to these hospital based studies
limits extrapolation to the community level. To our knowl-
edge, only one study has documented the prevalence of
symptoms traditionally associated with tuberculosis, such as
a prolonged cough, night sweats, subjective weight loss, etc,
in a random selection of children from an endemic area.8 This
community based survey found that these poorly defined
symptoms were extremely common, even in children without
tuberculosis.8
This finding prompted a careful re-evaluation of the
symptoms associated with tuberculosis in children, which
are best documented in the pre-chemotherapy literature that
described the natural history of tuberculosis in children.9
According to this literature, children can be categorised into
two main risk groups: high risk children (,3 years of age
and/or immune compromised children) and low risk children
(immune competent children >3 years of age).9 In low risk
children, progressive disease following primary infection with
Mycobacterium tuberculosis was rare and was associated with
persistent, non-remitting symptoms.9 In high risk children,
progressive disease occurred more frequently, but symptoms
were also persistent and non-remitting, and sometimes had a
more acute onset.9 In the vast majority of children (.95%),
disease progression occurred within 12 months of primary
infection.9 10 Careful review of these disease descriptions from
the pre-chemotherapy literature identified previously unex-
plored symptom characteristics that may improve symptom
specificity, namely persistent and non-remitting symptoms of
recent onset.
The aims of this study were to investigate whether improved
symptom definition is possible in a clinical setting, and whether
the use of these well defined symptoms has improved value in
the diagnosis of childhood pulmonary tuberculosis.
METHODS
A prospective, community based study was conducted from
September through December 2003 in Cape Town, South Africa.
Setting
The study community is adjacent to the community where
the previous symptom survey was carried out.8 These
communities are similar as regards ethnic and socio-
economic parameters,11 high tuberculosis incidence (.300/
100 000 new smear positive cases per year), and relatively
low prevalence of HIV infection (,8%).12
Study population
All children under the age of 13 years who presented to the
local clinic with a cough of more than 2 weeks duration, not
responding to first line antibiotic therapy (5 days of oral
amoxacillin), were referred to the investigator. A standard
symptom based questionnaire was completed and reported
symptoms were individually characterised. A tuberculin skin
test (TST) and chest radiograph (CXR) were performed in all
children.
Abbreviations: CXR, chest radiograph; PCR, polymerase chain
reaction; TST, tuberculin skin test
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Questionnaire
The questionnaire was identical to that used in the previous
community based symptom survey.8 Parents were asked
about the presence and duration of symptoms during the
previous 3 months, including cough, shortness of breath,
chest pain, haemoptysis, fever, fatigue, night sweats,
anorexia, and weight loss. Reported symptoms were then
characterised in a standard fashion to identify those with a
persistent, non-remitting character.
Symptom characterisation
Parents were asked the following standard questions to
characterise reported symptoms: (i) Is your child sympto-
matic at present? and (ii) What is/was the uninterrupted
symptom duration? This allowed differentiation between
persistent, non-remitting symptoms and those that resolved
spontaneously (without specific anti-tuberculosis treatment).
Children not diagnosed with tuberculosis after initial screen-
ing were treated according to the most likely alternative
diagnosis and followed up after 2–4 weeks. If symptoms
persisted beyond 4 weeks of follow up, a repeat TST and CXR
were performed. The uninterrupted symptom duration, until
spontaneous symptom resolution or the onset of anti-
tuberculosis chemotherapy, was recorded in weeks.
In addition, three distinct cough patterns were differen-
tiated: (i) acute cough with delayed recovery, (ii) recurrent
acute cough, and (3) persistent, non-remitting cough (fig 1).
Parents were shown a graphic illustration of these three
cough patterns and requested to identify the pattern that best
described their child’s condition. Questions were piloted in
the community prior to the onset of the study.
Weight loss
Both subjective (reported) and objective weight loss were
recorded. Objective weight loss was defined as crossing at least
one centile line in the preceding 3 months or the loss of more
than 10% of bodyweight (minimum 1 kg) over any time
interval.
Tuberculin skin test
A TST, using intra-dermal injection of 2 tuberculin units of M
tuberculosis PPD RT 23 (Statens Serum Institut, Copenhagen,
Denmark) was performed on the volar aspect of the left
forearm. The largest transverse diameter of induration was
measured after 48–72 h.
Chest radiograph
Standard antero-posterior and lateral views were taken. Two
independent experts, blinded to all clinical information,
evaluated the CXRs and documented their findings on a
standard report form.
M tuberculosis culture
Children with a CXR suggestive of tuberculosis had sputum
or gastric aspirate samples taken for culture. Samples were
inoculated into Bactec 12B liquid medium (Becton Dickinson,
Sparks, MD, USA). Positive cultures were confirmed as
M tuberculosis by polymerase chain reaction (PCR).
Definitions used for clinical diagnoses
Probable tuberculosis was defined as a CXR indicative of
tuberculosis, confirmed by two independent experts. Where
the two objective experts disagreed, a third expert made the
final decision. Confirmed tuberculosis was defined as
isolation of M tuberculosis on culture. Viral infection was
defined as a transient runny nose and/or fever at symptom
onset, no clinical response to antibiotics, and no CXR signs
suggestive of tuberculosis. Asthma was defined as recurrent
cough episodes together with current and/or exercise induced
wheeze with bronchodilator response, without CXR signs
suggestive of tuberculosis.
Children diagnosed with probable or confirmed tubercu-
losis received anti-tuberculosis treatment and were offered a
rapid HIV test (Determine HIV1/2; Abbott, Wiesbaden-
Delkenheim, Germany) after appropriate counselling. All
children not treated for tuberculosis were monitored for a
period of 6 months to exclude subsequent treatment for
tuberculosis. The study was approved by the Ethics Review
Board of Stellenbosch University, the City of Cape Town
Health Department, and local health committees.
Statistical analysis
Statistical analysis was carried out with SPSS for Windows
version 11.0 (SPSS, Chicago, IL, USA). Symptom frequencies
and symptom characteristics were compared between age
groups and between different clinical diagnoses.
Comparisons were performed using the Mantel-Haenszel x2
test and Fisher’s exact test to determine two sided p values.
RESULTS
Of 156 referred children, 151 (96.8%) were enrolled in the
study. Four children did not turn up for evaluation and study
participation was refused in one child. A questionnaire and
TST was completed in all 151 children and a CXR in 129
(85.4%). The 22 children who did not receive a CXR, all
reported spontaneous symptom resolution before evaluation
by the investigator. Table 1 describes the demographics and
clinical diagnoses; 102 (67.6%) children were less than
5 years of age, viral infection (100, 66.2%) and asthma (24,
15.9%) were the most frequent clinical diagnoses.
Viral infection was the most common diagnosis in all age
groups, particularly in children less than 2 years of age (45/
54, 83.3%). The frequency of asthma peaked in the 5–9 year
age group (16/38, 42.1%), where it rivalled viral infection as
the most common clinical diagnosis. Tuberculosis was
diagnosed in a total of 16/151 (10.6%) children, of whom
nine (56.2%) were less than 5 years of age. The two radiology
experts disagreed in two cases judged to have tuberculosis;
one had culture confirmation, while the other was less than
2 years of age, had a TST of 18 mm, and showed excellent
clinical response to treatment. Bacteriological confirmation
was achieved in 10/16 (62.5%) children with tuberculosis.
The bacteriological yield was highest in children with
cavitating disease (4/4, 100%) and in those with alveolar
consolidation (4/6, 66.7%). None of the children had clinical
signs indicative of AIDS. All 16 diagnosed with tuberculosis
were tested for HIV and none were HIV infected.
Figure 2 shows the association between specific cough
patterns and clinical diagnoses. An acute cough with delayed
recovery was most common in children under 2 years of age
and was associated with a diagnosis of viral infection.
Recurrent acute cough
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Figure 1 Differentiated cough patterns.
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Recurrent cough episodes were most common in children
aged 2–10 years, and were associated with either recurrent
viral infections or asthma. A persistent, non-remitting cough
was uncommon in all age groups and was almost exclusively
(16/18, 88.9%) associated with tuberculosis. Only two
children without tuberculosis reported a persistent cough
beyond 4 weeks of follow up. One was a previous premature
baby with bronchiectasis whose symptoms were not of recent
(,12 months) onset, and the other a child with atypical
pneumonia in whom the cough resolved over a period of
2 months. No child who reported spontaneous symptom
resolution was diagnosed with tuberculosis in the 6 months
subsequent to the study.
Table 2A shows the frequency of the five most relevant
symptoms (cough, chest pain, weight loss, fatigue, and fever)
in children with and without tuberculosis. In agreement with
the inclusion criteria, all children reported a cough.
Additional symptoms were common: chest pain (33,
21.9%), weight loss (40, 26.5%), fatigue (37, 24.5%), and
fever (50, 33.1%). Only weight loss and fatigue were
significantly more frequent in children with tuberculosis.
The results for difficult breathing, haemoptysis, poor appetite
(anorexia), and night sweats are not reported as parents
showed variable symptom interpretation. Difficult breathing
was interpreted as either dyspnoea at rest or exercise induced
wheezing. Haemoptysis was uncommon, being reported in
only two children, neither of whom had tuberculosis, but it
was frequently confused with nose bleeds or haematemesis.
Night sweats were frequently reported (37/151, 24.%),
especially in children less than 2 years of age (20/54, 37%)
who shared a bed with their parents; it was generally not
associated with a tuberculosis diagnosis.
Table 2B focuses on symptoms of recent onset with a
persistent, non-remitting character. These well defined
symptoms were uncommon: cough (16, 10.6%), chest pain
(4, 2.6%), objective weight loss (9, 6.0%), fatigue (14, 9.3%),
and fever (4, 2.6%), and were all significantly associated with
tuberculosis. A persistent, non-remitting cough was reported
in 15/16 (93.8%) children with tuberculosis and in 2/135
(1.5%) children without tuberculosis, indicating a specificity
of 98.5% (135/137). Persistent fatigue of recent onset was
also sensitive (13/16, 81.3%) and specific (134/135, 99.3%).
Persistent fever and/or chest pain were exclusively reported in
children with tuberculosis but were present in only 4/16
(25.0%) children with tuberculosis, two of whom had a
pleural effusion.
DISCUSSION
The results of this study demonstrate that it is possible to
identify symptoms with a persistent, non-remitting character
at primary health care level, even in resource limited settings.
It may be difficult to distinguish between the different cough
patterns at the initial evaluation, but clinical follow up after
2–4 weeks proved to be a valuable diagnostic tool. Only two
children without tuberculosis reported a non-remitting cough
that persisted beyond 2–4 weeks of follow up.
Table 1 Demographics and clinical diagnoses of all
children enrolled (n = 151)
Number (%)
Demographics
Gender
Male 79 (52.3)
Female 72 (47.7)
Age
,2 years 54 (35.8)
2–4 years 48 (31.8)
5–9 years 38 (25.2)
10–12 years 11 (7.2)
Clinical diagnoses
Viral infection 100 (66.2)
Bacterial infection (good antibiotic response) 10 (6.6)
Asthma 24 (15.9)
Tuberculosis 16 (10.6)
Other 1 (0.7)
A total of 156 children were referred of whom 151 (96.8%) were
enrolled.
Table 2 Symptoms reported in children without TB compared to children with TB
Symptoms No TB (n = 135) TB (n = 16) OR (95% CI) p value
A. Symptoms reported in children without TB compared to children with TB
Cough 1335 (100%) 16 (100%) NA NA
Chest pain 29 (21.8%) 4 (25.0%) 1.2 (0.4–4.1) 0.752
Weight loss 30 (22.6%) 10 (62.5%) 5.8 (2.0–17.4) 0.001
Fatigue 23 (17.3%) 14 (87.5%) 34.1 (7.3–160.3) ,0.001
Fever 45 (33.8%) 5 (31.3%) 0.9 (0.3–2.8) 1.000
B. Persistent, non-remitting symptoms reported in children without TB compared to children with TB
Cough 2 (1.6%) 15 (93.8%) 2010.0 (119.5–33812.9) ,0.001
Chest pain (confirmed by child) 0 (0.0%) 4 (25.0%) NA ,0.001
Weight loss (objective) 3 (2.6%) 6 (37.5%) 25.0 (3.4–184.5) 0.001
Fatigue 1 (0.8%) 13 (81.3%) 580.7 (56.3–5990.1) ,0.001
Fever 0 (0.0%) 4 (25.0%) NA ,0.001
CI, Confidence interval; OR, odds ratio; NA, not applicable (2A: all children coughed; 2B: no children without TB reported persistent chest pain or fever); TB,
tuberculosis.
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Figure 2 The frequency of specific cough patterns associated with
different clinical diagnoses (n = 151).
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In this study, well defined symptoms had excellent
diagnostic value. Both a persistent cough and/or persistent
fatigue of recent onset were highly sensitive and specific.
Persistent chest pain, confirmed by the child, was the
presenting symptom in both children with tuberculous
pleural effusion, which correlates with the typical clinical
picture described in children with this disease manifestation,9
although it was present in only 25% of all children diagnosed
with tuberculosis. Subjective and objective weight loss
showed poor correlation with each other, but both were
significantly associated with tuberculosis. In endemic tuber-
culosis settings, the diagnostic value of weight loss may be
enhanced by first eliminating other common causes of poor
weight gain, such as worm infestation and food insecurity.
The study had several limitations. It was questionnaire
driven and thus subject to recall bias and reporter sub-
jectivity. Recall bias was limited by focusing on current
symptoms. Reporter subjectivity was reduced by standard
symptom characterisation. Investigator bias was limited, as
symptom characterisation was done before the TST or CXR
results were known. The study population was a very select
group; only those presenting with a cough of more than
2 weeks duration, not responding to first line antibiotics,
were recruited. The use of a therapeutic trial of broad
spectrum antibiotics is widely advocated,13 14 but is contro-
versial, as patients with tuberculosis may show some
symptomatic response, and anti-tuberculosis treatment of
infectious patients may be delayed.14–16 However, first line
antibiotics should not lead to complete symptom resolution
in children with tuberculosis. In this study, antibiotics were
given before referral and thus did not prolong diagnostic
delay. Furthermore, none of the children with complete
symptom resolution required anti-tuberculosis treatment in
the subsequent 6 months, indicating that they did not have
tuberculosis.
In conclusion, the use of well defined symptoms is feasible,
even in resource limited settings, and may offer significantly
improved value in the diagnosis of childhood pulmonary
tuberculosis. A large prospective, community based study is
required to validate the diagnostic value of this symptom
based approach.
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What this study adds
N Well defined symptoms, including only persistent, non-
remitting symptoms of recent onset, are uncommon
and offers potentially excellent diagnostic value in HIV
uninfected children in high burden tuberculosis settings
N Prospective, community based studies are required to
validate the diagnostic value of these well defined
symptoms in communities with a high burden of
tuberculosis
What is already known about this topic
N Current symptom based diagnostic algorithms are
poorly validated; symptoms traditionally associated
with tuberculosis are too common in children from high
burden communities to be of real diagnostic value
N There is a need to reassess the value of symptom based
approaches for the diagnosis of childhood pulmonary
tuberculosis, especially in high burden settings with
limited resources
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Abstract 
Background 
The difficulty of diagnosing childhood tuberculosis contributes to the poor treatment access of 
children with tuberculosis. We determined the value of a novel symptom-based approach to 
diagnose childhood tuberculosis in a tuberculosis-endemic area.   
Methods 
A prospective, community-based study conducted in Cape Town, South Africa.  All children 
<13 years of age reporting a persistent, non-remitting cough of >2 weeks duration were 
evaluated for tuberculosis.  In addition, comprehensive disease surveillance was done to 
document the possible disadvantages of this symptom-based diagnostic approach.   
Results 
In total, 1024 children were referred for evaluation. A resolving cough was reported in 596 
(58.2%); 428 (41.8%) with persistent, non-remitting symptoms at evaluation, were 
investigated for tuberculosis.  Pulmonary tuberculosis was diagnosed in 197; 96 were 
categorized as “bacteriologically confirmed TB”, 75 as “radiologically certain TB”, and 26 as 
“probable TB”.  Combining a persistent non-remitting cough of >2 weeks duration, 
documented failure to thrive, and fatigue, provided reasonable diagnostic performance 
(sensitivity 62.6%, specificity 89.8%, PPV 83.6%) in HIV-uninfected children, but performed 
poorly in HIV-infected children (sensitivity 56.2%, specificity 61.8%, PPV 61.9%).   In the HIV-
uninfected group, the diagnostic performance was better in children 3 years (sensitivity 
82.3%, specificity 90.2%, PPV 82.3%) than in children <3 years (sensitivity 51.8%, specificity 
92.5%, PPV 90.1%).   
Discussion 
Although its performance varied within relevant risk groups, this novel symptom-based 
approach would have enabled accurate diagnosis of pulmonary tuberculosis in the majority of 
children. It offers the exciting prospect of improving antituberculosis treatment access for 
children in tuberculosis-endemic areas with limited resources.   
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Background 
Tuberculosis control programs in endemic areas place an almost exclusive emphasis on 
adults with sputum smear-positive disease, as they are the most infectious and therefore 
mainly responsible for transmission, which maintains the epidemic. However, children 
contribute a significant proportion of the global tuberculosis caseload1,2 and experience 
considerable tuberculosis-related morbidity and mortality. 3 Despite this huge disease burden, 
few children have access to antituberculosis treatment; particularly in endemic areas with 
limited resources.4 The difficulty of diagnosing childhood tuberculosis is considered one of the 
major obstacles to the provision of antituberculosis treatment to children in these areas.5,6    
 
The diagnosis of tuberculosis in children is complicated by the lack of a practical gold 
standard test.  Bacteriologic confirmation, the gold standard test used in adults is not 
considered feasible in children, as bacteriologic specimens are difficult to collect and the 
reported bacteriologic yield is low.5,6 Sputum smears, often the only test available in resource 
limited settings is positive in less than 10-15% of children diagnosed with tuberculosis; while 
confirmation by culture is achieved in only 30-40%.4,7 In the absence of a gold standard test, 
the diagnosis of childhood tuberculosis in non-endemic areas is usually based on; 1) 
exposure to an adult index case, 2) a positive tuberculin skin test (TST), and 3) the presence 
of suggestive signs on the chest radiograph.  This triad provides a fairly accurate diagnosis in 
non-endemic areas, but it has reduced value in endemic areas where exposure to 
Mycobacterium tuberculosis and/or a positive TST are both common occurrences.  
Consequently, the diagnosis of childhood tuberculosis in endemic areas rests predominantly 
on the subjective interpretation of the chest radiograph,8,9 which has well known limitations.10  
In addition, chest radiography is rarely available in areas with limited resources.  
 
Various clinical diagnostic approaches that incorporate symptoms suggestive of 
tuberculosis have been developed, but a review of these approaches emphasized the 
lack standard symptom definitions and inadequate validation.11 Descriptive hospital-based 
studies report widely variable results regarding the potential value of symptoms to 
diagnose tuberculosis in children,12,13 but the selection bias inherent to hospital-based 
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studies complicates interpretation and prevents extrapolation of these results to the 
community level.  A recent community-based survey reported that poorly defined 
symptoms traditionally associated with tuberculosis, such as a cough of >3 weeks 
duration, occurred frequently in a random selection of healthy children, demonstrating the 
limited diagnostic value of poorly defined symptoms.14 In general there is a sense of 
scepticism towards the potential value of symptom-based approaches to diagnose 
childhood tuberculosis with accuracy, and bacteriologic confirmation is considered the 
only way to establish a definitive diagnosis. 
  
However, a critical review of the natural history of childhood tuberculosis confirmed the 
potential diagnostic value of symptom-based approaches, but it also emphasized the 
importance of appropriate risk stratification.15 In low-risk children (immune competent and 
3 years), progression to disease after primary infection with M. tuberculosis was rare 
and disease was associated with persistent, non-remitting symptoms, which provided a 
window of opportunity for symptom-based diagnosis.15 In high-risk children (<2-3 years 
and/or immune compromised), progression to disease after primary M. tuberculosis 
infection occurred more frequently and was associated with more acute symptom onset,15 
reducing the opportunity and safety of establishing a symptom-based diagnosis.   
 
In a limited prospective study, the use of well-defined symptoms that incorporate the 
symptom characteristics identified from the natural history of disease (persistent, non-
remitting symptoms of recent onset) provided excellent diagnostic value.16 The diagnostic 
value of these well-defined symptoms required further validation in a prospective 
community-based study. Community-based recruitment is necessary to limit selection 
bias, while comprehensive disease surveillance is essential to document the potential 
disadvantages of such a novel symptom-based diagnostic approach.  The current study 
aimed to determine the potential value, within relevant risk groups, of using well-defined 
symptoms to diagnose pulmonary tuberculosis in children from a highly endemic area. 
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Methods 
Study setting  
A prospective, community-based study was conducted from February 2003 through January 
2005 in Cape Town, Western Cape Province, South Africa.  The incidence of all tuberculosis 
in Cape Town was 678/100 000,17 and the prevalence of human immunodeficiency virus 
(HIV) infection amongst women attending public antenatal clinics in the Western Cape 
Province was 13.1% [95% confidence interval (CI) 8.5-17.7%],18 in 2003. 
 
Five primary health care clinics, which utilize the same referral hospital (Tygerberg Children’s 
Hospital) were selected. These clinics serve impoverished urban communities, providing both 
primary health care services and supervised antituberculosis treatment. The study population 
rarely access private medical services, and children diagnosed with tuberculosis are routinely 
referred to the primary health care clinic for antituberculosis treatment.  Paediatric services 
are accessible to children <13 years of age.  
    
Study population 
Study entry criteria were defined as all children <13 years who reported a persistent, non-
remitting cough of >2 weeks duration, without response to a course of oral antibiotics.  The 
paediatric nurses within the selected clinics were trained regarding the study entry criteria and 
requested to refer all eligible children to the investigator.  The investigator visited each clinic 
twice weekly to evaluate the children that were referred. The following measures were put in 
place to ensure that all children who met the entry criteria were evaluated by the investigator; 
1) prominent notices in all the clinics, 2) clinic nurses received weekly feed-back and 
motivation from the investigator, 2) a study nurse was employed to screen all children 
admitted to the local referral hospital (Tygerberg Children’s Hospital), as some children may 
have been sent to hospital without referral to the investigator.  These hospitalised children 
were referred to the investigator by the study nurse and evaluated in the same fashion as 
those referred by the clinic nurses.   
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Data collection  
A screening questionnaire that documented the presence and uninterrupted duration of 
symptoms was completed in all children. Children who were referred, but whose symptoms 
resolved or showed marked improvement before evaluation by the investigator, were not 
investigated for tuberculosis. However, they completed a screening questionnaire and were 
followed until symptom resolution.  Children were only discharged after documented symptom 
resolution, and they were instructed to return at any time if symptoms recurred.  Referral was 
not restricted to a single episode and children were evaluated in a similar fashion in the event 
of a second referral.   
 
Initial assessment and management 
All children with persistent, non-remitting symptoms were investigated for tuberculosis. 
Investigation included; completion of a comprehensive questionnaire, weight measurement 
and assessment of the Road-to-Health growth chart for poor weight gain during the preceding 
3 months, performance of a TST and chest radiograph (CXR), and the attempted collection of 
at least one gastric aspirate and/or sputum specimen.  HIV testing was offered together with 
standard pre- and post-test counseling.    
 
Children diagnosed with tuberculosis were started on antituberculosis therapy.  Children <2 
years of age with known exposure or a positive TST, without active tuberculosis, received 
isoniazid preventative chemotherapy.  All other children were treated according to the most 
likely alternative diagnosis and reviewed after 2-4 weeks. If symptoms persisted beyond an 
additional 4 weeks; full assessment, including TST (if previously negative), CXR and 
mycobacterial cultures, were repeated.  At this time every effort was made to establish a final 
diagnosis, and antituberculosis treatment was initiated in all children in whom an alternative 
diagnosis could not be established.   The duration of uninterrupted symptoms, until 
spontaneous symptom resolution or the onset of antituberculosis chemotherapy, was 
recorded.  Children who received antituberculosis treatment were reviewed after 3 months to 
document response to therapy. 
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Comprehensive disease surveillance 
All children who received antituberculosis treatment during the period of study enrollment, and 
for an additional period of 3 months after enrollment was stopped, were documented and 
reviewed by the investigator. The same two independent experts used in the study assessed 
all chest radiographs.  Disease surveillance provided a comprehensive overview of all 
children affected by tuberculosis, irrespective of study inclusion, which allowed us to assess 
the possible disadvantages of applying this symptom-based diagnostic approach.  
 
Tuberculin skin test (TST) 
A tuberculin skin test, using intradermal injection of 2 tuberculin units of M. tuberculosis PPD 
RT 23 (Statens Serum Institut, Copenhagen, Denmark), was performed on the volar aspect of 
the left forearm. The transverse diameter of induration was measured in millimeter after 48-72 
hours. A positive TST was regarded as a measurement of 10mm in HIV-uninfected children, 
and 5mm in HIV-infected children.  
 
Chest radiograph (CXR) 
Standard antero-posterior (AP) and lateral views were done and read by two independent 
experts, blinded to all clinical information and to each other’s interpretation. Findings were 
documented on a standard report form and categorized as “certain TB, “uncertain TB” or 
“certain not TB”. Disease manifestations were classified according to a recently proposed 
radiologic classification of intra-thoracic tuberculosis.19 
 
HIV testing 
A rapid test was used to screen for HIV infection (Determine Rapid HIV test, Abbott).  All 
children with a positive rapid test result were referred to the HIV family clinic at Tygerberg 
Children’s Hospital for confirmatory tests (PCR in children <18 months and ELISA in older 
children) and clinical management.   
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Specimen collection and mycobacterial culture 
We attempted to collect at least one culture specimen from each child, but multiple specimens 
were collected from children sent to the referral hospital.  Samples were inoculated into liquid 
medium using either BACTEC or MGIT systems (Becton Dickinson, Sparks, MD, USA).  
Positive cultures were confirmed to be M. tuberculosis by routine polymerase chain reaction 
(PCR) speciation.20  
 
Definitions 
Children were categorized as; “bacteriologically confirmed TB”, “radiologically certain TB“, 
“probable TB”, or “not TB”. “Bacteriologically confirmed TB” was defined as the presence of 
acid-fast bacilli on sputum microscopy and/or M. tuberculosis cultured from a respiratory 
specimen or gastric aspirate.  “Radiologically certain TB” was defined as agreement between 
both independent experts that the chest radiograph indicated “certain TB”; in the absence of 
bacteriologic confirmation. “Probable TB” was defined as the presence of suggestive 
radiologic signs and good clinical response to antituberculosis treatment; in the absence of 
bacteriologic confirmation and radiologic certainty.  Good clinical response was defined as 
complete symptom resolution and weight gain of at least 10% of bodyweight at diagnosis, 
within 3 months of starting antituberculosis treatment.  “Not TB” was defined as spontaneous 
symptom resolution or no response to antituberculosis therapy; in the absence of 
bacteriologic confirmation or radiologic signs suggestive of tuberculosis. 
 
Pulmonary tuberculosis was defined as a symptomatic child with; 1) “bacteriologically 
confirmed TB” or 2) “radiologically confirmed TB”, or 3) “probable TB” (as defined), excluding 
isolated pleural effusion.   
 
Ethics 
Parents gave written informed consent for study participation and gave separate written 
consent for HIV testing after pre-test counselling.  Ethics approval was obtained from the 
Institutional Review Board of Stellenbosch University, the City of Cape Town Health 
Department and from local community health advisory boards.  
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Statistical analysis  
Data was dually entered into an Access relational database and validated.  Descriptive 
analyses were done using SPSS (version 13, SSPS Inc., Chicago, IL).  The sensitivity, 
specificity and positive predictive value (PPV) of individual variables were calculated.   
 
Multivariate tree regression analysis was used to identify the individual variables that 
statistically contributed most diagnostic value. For analysis purposes, two high-risk groups 
were identified; 1) HIV-uninfected children <3 years of age and 2) HIV-infected children 
irrespective of age.  HIV-uninfected children 3 years were regarded as low-risk.  The 
sensitivity, specificity and PPV were calculated for each of these relevant risk groups, when 
cumulatively combining the 3 variables that statistically contributed the most diagnostic value 
on multivariate tree regression analysis.  Results were reflected on a ROC-type curve, with 
sensitivity on the y-axis and 1-specificity on the x-axis.   
 
Results 
In total, 1024 children were referred with a cough of >2 weeks duration.  In 596 (58.2%) 
children the cough resolved or showed marked improvement before evaluation by the 
investigator; 428 (41.8%) children were enrolled with a persistent, non-remitting cough at 
evaluation, of whom 197 were diagnosed with pulmonary tuberculosis. (Figure 1)  
 
Of those diagnosed with pulmonary tuberculosis, 96 were categorized as “bacteriologically 
confirmed TB”, 75 as “radiologically certain TB”, and 26 as “probable TB”. There were no 
significant differences in age, sex or HIV-status between children with “bacteriologically 
confirmed TB” and those with “radiologically certain TB”, or “probable TB”.  Alternative clinical 
diagnoses established in the 11 children, not treated for tuberculosis, in whom a non-remitting 
cough persisted beyond 4 weeks of follow-up were; known asthmatic with viral infection (1), 
bronchiolitis with cigarette smoke exposure (2), ex-premature baby with broncho-pulmonary 
dysplasia and bronchiectasis (1), cystic fibrosis (1), lymphocytic interstitial pneumonia (LIP) 
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with bronchiectasis (2), atypical pneumonia (2), and initial viral infection with secondary 
bacterial infection (2).  
 
Table 1 reflects the demographics and clinical characteristics of all children referred for study 
participation.  Demographic variables (gender and age group) were comparable between the 
hospital and clinic recruited cohorts.  The only significant difference was the proportion of 
HIV-infected children; 19/87 (21.8%) in hospital, and 8/934 (0.9%) in the clinic (OR 21.1, 95% 
CI 8.5- 54.0). None of the other variables showed significant differences based on hospital or 
clinic recruitment.   
 
Table 2 indicates the value of individual variables to diagnose pulmonary tuberculosis at 
presentation.  A cough of >2 weeks duration was not included, as this was the entry criterion 
used.  The diagnostic value of a positive TST differed significantly between relevant risk 
groups.  The diagnostic value of a positive TST in HIV-uninfected children with pulmonary 
tuberculosis, comparing children <3 years to those 3 years, demonstrated similar sensitivity 
(81/93, 87.1% vs 75/86, 87.2%), but the specificity of a positive TST result was significantly 
better in children <3 years [44/67, 65.7% vs 65/135, 48.1%; odds ration (OR) 2.1, 95% CI 1.1-
3.9].  Comparing the diagnostic value of a positive TST in HIV-uninfected and HIV-infected 
children demonstrated that the sensitivity of the TST was significantly better in HIV-uninfected 
children (156/179, 87.2% vs 3/17, 17.6%; OR 31.6, 95% CI 7.6-151.5).  In HIV-infected 
children, a history of household contact with an adult tuberculosis index case seemed more 
sensitive (9/17, 52.9%) than a positive TST (3/17, 17.6%), but this did not reach statistical 
significance (OR 5.2, 95% CI 0.89-34.7).  There were no significant differences between the 
symptoms recorded in children with “bacteriologically confirmed TB” versus those with  
“radiologically certain TB” or “probable TB”. 
 
Table 3 reflects data from the comprehensive disease surveillance, which included all 425 
children treated for tuberculosis during the study period, irrespective of study inclusion.  Of 
the 214 children diagnosed with pulmonary tuberculosis (as defined), 197 (92.1%) met the 
study entry criteria.  Of the 17 children who did not meet the study entry criteria; 5/17 (29.4%) 
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had hilar adenopathy, all 5 were actively traced household contacts of an adult index case, 3 
were completely asymptomatic and 2 reported a cough of <2 weeks duration; 3/17 (17.6%)  
had parenchymal consolidation and/or airway compression, all reported a cough of <2 weeks 
duration, 1 was HIV- infected, 2 were HIV-uninfected and <3 years of age; 9/17 (53.0%) had 
disseminated (miliary) disease,  3 reported a cough of <2 weeks duration and 6 reported no 
cough at all, 2 were HIV-infected, 6 were HIV-uninfected <3 years and 1 was HIV-uninfected 
3 years of age.  
 
None of the children with an uncertain diagnosis at the initial assessment progressed to 
severe disease such as disseminated (miliary) disease, tuberculous meningitis (TBM) or 
cavitation, during the period of observation.  Fourteen children were referred twice, of whom 2  
were diagnosed with pulmonary tuberculosis during the second episode.  None of the children 
discharged without a tuberculosis diagnosis, were subsequently treated for tuberculosis 
during the period of surveillance, apart from the two who were referred a second time.  One 3-
month-old HIV-uninfected child presented with acute symptom onset and died in hospital from 
disseminated (miliary) disease.    
  
Figure 2 illustrates the improved specificity achieved (moving closer to 0 on the x-axis), and 
the sensitivity sacrificed (moving away from 1 on the y-axis), by cumulatively combining the 3 
variables that statistically contributed the most diagnostic value on multi-variate tree 
regression analysis.  It reflects the symptoms documented at initial presentation in all HIV-
uninfected children and in the 2 most relevant sub-groups; children <3 years and those 3 
years of age. The sensitivity used as departure point (in the top right hand corner) considered 
all children diagnosed with pulmonary tuberculosis (as defined), as identified by the 
comprehensive disease survey.   
 
Combining the 3 variables; 1) persistent, non-remitting cough of >2 weeks, which was the 
entry criterion, 2) documented failure to thrive during the preceding 3 months, and 3) fatigue, 
provided reasonable diagnostic performance in the HIV-uninfected group as a whole 
(sensitivity 62.6%, specificity 89.8%, PPV 83.6%), but it performed exceptionally well in the 
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sub-group 3 years (sensitivity 82.3%, specificity 90.2%, PPV 82.3%).   In children <3 years, 
the use of a positive TST as the third cumulative variable provided better diagnostic accuracy 
(sensitivity 67.3%, specificity 93.8%, PPV 93.2%), than fatigue (sensitivity 51.8%, specificity 
92.5%, PPV 90.1%). This was not the case in HIV-uninfected children 3 years where the use 
of a positive TST as the third cumulative variable, instead of fatigue, made little difference 
(sensitivity 69.6%, specificity 91.1%, PPV 81.8% with fatigue vs sensitivity 81.3%, specificity 
90.2, PPV 82.3% with TST).     
 
Figure 3 illustrates the diagnostic value of clinical follow-up, and the improved specificity 
achieved when using the presence of a persistent, non-remitting cough as an additional 
diagnostic criterion in HIV-uninfected children.  Children diagnosed with tuberculosis during 
the initial assessment received antituberculosis treatment; for this analysis we accepted that 
their cough would have persisted in the absence of treatment, which explains why the 
sensitivity remained fixed during this analysis.  In HIV-uninfected children 3 years, a non-
remitting cough that persisted >2 weeks after initial evaluation, improved the specificity to 
91.2% (sensitivity 98.9%, PPV 85.1%).   In those <3 years, the specificity improved to 82.6% 
(sensitivity 92.2%, PPV 88.6%) after 2 weeks of follow-up, with further improvement 98.6% 
(sensitivity 92.2%, PPV 88.6%) if a non-remitting cough persisted >4 weeks of follow-up.   
 
Figure 4 illustrates the sensitivity and specificity obtained in HIV-infected children, by 
cumulatively combining the same variables used in HIV-uninfected children; 1) persistent non-
remitting cough of >2 weeks, 2) documented failure to thrive and 3) fatigue.  The diagnostic 
performance was poor (sensitivity 56.2%, specificity 61.8%, PPV 61.9%), and the use of a 
persistent, non-remitting cough at follow-up provided little improvement in specificity; after 2 
weeks, (sensitivity 56.2%, specificity 67.8%, PPV 65.9%), after 4 weeks (sensitivity 56.2%, 
specificity 75%, PPV 77.2%).   
 
Discussion 
In this study, a simple symptom-based approach diagnosed childhood pulmonary tuberculosis 
with a high degree of accuracy, particularly in HIV-uninfected children 3 years.  It is often 
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assumed that these children, who are at lowest risk to progress to disease following primary 
infection, contribute little to the tuberculosis disease burden.  This is not true, as nearly 50% 
of pulmonary tuberculosis cases in this study were 3 years, which probably reflects the fact 
that the vast majority of children, even in highly endemic areas, become infected with 
M.tuberculosis after 2 years of age.   
 
The observation that the diagnostic value of this symptom-based approach differed between 
relevant risk groups illustrates the importance of risk stratification.  The concept of risk 
stratification is not novel; it provides the motivation behind current World Health Organization 
(WHO) guidelines to screen all children <5 years in household contact with an adult index 
case,21 but it has not been widely incorporated into clinical diagnostic approaches.  Exposure 
to, or primary infection with M.tuberculosis poses a high risk to very young and/or HIV-
infected children, as demonstrated by the fact that 11/12 (91.7%) children with parenchymal 
consolidation and/or airway compression and/or disseminated (miliary) disease, who did not 
meet the entry criteria, were either <3 years or HIV-infected. An age of <3 years was used to 
define high-risk children, as the natural history of disease demonstrated a substantial risk of 
progression to disease within 12 months, following primary M.tuberculosis during the first 2 
years of life.15,22 Particular emphasis should be placed on the provision of preventive 
chemotherapy following exposure and/or documented infection in these high-risk children.   
 
The combined presence of 3 well-defined symptoms; 1) a persistent, non-remitting cough of 
>2 weeks duration, 2) documented failure to thrive during the preceding 3 months, and 3) 
fatigue, provided good diagnostic accuracy in HIV-uninfected children 3 years.  However, the 
sensitivity of 81.0% implies that nearly 20% of pulmonary tuberculosis cases would have 
been missed at presentation.  The study demonstrates that clinical follow-up is a valuable 
diagnostic tool that may be used to identify those children missed at presentation, as 
symptom resolution occurred within 2 weeks of follow-up in >90% of HIV-uninfected children 
3 years without tuberculosis.  It has to be stated that the excellent diagnostic accuracy 
achieved in this highly endemic setting, using a combination of symptoms at presentation 
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and/or follow-up, may be much reduced in non-endemic areas where the pre-test probability 
of tuberculosis is lower.   
 
The same symptom-based diagnostic approach performed less well in HIV-uninfected 
children <3 years.  In this age group, fatigue added less diagnostic value, as it was difficult for 
parents/legal guardians to comment on its presence.  However, the presence of a persistent, 
non-remitting cough together with documented failure to thrive provided a fairly accurate 
diagnosis on its own (sensitivity 68.3%, specificity 80.1%, PPV 82.1%). This illustrates the 
importance of regular weight monitoring, at least during the first 2-3 years of life.  In our 
experience, documenting the response to simple measures such as food and/or iron 
supplementation and/or deworming, may improve the diagnostic value of weight monitoring 
considerably, as the majority of children referred with isolated weight loss responded well to 
one of these interventions.  In contrast to the situation in older HIV-uninfected children, the 
use of a positive TST as the third cumulative variable, instead of fatigue, provided improved 
specificity in children <3 years.  This is not unexpected in this highly endemic area, where the 
majority of older children would have been exposed to tuberculosis and may test TST 
positive.23  
 
As in children 3 years, the use of clinical follow-up as an additional diagnostic tool seemed to 
offer good diagnostic value, apart from the fact that more children without tuberculosis 
reported symptom persistence beyond 2 weeks of follow-up.  The majority of these children 
had a clinical diagnosis of viral bronchiolitis with household exposure to cigarette smoke.  
However, it is important to point out that in children who are at high risk to progress to disease 
following primary M.tuberculosis infection and in whom disease progression may occur 
rapidly, such as very young and/or HIV-infected children, prolonged follow-up is not advised.  
 
In HIV-infected children, this symptom-based diagnostic approach was limited by poor 
sensitivity and specificity. Three of 20 (15%) HIV-infected children with pulmonary 
tuberculosis did not report symptoms of sufficient duration to warrant study inclusion, while 
25% reported persistent, non-remitting symptoms even in the absence of tuberculosis.  A 
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positive TST was insensitive, being positive in less than 30% of HIV-infected children 
diagnosed with pulmonary tuberculosis.  The poor sensitivity of the TST in HIV-infected 
children with tuberculosis is well documented and has been shown to correlate with the 
degree of immune suppression.24 Therefore, it is important to consider alternative tests that 
are more sensitive than TST to confirm infection with M.tuberculosis are required.  New T-cell 
based assays, particularly the ELISPOT test, seem to offer improved sensitivity in HIV-
infected children with tuberculosis.25 In addition, it has been reported in HIV-infected adults 
that the performance of the ELISPOT test seems independent of the degree of immune 
suppression.26 In this study, recent household contact with an adult index case seemed to 
provide more diagnostic value than a positive TST in HIV-infected children, although the 
sensitivity and specificity remained poor and numbers were small. 
 
Study limitations include the small number of HIV-infected children enrolled, which limits our 
ability to comment on this particular group.  However, we were able to demonstrate that a 
symptom-based approach, which does not include an accurate measure of M.tuberculosis 
infection, has little diagnostic value in HIV-infected children. An the positive side, the large 
number of HIV-uninfected children provided an excellent opportunity to describe both the 
diagnostic performance and potential disadvantages of this novel symptom-based approach 
in HIV-uninfected children.  Despite the high risk of tuberculosis in HIV-infected children, the 
majority of children with tuberculosis remain HIV-uninfected, even in settings where most 
adults with tuberculosis are HIV-infected.3,27 This indicates that a symptom-based diagnostic 
approach will retain its value in HIV-endemic areas, but it emphasizes the importance of 
ascertaining a child’s HIV-status before symptom-based diagnosis is attempted.   
 
In this study, children were recruited at both primary health care clinics and at the referral 
hospital.  Hospital recruitment may have introduced some selection bias, however, the only 
significant difference between these two groups was the proportion of HIV-infected children.  
Pulmonary tuberculosis was diagnosed with different levels of certainty, but the fact that 
bacteriologic confirmation was achieved in nearly 50% of pulmonary tuberculosis cases, is a 
major strength of the study.  In addition, there were no significant differences between the 
Stellenbosch University  http://scholar.sun.ac.za 
 131
symptoms recorded in children with “bacteriologically confirmed TB” versus those with  
“radiologically certain TB” or “probable TB”.  
 
Isolated pleural effusion was excluded from the case definition as it represents a different 
pathologic mechanism and has a different prognosis.  These children presented with a very 
typical clinical picture that allowed accurate clinical diagnosis.  All 17 children with isolated 
pleural effusion presented with severe localized unilateral chest pain and intermittent fever.  
On examination the most distinctive features were an absence of acute illness or respiratory 
distress and the presence of extensive unilateral dullness on percussion 
 
In conclusion; accurate diagnosis of pulmonary tuberculosis, using a simple symptom-based 
approach, could be achieved in the majority of HIV-uninfected children in this highly endemic 
setting. Although it is difficult to generalize these results without confirmation from other highly 
endemic areas, this novel diagnostic approach offers the exciting prospect of extending 
antituberculosis treatment to children in resource-limited settings, where current treatment 
access is poor due to a perceived inability to diagnose children with tuberculosis. 
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Table 1  
Demographics and clinical characteristics of all children referred with a cough of >2 
weeks duration (n=1024) 
 
Not investigated for TB 
Resolving cough at evaluation (n=596) 
 
Number (%) 
 
Age group: <3 years 
                   3 years 
 
Gender: Male  
              Female 
 
HIV tested 
PTB 
 
     287 (48.2) 
     309 (51.8) 
 
      297 (49.8) 
      299 (50.2) 
 
0 
0 
Investigated for TB 
Persistent, non-remitting cough at evaluation (n=428) 
 
Number (%) 
 
Age group: <3 years 
                   3 years 
 
Gender: Male  
              Female 
 
HIV:  tested 
         infected 
          
TST: done 
         10mm (HIV-uninfected) 
        5mm (HIV-infected) 
   
PTB 
Relevant risk groups 
   HIV-infected 
   <3 years (HIV-uninfected) 
   3 years (HIV-uninfected) 
 
 
185 (43.2) 
243 (56.8) 
 
225 (52.6) 
203 (47.4) 
 
297 (69.4) 
37/297 (12.5) 
 
421 (98.4) 
226/384 (58.8) 
6/37 (16.2) 
 
197 (46.0) 
 
17/197 (8.6) 
94/197 (47.7) 
86/197 (43.6) 
 
 
TB – tuberculosis 
PTB – pulmonary tuberculosis defined as a symptomatic child with; 1) “bacteriologically 
confirmed TB” (from a respiratory or gastric aspirate specimen), or 2)“radiologically confirmed 
TB”, or 3) “probable TB” (as defined), excluding isolated pleural effusion.   
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Table 2  
The value of individual variables, documented at presentation, to diagnose pulmonary 
tuberculosis in children  
 
 
Individual variables at presentation* 
 
Sensitivity 
 
 
Specificity 
 
 
PPV 
 
Cough >3weeks 
 
Cough >4weeks  
 
Chest pain 
 
Haemoptysis 
 
Respiratory distress 
 
Fever 
 
Night sweats 
 
Fatigue 
 
Weight loss subjective 
 
Weight loss objective 
 
TST positive 
 
Household contact 
 
86.8% 
 
68.0% 
 
5.6% 
 
3.0% 
 
9.1% 
 
41.6% 
 
47.7% 
 
81.7% 
 
67.5 
 
80.0% 
 
79.9% 
 
58.9% 
 
61.5% 
 
89.8% 
 
98.1% 
 
98.7% 
 
96.2% 
 
89.6% 
 
93.3% 
 
88.8% 
 
86.3% 
 
75.9% 
 
67.1% 
 
65.5% 
 
34.9% 
 
73.5% 
 
40.7% 
 
40.0% 
 
37.5% 
 
49.1% 
 
63.5% 
 
64.7% 
 
54.0% 
 
74.5% 
 
67.9% 
 
59.2% 
 
PPV - positive predictive value 
 
*Definition of individual variables 
Cough - persistent, non-remitting cough not responding to a course of oral anti-biotics 
Chest pain – chest pain reported by the child  
Haemoptysis – blood in the sputum (not haematemesis or a nose bleed) 
Respiratory distress – difficult breathing at rest, reported by the parent /caregiver 
Fever – fever reported by the parent /caregiver 
Night sweats – regular sweating that requires a dry set of nightclothes 
Fatigue - a perceived decrease in playfulness/activity since the onset of coughing, reported by 
the parent/caregiver.   
Weight loss subjective - perceived weight loss during the preceding 3 months, reported by the 
parent/caregiver.   
Weight loss objective - clear deviation from a previous growth trajectory and/or documented 
crossing of centile lines in the preceding 3 months, using accurate weight-for-age centiles,28 
in addition to the Road-to-Health growth chart   
TST positive – Tuberculin skin test size 10mm (or 5mm if HIV-infected) 
Household contact – Household exposure to an adult index case in the preceding 12 months 
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Table 3  
Comprehensive surveillance data, including all children treated for tuberculosis during 
the study period, irrespective of study inclusion  
 
Treated for tuberculosis Total 
Number (%) 
PTB 
diagnosis* 
Study 
inclusion 
CXR signs absent 
Exposure/infection 
Extra-thoracic TB 
 
CXR signs present 
Uncertain HA 
Certain HA 
Parenchymal consolidation and/or 
airway compression 
Disseminated (miliary) disease 
Adult-type disease 
 
Pleural effusion only (excluded from 
PTB outcome definition) 
 
Total 
 
84 (19.8) 
45 (10.6) 
 
 
69 (16.2) 
76 (1.2) 
107 (25.2) 
 
14 (3.0) 
14 (3.3) 
 
17 (4.0) 
 
 
425 (100) 
 
0 
0 
 
 
3 (1.4) 
76 (35.6) 
107 (50.0) 
 
14 (6.5) 
14 (6.5) 
 
0 
 
 
214 (100) 
 
4 (1.7) 
0 
 
 
27 (11.8) 
71 (31.0) 
104 (45.4) 
 
5 (2.2) 
14 (6.1) 
 
4 (1.8) 
 
 
229 (100) 
 
CXR – chest radiograph 
TB – tuberculosis 
CXR signs – signs suggestive of PTB on the chest radiograph 
HA – Hilar adenopathy 
*PTB diagnosis – pulmonary tuberculosis defined as a symptomatic child with; 1) 
“bacteriologically confirmed TB” (from a respiratory or gastric aspirate specimen), or 
2)“radiologically confirmed TB”, or 3) “probable TB” (as defined), excluding isolated pleural 
effusion.    
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Figure 1 
Flow diagram of all children evaluated 
 
 
 
 
 
 
 
 
      
 
        
 
 
         
        
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
TB – tuberculosis 
PTB – pulmonary tuberculosis defined as a symptomatic child with; 1) “bacteriologically 
confirmed TB” (from a respiratory or gastric aspirate specimen), or 2)“radiologically confirmed 
TB”, or 3) “probable TB” (as defined), excluding isolated pleural effusion.    
 
Children (<13 years) referred 
with a cough of >2 weeks 
duration 
1024
Resolving cough at 
evaluation 
596 
Persistent, non-remitting 
cough at evaluation 
Investigated for tuberculosis 
428Followed until 
symptom resolution 
Not PTB 
596 Treated for TB 223 
Cough persisted beyond  
4 weeks follow-up  
17 
Not treated for TB  
205 
Cough resolved before 
4 weeks follow-up 
Not PTB 
188 
Alternative diagnosis 
established  
Not PTB 
11
Treated for TB 
6 
PTB 
197 
“bacteriologic 
confirmed TB” 
96 
“radiologic certain TB” 
75 
“probable TB” 
26 
 
Not PTB 
32 
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Figure 2 
Title: Symptoms documented at presentation in HIV-uninfected children diagnosed with 
pulmonary tuberculosis  
 
Subscript: This graph illustrates the improved specificity achieved (moving closer to 0 on the 
x-axis), and the sensitivity sacrificed (moving away from 1 on the y-axis), by cumulatively 
combining the 3 optimal variables identified by multi-variate tree regression analysis; 1) 
persistent non-remitting cough of >2 weeks, which was the entry criterion used, 2) 
documented failure to thrive during the preceding 3 months, and 3) reported fatigue, to 
diagnose pulmonary tuberculosis in HIV-uninfected children.  The denominator used to 
calculate the sensitivity, included all children with pulmonary tuberculosis identified during 
comprehensive disease surveillance, irrespective of study inclusion.  
 
Figure 3 
Title: The value of persistent, non-remittent coughing at follow-up to diagnose pulmonary 
tuberculosis in HIV-uninfected children 
 
Subscript: This graph illustrates the improved specificity achieved (moving closer to 0 on the 
x-axis), by using the presence of a persistent, non-remitting cough at follow-up as an 
additional diagnostic criterion, to diagnose pulmonary tuberculosis in HIV-uninfected children.  
The denominator used to calculate the sensitivity, included all children with pulmonary 
tuberculosis identified during comprehensive disease surveillance, irrespective of study 
inclusion. For this analysis we accepted that coughing would have persisted in the absence of 
treatment in those children who were diagnosed with tuberculosis during the initial 
assessment, which explains why the sensitivity remained fixed.   
 
Figure 4 
Title: Symptoms documented at presentation in HIV-infected children diagnosed with 
pulmonary tuberculosis, and the value of persistent, non-remittent coughing at follow-up. 
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Subscript: This graph illustrates the improved specificity achieved (moving closer to 0 on the 
x-axis), and the sensitivity sacrificed (moving away from 1 on the y-axis), by cumulatively 
combining 3 variables; 1) persistent non-remitting cough of >2 weeks, which was the entry 
criterion used, 2) documented failure to thrive during the preceding 3 months, and 3) reported 
fatigue, to diagnose pulmonary tuberculosis in HIV-infected children.  The denominator used 
to calculate the sensitivity, included all children with pulmonary tuberculosis identified during 
comprehensive disease surveillance, irrespective of study inclusion.  In addition, it illustrates 
the improvement in specificity achieved by using the presence of a persistent, non-remitting 
cough at follow-up, 1) after 2 weeks, and 2) after 4 weeks, as an additional diagnostic 
criterion.   
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Chapter 6. 
Conclusion 
 
 
The aim of this dissertation was to address the dilemma of diagnosing childhood intra-thoracic 
tuberculosis, as the current diagnostic dilemma is one of the main reasons that limit the 
access of children from endemic areas to anti-tuberculosis treatment.    
 
We first clarified basic disease concepts by critically reviewing the pre-chemotherapy 
literature that described the natural history of disease.  Three central concepts were identified; 
1) the need for accurate case definitions, 2) the importance of risk stratification, and 3) the 
diverse spectrum of disease, which necessitates accurate disease classification.   
 
We then described the current situation regarding childhood tuberculosis in an endemic area.  
We documented the heavy burden of disease that children carry and the severe tuberculosis-
related morbidity that they suffer.  We demonstrated that the concepts identified from the pre-
chemotherapy literature apply to endemic areas today and documented a similar spectrum of 
disease.  In addition, we demonstrated that bacteriologic confirmation may be achieved in the 
majority of children with intra-thoracic tuberculosis, in highly endemic areas.   
 
Current screening and diagnostic practices depend almost exclusively on the interpretation of 
the chest radiograph, but radiography is rarely available in resource-limited settings.  We 
demonstrated that simplified symptom-based screening may be justified to improve access to 
preventive chemotherapy for children exposed to tuberculosis in resource-limited settings.  In 
addition, we developed a novel symptom-based approach to diagnose pulmonary 
tuberculosis in children and validated its diagnostic value in a large prospective, community-
based study. The use of this simple symptom-based diagnostic approach identified pulmonary 
tuberculosis with a remarkable degree of accuracy, particularly in HIV-uninfected children 3 
years of age.  In addition, we demonstrated that isolated pleural effusion, which was excluded 
from the pulmonary tuberculosis case definition used, had a typical clinical presentation, as 
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had tuberculous cervical lymphadenitis, which is the most common extra-thoracic 
manifestation of tuberculosis in children.     
 
Using a symptom-based approach to diagnose tuberculosis in children offers the exciting 
prospect of extending antituberculosis treatment to children in endemic areas with limited 
resources, where current treatment access is poor. It is time to introduce a spirit of optimism 
to the field of childhood tuberculosis.  Dedicated efforts are urgently needed to extend both 
preventive chemotherapy and antituberculosis treatment to children in endemic areas. 
 
The main challenge that remains is the accurate diagnosis of tuberculosis in HIV-infected 
children.  However, as in other high-risk groups, the emphasis in HIV-infected children should 
be on the provision of preventive chemotherapy.  In this regard, the improved sensitivity 
provided by T-cell based assays to diagnose latent tuberculosis infection may be useful, while 
it may also provide important supportive evidence to establish a diagnosis of active 
tuberculosis in HIV-infected children.   
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Chapter 7. 
The bigger picture 
 
For the purpose of this dissertation I have restricted my focus to address the dilemma of 
diagnosing tuberculosis in children.  Accurate diagnosis is important as the provision of 
effective antituberculosis treatment will drastically reduce the severe tuberculosis-related 
morbidity and mortality suffered by children in endemic areas.  However, accurate diagnosis 
and effective treatment will not achieve a permanent reduction in the burden of childhood 
tuberculosis, as this is mainly determined by the level of epidemic control achieved within a 
particular community.  We reviewed the main determinants of epidemic control and the 
burden of childhood tuberculosis.  However, our vision should extend beyond the reduction of 
tuberculosis, to the promotion of child health in the broadest sense of the word.  The final two 
letters reflect my personal view regarding our ultimate ethical obligation. 
  
1. Marais BJ, Obihara CC, Wareen RM, Schaaf HS, Gie RP, Donald PR. The burden 
of childhood tuberculosis – a public health perspective.  Int J Tuberc Lung Dis 
2005; 9: 1305-1313 
This review describes the main determinants of the burden of childhood tuberculosis within a 
particular community.  Basic infectious disease principles identify the community, and not the 
individual, as the central entity that sustains an epidemic.  The prevalence of tuberculosis is 
determined by both the community’s exposure to M. tuberculosis and their vulnerability to 
develop disease following exposure.  Current efforts to control the tuberculosis epidemic are 
mainly directed towards reducing community exposure by treating sputum smear-positive 
adults, while little emphasis is placed on reducing the vulnerability of the community.  
Successful control of the tuberculosis epidemic is the most effective way to reduce the burden 
of childhood tuberculosis.  This will require a holistic approach that acknowledges the 
importance of sustainable poverty alleviation.   
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2. Marais BJ. Judged by our legacy. Arch Dis Child 2004; 89: 796  
As paediatricians we need to provide an articulate voice for all the children of our planet.  This 
letter emphasizes the fact that while short-term goals are important, the true challenge facing 
our generation is to work towards improved health for all children, both for current and future 
generations. 
 
3. Marais BJ. Ethics: the third dimension. Arch Dis Child 2004, 89: 1077-1078   
Current ethical debate focuses on the delicate two-dimensional balance that should be 
maintained between the interests of the individual and that of the community.  This letter 
introduces the novel concept that our ethical responsibility has a neglected third dimension, 
which we cannot afford to ignore any longer.  It is not only the interests of the individual 
versus that of the community that requires a fair balance, but also the interests of future 
generations.  The third millennium demands a broadened ethical perspective, where 
established ethical principles are applied within the framework of a global community and a 
vulnerable planet.    
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The burden of childhood tuberculosis: 
a public health perspective
B. J. Marais,* C. C. Obihara,* R. M. Warren,† H. S. Schaaf,* R. P. Gie,* P. R. Donald*
* Center for TB Research and Education and the Department of Paediatrics and Child Health, Tygerberg Children’s 
Hospital and the Faculty of Health Sciences, Tygerberg, † Medical Research Council (MRC) Centre for Molecular and 
S U M M A R Y
Cellular Biology, Department of Medical Biochemistry, Stellenbosch University, Tygerberg, South Africa
The burden of childhood tuberculosis (TB) reflects re-
cent transmission within a community and the level of
TB control achieved within the adult (maintenance host)
population. Children contribute little to the mainte-
nance of the TB epidemic, but they may suffer severe
TB-related morbidity and mortality. This review de-
scribes the main determinants of the burden of child-
hood TB within a particular community.
Basic infectious disease principles identify the com-
munity, and not the individual, as the central entity that
sustains an epidemic. The prevalence of TB is deter-
mined by the community’s exposure to Mycobacterium
tuberculosis, and their vulnerability to developing dis-
ease following exposure. The main variables that influ-
ence both exposure and vulnerability are discussed.
Multiple variables are linked to poverty, and it is their
cumulative effect, rather than the exact degree of pov-
erty, that seems most important.
Diligent contact tracing and the use of preventive
chemotherapy will reduce the TB-related suffering of
children. The burden of childhood TB, however, is a re-
flection of our ability to control the epidemic; this re-
mains the ultimate challenge. Current efforts to control
the TB epidemic aim to reduce transmission by treating
sputum smear-positive adults, while very little emphasis
is placed on reducing the vulnerability of high-burden
communities. Successful control of the epidemic is the
most effective way to reduce the burden of childhood TB,
but this will require a holistic approach that acknowl-
edges the importance of sustainable poverty alleviation.
KEY WORDS: childhood tuberculosis; burden; preva-
lence; exposure; vulnerability
CHILDHOOD TUBERCULOSIS (TB) is difficult to
diagnose accurately, has a low public health priority
and its global epidemiology is consequently poorly
documented.1,2 The lack of public health priority re-
sults from the fact that the TB epidemic is maintained
by adults with cavitating pulmonary disease, while
children contribute little to disease transmission. How-
ever, cavitating disease becomes a prominent disease
manifestation in children aged over 10 years,3–5 and
these children do pose a high transmission risk.6
From an epidemiological perspective, children aged
over 10 may be viewed as part of the adult, mainte-
nance host population.
In essence, young children (10 years of age) who
tend to develop non-cavitating, paucibacillary disease,
act as a ‘spill-over’ host for Mycobacterium tuberculo-
sis and are an epidemiological dead-end for the organ-
ism.7 However, children do contribute significantly to
the TB caseload (up to 40%) in high-burden settings,8,9
and may suffer severe morbidity and mortality.3,10
One of the most striking and intriguing epidemio-
logical observations is the huge variation observed in
the prevalence of TB between different communities.11
Previous explanations and debate focused on the con-
tribution of genetic vs. socio-economic factors,12–14
while recent emphasis shifted to the profound influ-
ence of human immunodeficiency virus (HIV) infec-
tion.15–17 The difficulty with such a multifactorial
problem is that research tends to focus on a single as-
pect at a time, and while individual research reports
contribute valuable knowledge, they may also confuse
the priorities for public health intervention. Therefore,
it is essential to evaluate the public health relevance of
these findings within an objective scientific frame-
work, based on basic infectious disease principles.
The aim of this review is to provide a systematic
overview of current knowledge, within an objective
scientific framework, trying to explain differences in
the prevalence of TB, and by extrapolation, the bur-
den of childhood TB between particular communi-
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ties. An improved understanding of the disease dy-
namics at the community level may guide future
research and public health intervention.
Definition of terms
Maintenance host: the population that contributes to
disease transmission and maintains the epidemic.
‘Spill-over’ host: the population that, although
they may become ill, rarely contributes to disease
transmission.
Community exposure: the combined exposure of
all the individuals within a particular community.
Community vulnerability: the combined vulnera-
bility of all the individuals within a particular com-
munity to develop disease following M. tuberculosis
exposure.
BURDEN OF DISEASE
In the absence of preventive chemotherapy, the bur-
den of childhood TB is an accurate reflection of the
level of TB control achieved within a particular com-
munity, because TB in children results from recent
transmission. This is supported by several observa-
tions. The natural history of disease in children indi-
cates that more than 95% of children who develop
TB do so within 12 months after infection.3,18 The in-
cidence of childhood TB rises in tandem with adult
incidence when control of the epidemic is lost and the
geographical clustering of child and adult TB cases
overlap.19–21 In addition, the patterns of primary re-
sistance to anti-tuberculosis drugs are similar in recently
diagnosed adults and children, which indicates that
disease in children reflects recent transmission within
the community.22,23 Children will continue to suffer
from TB as long as adults do,7 and the huge burden of
childhood TB in developing countries alerts us to the
fact that the pandemic remains out of control.
It is possible to considerably reduce the number of
diseased children by diligent contact tracing and the
use of preventive chemotherapy. The dramatic effect
that may be achieved by the use of active case finding
and treatment together with prophylaxis and treat-
ment of latent infection was demonstrated in the Inuit
populations of Canada and Alaska during the early
1960s.24 The extreme isolation of these populations
enabled this pro-active approach to ‘stamp out’ active
disease and to eliminate all reservoirs of M. tuberculo-
sis at the same time. The situation is unfortunately far
more dynamic in today’s high-burden settings where
populations are highly mobile. Taking isoniazid
(INH) for 6–9 months eliminates two thirds of the TB
risk (with good adherence it may be as high as 90%)19
in exposed children, while a 3-month course of INH
and rifampicin (RMP) has also shown good efficacy.25
However, poor adherence is a major concern, and it is
not unusual for less than one third of participants to
complete the full course of unsupervised preventive
treatment.7 Active contact tracing and screening
places an excessive burden on the health care system,
and is a luxury that most high-burden countries sim-
ply cannot afford. In these settings, it seems appropri-
ate to focus scarce resources only on those children
who are at greatest risk of progression to disease fol-
lowing exposure.7 This risk is highest in very young
(3 years of age) and immune-compromised chil-
dren.3 Fifty per cent of infants and 20–30% of 1–2
year olds progress to disease, usually within 12
months after primary infection. It is prudent there-
fore to give preventive chemotherapy to all infected
or recently exposed children under 3 years of age
once active disease has been excluded. Immune-
compromised children share a similar high risk, irre-
spective of their age, and the same guideline should
apply.3 Immune-competent children older than 3
years of age are at a relatively low risk (less than 5%
progress to disease following primary infection),3 and
their need for preventive chemotherapy may be re-
assessed, especially in settings where health care ser-
vices are already overstretched.
BASIC PRINCIPLES
Conventional herd dynamics describe three factors
that determine the ability of an organism to multiply
and spread successfully within a community. These
include the intensity of exposure to the organism, the
virulence of the organism, and the vulnerability of
the community to develop disease that will sustain or-
ganism transmission following exposure. In this re-
spect, it is essential to view the community, and not
the individual, as the central entity.
Genetic variability provides for continuous adap-
tation by the pathogen to the challenges posed by its
environment. Different strains of M. tuberculosis
have emerged and differences in virulence between
strains are well documented.26,27 Strain-specific viru-
lence may be an important variable of disease preva-
lence in a particular community, but geographical iso-
lation has been greatly reduced by the mobility of
modern populations. This will encourage the most vir-
ulent strains, such as the modern lineage of the Beijing
strain, to spread globally over time.28,29 Because the
geographic localisation of virulent strains is transient,
differences in organism virulence are unlikely to ex-
plain persistent differences in disease prevalence be-
tween communities. This places the focus on the two
remaining factors, namely community exposure and
vulnerability (Figure).
Community exposure
Basic infectious disease principles indicate that the
combined exposure of the community is determined
by the number of individuals exposed and the inten-
sity of their exposure. The intensity of individual expo-
sure depends on the exposure duration and the num-
ber of infectious particles in the ambient air.30 Using
public health terminology, this implies that commu-
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nity exposure is determined by the number of infec-
tious cases, their degree and duration of infectious-
ness, their mobility within the community and the
degree of crowding.
Number of infectious cases
It is self-evident that the level of disease transmission
will depend on the number of infectious source cases
that spread the disease within a community. New source
cases may arise following exposure inside or outside
the community. In most low-burden countries, the ep-
idemic is sustained by the constant introduction of
new source cases, following exposure outside the
community. The introduction of new infectious cases
may also fuel the epidemic in high-burden settings.
The theoretical risk posed by those who are exposed
outside the community can be illustrated using pris-
ons as an example. The risk posed to the community
by individuals who are incarcerated is determined by
the intensity of their exposure inside the prison (the
main variables of exposure remain constant: the num-
ber of infectious cases, their degree and duration of
infectiousness, and the levels of crowding within the
prison),31,32 their vulnerability to developing infec-
tious disease and the frequency of their release back
into the community. Effective treatment before their
release from prison will eliminate the risk they pose,
but the concern is that most adult-type disease devel-
ops only 1–2 years (up to 5 years) after exposure, and
disease may not be present at initial screening.3,33
Short-term prisoners are most likely to develop dis-
ease only after release back into the community, and
therefore prisoners who cycle in and out of prisons with
a high prevalence of TB pose a considerable risk to the
community. These same principles apply to immigrant
populations, tourists and migrant workers who may in-
troduce M. tuberculosis into their community.29,34–36
Degree and duration of infectiousness
Early diagnosis and treatment interrupt disease progres-
sion and drastically reduce organism transmission.37,38
Early intervention is essential to limit the reproductive
rate of the organism.39 In the absence of early interven-
tion, transmission represents a self-replicating cycle,
and the reproductive rate of the organism will escalate
according to the favourability of the circumstances.
DELAYED DIAGNOSIS
Diagnostic delay increases both the degree and dura-
tion of infectiousness. Due to the magnitude of the TB
pandemic, current guidelines advocate passive case
finding. The success of passive case finding depends on
early symptomatic presentation, together with ade-
quate diagnostic vigilance and access to sensitive diag-
nostic tools at the point of presentation.40 Diagnostic
delay is greatly exacerbated by factors that reduce
health awareness and access to health care, such as
poverty and discrimination.41–43 There is also a need
for more sensitive diagnostic tools to detect early dis-
ease, as sputum smear microscopy only identifies ad-
vanced cavitating disease.
Although most transmission in high-burden settings
occurs outside the household,44,45 household exposure
to a sputum smear-positive source case represents an
opportunity for active intervention.46–48 Child contacts
aged 2–3 years or less and immune-compromised in-
dividuals are particularly vulnerable to developing
disease,3,49 and should receive chemoprophylaxis once
active TB has been excluded. Those aged over 10
years, with recent primary infection, are also at high
risk of developing disease (10–20% progress to adult-
type cavitating disease within 2 years after primary
infection),3,46 and it may be important to reconsider
the use of preventive chemotherapy in such chil-
dren.46,47 The problem is that they are difficult to
identify, especially in high-burden settings where many
children are already tuberculin skin test (TST) posi-
tive by the age of 10 years. A major shortcoming of
the TST is its inability to differentiate recent from
previous primary infection.
DELAYED TREATMENT
Shortening the duration of infectiousness will reduce the
exposure of the community and the reproductive rate of
the organism. To achieve this requires not only limiting
the diagnostic delay, but also ensuring that effective
treatment is instituted as quickly as possible following
diagnosis. Treatment may be ineffective due to inappro-
priate drug regimens, poor drug quality, poor adherence
or drug resistance, but with proper implementation the
current DOTS and DOTS expansion strategies ade-
quately address most of these treatment-related issues.50
Crowding
The degree of crowding and the mobility of source
cases within the community influence both the number
of individuals exposed and the intensity of their expo-
sure. The transmission of M. tuberculosis is strongly
Figure The main variables that contribute to the prevalence of
TB in adults and by extrapolation the burden of childhood TB.
TB  tuberculosis; HIV  human immunodeficiency virus.
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associated with the degree of crowding.51,52 Crowd-
ing is relevant in all congregate settings, including pri-
vate homes, public transport systems, institutions
such as prisons or health care facilities, and places of
socialisation. The worst crowding occurs in urban
and peri-urban slum areas, due to rapid urbanisation
and overpopulation.53 Paradoxically, crowding may
be enhanced within formal housing structures that
provide effective protection against the elements, en-
couraging dense congregation. Transmission is fur-
ther facilitated by poor ventilation.54–55 The seasonal
variation observed in the frequency of childhood TB
cases may illustrate increased transmission during peri-
ods of confinement in poorly ventilated, overcrowded
conditions, enforced by harsh weather conditions.56,57
Community vulnerability
Herd immunity, the ability of a particular community
to resist the spread of an infectious organism, forms a
crucial element of infectious disease control and erad-
ication. Although often restricted to acquired immu-
nity within the immunisation context, this concept
may be applied to any communicable disease. Com-
munity vulnerability is a more inclusive term, which
reflects the combined resistance offered by the full
spectrum of defence mechanisms that may limit dis-
ease spread within a particular community. In the im-
munisation model, effective disease containment is
achieved by creating a high level of herd immunity
within a naturally vulnerable population, using im-
mune stimulation (vaccination). However, the level of
natural resistance (without immune stimulation from
vaccination or natural mycobacterial infection) of-
fered by immune-competent individuals to M. tuber-
culosis is high, and the vast majority (90%) of
persons infected with the bacillus will never develop
any clinical illness.58 This high level of natural resis-
tance against M. tuberculosis implies that a high de-
gree of ‘natural herd immunity’ pre-exists in immune-
competent communities. It is therefore reasonable to
expect that the level of community vulnerability may
be affected as much, or even more, by factors that
compromise this high level of natural resistance as by
those that aim to enhance it.
Immune compromise
The analogy of acquired herd immunity illustrates
that a relatively small reduction in ‘natural herd im-
munity’ may cause a considerable increase in the vul-
nerability of a particular community to sustain the TB
epidemic. On a public health scale, the biggest influ-
ence may be exerted by the cumulative effect of minor
factors that affect large numbers of people within the
community, even though their individual effect is small.
NUTRITION
Both macro- and micro-nutrient deficiency may reduce
cellular immunity and the natural resistance against
TB.59–62 The effect of malnutrition is best quantified
for severe protein-calorie deficiency,62,63 while evidence
for moderate nutrient deficiencies often lacks scientific
rigour. However, the large numbers of people who are
affected by moderate degrees of malnutrition64 proba-
bly contribute more to the overall vulnerability of a
particular community than the few who suffer from
severe malnutrition.62 In this regard, the combined ef-
fects of malnutrition and alcohol (or other drug)
abuse may be especially relevant in poverty stricken
areas where large numbers of people are dually af-
fected. Alcohol abuse does damage the immune sys-
tem and seems to increase the vulnerability to develop
TB,65 but it is difficult to separate its independent ef-
fect due to the multiple comorbidities and increased
exposure within the social context. People with drug
and/or alcohol problems frequently congregate and
their exposure is increased by prolonged diagnostic
delay and poor compliance with therapy among their
companions.66
HIV
HIV infection has a devastating effect on the immune
system,67 which explains the increased incidence of
TB amongst HIV-infected individuals.15–17 Rapid dis-
ease progression in severely immune-compromised in-
dividuals may reduce their duration of infectiousness
and their contribution to transmission, as suggested
by reports that TB incidence rates amongst non-HIV-
infected adults remain stable in HIV-affected areas.68
However, the widespread use of antiretroviral ther-
apy in high-burden settings may increase the number
of people in the community who are mildly immune-
compromised, thereby increasing transmission and
the incidence of TB at the community level.69 Chil-
dren from HIV-affected households may be particu-
larly vulnerable, because TB cases tend to cluster
within these households, and they may be immune-
compromised themselves.
HOST GENETICS
The influence that infectious diseases exert on popu-
lation genetics is well documented for many diseases,
such as malaria and leprosy.70,71 However, in TB it re-
mains extremely difficult to differentiate between the
impact of genetic and environmental influences. The
fact that individual vulnerability is partly influenced
by genetic variability is illustrated by adult adoptee
studies,72–74 and by the vulnerability of individuals
with mutations or specific polymorphisms of the
interferon-gamma (IFN-) receptor gene.75,76 Host
genetics certainly play an important role at the indi-
vidual level, but the majority of genetic influences re-
sult from the complex interaction of multiple genes,72–74
and their effect on vulnerability at the population
level remains uncertain. The fact that TB incidence
rates have plummeted wherever social upliftment suc-
ceeded argues strongly for the overriding influence of
150
Stellenbosch University  http://scholar.sun.ac.za 
Applying basic infectious disease principles 1309
the environment in the nurture vs. nature debate. This
is best illustrated in the African-American popula-
tion, where TB was nearly eliminated within a single
generation (same gene pool) after their standard of
living improved dramatically.77 If genetic susceptibility
is an important variable at the individual level, it im-
plies that successful treatment will return these sus-
ceptible individuals to the community. This is of par-
ticular relevance in high-burden settings where the
risk of future re-infection is high, and it is demon-
strated by the fact that the rate of re-infection TB is
higher in successfully treated individuals than the rate
of new TB in individuals without previous TB.78
AGE 
Both the innate and acquired immune response show
prominent age-related variation. Young children under
2–3 years of age in whom the immune system is still
immature are highly susceptible to developing disease
following primary M. tuberculosis infection.3 At the
other end of the age spectrum, elderly people are
often considered at high risk for reactivation disease,
because they are over represented among cases in in-
dustrialised countries with a historic high prevalence
of TB.79,80 However, it is extremely difficult to dem-
onstrate the contribution of old age, independent
from the cohort effect, in such a setting. The ontog-
eny of the immune response is an important variable,
as demonstrated by the fact that adult-type cavitating
disease, which is responsible for continued disease
transmission within the community, only emerges
after 8–10 years of age.
STRESS
Stress has deleterious effects on the immune system,
but the causal link between stress, immune function
and TB requires further clarification.81 The existence
of a psychoneuro-immunological network is well de-
scribed, and although it is still poorly understood, it
represents a possible mechanism for increased com-
munity vulnerability.82 The fact that TB incidence
rates increase during times of war may be attributed to
a combination of malnutrition, overcrowding, disrup-
tion of medical services and increased levels of stress.83
Many other factors may cause immune compro-
mise, but these affect few individuals and will not in-
fluence the disease prevalence at a population level.
These factors, which include rare immunodeficiency
syndromes and iatrogenic immune deficiency caused
by corticosteroid treatment or cancer chemotherapy,
remain very important from an individual perspective.
Immune stimulation
Immune stimulation in the form of vaccination has
practically eradicated some of the world’s most dev-
astating infectious diseases. However, compared to
these highly virulent diseases, M. tuberculosis is a
rather innocuous organism to which the vast majority
of immune-competent people exhibit a high level of
natural resistance.
The effect of immune stimulation in the form of
bacille Calmette-Guérin (BCG) vaccination has shown
variable protection in different settings. This may be
due to variations in strain-specific immunogenicity,
timing or technique of vaccine administration, genetic
factors and the presence or absence of environmental
mycobacteria.84,85 Neonatal BCG vaccination pro-
tects mainly against disseminated forms of TB during
early childhood and confers no protection against
adult-type TB.84,85 BCG vaccination may offer im-
proved protection against adult-type TB when ad-
ministered to older children/adolescents who are
TST-negative in locations with a low prevalence of
environmental mycobacteria.86–88 In the presence
of exposure to environmental mycobacteria, the ad-
ditional protection provided by BCG is negligible,89
but without environmental mycobacterial exposure
the protection provided by BCG vaccination seems to
be of the same order (around 60%) as that afforded
by previous natural infection that failed to progress to
disease.90 The possible deleterious effect of repeated
exposure and multiple re-infections, as may occur in
high-burden settings, requires further elucidation.91,92
Novel vaccines are currently under development to
try and improve the degree of protection provided by
immune stimulation.93 The provision of additional
protection would be of particular value in high-burden
settings, where exposure is nearly universal.
Local defences
Compromised local defences may contribute to the vul-
nerability of particular communities. Poor organism
clearance, decreased mucosal immunity and a favour-
able micro-environment at the point of organism depo-
sition may increase the risk of pulmonary infection and
disease.94 This is demonstrated by the comorbidity that
exists between pulmonary silicosis and TB,95 and by the
increase in M. tuberculosis infection, subsequent dis-
ease and ultimate death from TB associated with ciga-
rette smoking.96–98 Passive smoking is also associated
with a greatly increased risk (odds ratio 5.29, 95% con-
fidence interval [CI] 2.33–12.82) in children to develop
TB following recent infection.99 The cumulative effect
of smoking, environmental airborne pollutants, recur-
rent chest infections and previous TB all contribute to
the total burden of lung disease within a community,
which may be an important variable that contributes to
the vulnerability of a particular community.
CONCLUSION
Although children rarely contribute to the mainte-
nance of the TB epidemic, they do suffer severe
morbidity and mortality. Their suffering can be
greatly reduced by diligent contact tracing and pre-
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ventive chemotherapy. In resource-limited settings,
it may be necessary to target high-risk groups (chil-
dren 3 years of age and immune-compromised in-
dividuals exposed to a sputum smear-positive house-
hold source case) for preventive chemotherapy. The
accurate diagnosis of TB in children remains a ma-
jor obstacle, and the development of new diagnos-
tic tools is anxiously awaited. However, the burden
of childhood TB results from recent transmission,
and in the absence of preventive chemotherapy it
represents a barometer of TB control within a par-
ticular community.
Basic infectious disease principles identify the ex-
posure and the vulnerability of the community as the
main determinants of TB prevalence. Multiple fac-
tors affecting both community exposure and vulner-
ability are linked to poverty, which explains why, on
a global scale, TB reflects the plight of poverty
stricken populations. It is the cumulative effect of
these factors, rather than the exact degree of poverty,
that seems most important. Exposure is increased by
the large number of infectious cases and their pro-
longed duration of infectiousness due to poor health
education, inaccessible health care, co-morbidity
and the all-absorbing daily struggle for survival. Ex-
posure is further enhanced within overcrowded,
poorly ventilated living conditions that children
share with adults. Poverty also increases the vulner-
ability of a community, due to the cumulative effect
of factors such as malnutrition, substance abuse,
stress and the total burden of lung disease, while the
triangular shape of the population pyramid reflects
the large number of very young and vulnerable chil-
dren. Like TB, poverty represents a self-replicating
cycle that requires active intervention. As stated by
J Kevany, ‘the world’s biggest killer and the greatest
cause of ill health and suffering across the globe is
listed almost at the end of the International Classi-
fication of Diseases. It is given the code Z59.5—
Extreme poverty.’100
The current DOTS and DOTS expansion pro-
grammes are aimed at reducing community expo-
sure to M. tuberculosis, but it seems as important
to reduce the vulnerability of communities if we
aim to control the TB pandemic. Basic infectious
disease principles emphasise the need to break the
cycle of poverty in high-burden settings and to
achieve sustainable social upliftment. The fight
against TB serves as a prime example of the inter-
dependence of the millennium development goals
and the need for global political commitment to
achieve these goals.
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R É S U M É
Le fardeau de la tuberculose (TB) infantile est le reflet
d’une transmission récente au sein d’une collectivité et
du niveau de contrôle de la TB obtenu au sein de la popu-
lation adulte (hôtes de persistance). Les enfants contri-
buent peu à la persistance de l’épidémie de TB mais peu-
vent souffrir d’une morbidité et d’une mortalité sévères
liées à la TB. Cette revue générale décrit les déterminants
principaux du fardeau de la TB infantile au sein d’une
collectivité particulière.
Les principes de base en matière de maladies infec-
tieuses identifient la collectivité et non l’individu comme
étant l’entité centrale de persistance d’une épidémie. La
prévalence de la TB est déterminée par l’exposition à
Mycobacterium tuberculosis dans la collectivité et par la
sensibilité de cette dernière au développement d’une
maladie à la suite de cette exposition. Les variables prin-
cipales influençant à la fois l’exposition et la vulnérabi-
lité ont été discutées. De multiples variables sont liées à
la pauvreté, et c’est leur effet cumulatif plutôt que le de-
gré exact de pauvreté qui semble le plus important.
Un dépistage attentif des contacts et l’utilisation de la
chimiothérapie préventive permettront de réduire les at-
teintes d’enfants liées à la TB. Le fardeau de la TB infan-
tile est toutefois un reflet de notre capacité de contrôler
l’épidémie ; celle-ci reste le défi final. Les efforts actuels
pour lutter contre l’épidémie de TB visent à réduire la
transmission en traitant les adultes à bacilloscopie posi-
tive alors que l’on attribue peu d’importance à la dimi-
nution de la vulnérabilité des collectivités à haute préva-
lence. Un contrôle couronné de succès de l’épidémie est
la manière la plus efficiente de réduire le fardeau de la
TB infantile, mais ceci exigera une approche holistique
prenant en compte l’importance d’une réduction persis-
tante de la pauvreté.
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R E S U M E N
La carga de morbilidad por tuberculosis (TB) infantil re-
fleja la transmisión reciente dentro de una comunidad y
también el grado de control de la TB alcanzado dentro
de la población adulta (huéspedes de mantenimiento de
la epidemia). Los niños contribuyen en poca medida al
mantenimiento de la epidemia de TB, pero pueden pade-
cer en forma considerable la mortalidad y morbilidad
causadas por la TB. En el presente análisis se describen
los principales determinantes de la carga de morbilidad
por TB infantil dentro de una comunidad particular.
Los principios fundamentales de las enfermedades in-
fecciosas designan la comunidad, y no el individuo, como
la entidad central que sostiene la epidemia. La prevalencia
de TB está determinada por la exposición de la comu-
nidad a Mycobacterium tuberculosis y la vulnerabilidad
de la misma a la aparición de enfermedad tras la ex-
posición. Se analizan aquí los principales factores que in-
fluyen en la exposición y la vulnerabilidad. Entre ellos,
los factores relacionados con la pobreza son múltiples y
parecen más importantes sus efectos acumulados que el
grado exacto de la pobreza.
El seguimiento cuidadoso de los contactos y el uso de
la quimioprofilaxis reducirá el padecimiento de los niños
por causa de la TB. Sin embargo, la carga de morbilidad
por TB infantil refleja la capacidad del sistema para lu-
char contra la epidemia de TB, y esta sigue siendo la
esencia del desafío. Las iniciativas actuales para contro-
lar la TB tienen como objetivo reducir la transmisión
mediante el tratamiento de los adultos con baciloscopia
positiva, y hacen poco hincapié en la reducción de la vul-
nerabilidad de las comunidades con alta carga de morbi-
lidad. El control exitoso de la epidemia constituye el me-
dio más eficaz para reducir la carga de morbilidad por TB
infantil, pero exigirá un enfoque integral que reconozca la
importancia de un alivio sostenible de la pobreza.
155
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Current global health strategies focus on important issues in child health, such as the 
eradication of polio by 2005 and the drastic reduction of child mortality by the year 2010.  
These short-term goals are essential to provide the necessary political focus and public health 
impetus.  However, the ultimate success of our current health initiatives will be measured by 
its ability to provide sustained health to present and future generations.   
 
At the beginning of the third millennium we celebrated the tremendous strides that health care 
has taken in the past century, while rightfully reflecting on current global inequities in access 
to health care.  Reflection also emphasizes the unequaled human impact exerted on our 
planet in the 20th century and the environmental responsibility that faces health care providers 
in the 21st century. 
 
As paediatricians we need to provide an articulate voice for all the children of our planet, both 
for current and future generations.  Current initiatives stir more emotion and elicit more 
political commitment, but protecting the health of future generations is as much our ethical 
responsibility, as the reduction of present mortality.  Short-term goals are important, but we 
have to redefine what is meant by the attainment of child health for all, within the framework 
of sustainability.  The real challenge facing our generation is to improve child health for all, 
now and in the future.  
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Ethics – the third dimension 
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In essence, ethics provide the guidelines for civilized human interaction. It is an evolving 
concept, but through the ages some accepted ethical principles crystallized.  The first crude 
definition focused on the individual’s responsibility towards his community, prioritizing the 
interests of the community.  However, the events preceding the French revolution and the 
brutality of the two world wars emphasized the need to protect individuals and minority groups 
against abuses of power.  The ethical focus shifted from individual responsibility towards the 
protection of individual human rights.  With the swing of the pendulum, individual rights were 
often protected to the detriment of the larger community.  
 
In medicine the same shift in emphasis forced the current ethical debate on the delicate 
balance between the interests of the individual and that of the community, especially in 
resource limited settings.  The reality of the third millennium is that all the world’s inhabitants 
are essentially part of the same global community. The two-dimensional balance between the 
individual and the community need to reflect this global ethical responsibility.   
 
The third millennium also confronts us with the neglected third dimension of our ethical 
responsibility.  It is not only the interests of the individual versus that of the community that 
require a fair balance, but also the interests of future generations.  No previous generation 
has been confronted with the importance of this third ethical dimension, as we have.  
Although current decisions may impact dramatically on the health of future generations, this 
has not entered into popular medical conscience or current ethical debate.  As medical 
doctors the health of future generations is as much our ethical responsibility as the health of 
our individual patients or our immediate community.  
 
Environmental issues are rarely viewed as medically relevant, but can the medical profession 
accept this status quo, when the health of future generations is at stake?  The third 
millennium demands a broadened ethical perspective, where established ethical principles 
are applied, but within the setting of a global community and a vulnerable planet.  
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